| 1 | ( L ) ASCORBATO DI CALCIO | - | - | - | - | [2] 96 96, 97 💬
|
| 2 | (-)-3-(4-Aminophenyl)-2-methoxypropionic acid | - | - | - | - | [1] 97 97 💬
|
| 3 | (R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid | - | - | - | - | [1] 97 97 💬
|
| 4 | (S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid | - | - | - | - | [1] 97 97 💬
|
| 5 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride | - | - | - | - | [1] 97 97 💬
|
| 6 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben | - | - | - | - | [1] 97 97 💬
|
| 7 | (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride | - | - | - | - | [1] 97 97 💬
|
| 8 | * D.3.4 Solution for infusion in pre-filled syringe | - | - | - | - | [1] 97 97 💬
|
| 9 | * D.3.4 Solution for injection in pre-filled syringe | - | - | - | - | [1] 97 97 💬
|
| 10 | * D.3.4 Solution for injection/infusion in pre-filled syringe | - | - | - | - | [1] 97 97 💬
|
| 11 | -aminosalicylic acid | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [2] 96 96, 97 💬
|
| 12 | 0 g/d CICR-NAM (blinded) | - | - | - | - | [1] 97 97 💬
|
| 13 | 0.03% using a foot pump | - | - | - | - | [1] 97 97 💬
|
| 14 | 0.25 mg RPC103 | - | - | - | - | [1] 97 97 💬
|
| 15 | 0.25 mg RPC1063 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 16 | 0.25mg RPC103 | - | - | - | - | [1] 97 97 💬
|
| 17 | 0.25mg RPC1063 | - | - | - | - | [2] 13 13, 97 💬
|
| 18 | 0.5 mg RPC1063 | - | - | - | - | [2] 13 13, 97 💬
|
| 19 | 1 mg RPC1063 | - | - | - | - | [2] 13 13, 97 💬
|
| 20 | 1 Serving of broccoli sprouts | [1] Broccoli Broccoli | - | - | - | [1] 97 97 💬
|
| 21 | 1.0 mg RPC103 | - | - | - | - | [1] 97 97 💬
|
| 22 | 1.0 mg RPC1063 | - | - | - | - | [1] 97 97 💬
|
| 23 | 1.Remicade | - | - | - | - | [1] 97 97 💬
|
| 24 | 10 mg Natura-alpha capsule | - | - | - | - | [1] 97 97 💬
|
| 25 | 100 | - | - | - | - | [2] 6 6, 97 💬
|
| 26 | 100 mg | - | - | - | - | [1] 97 97 💬
|
| 27 | 100% Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [6] 13 13, 15, 36, 96, 97, 269 💬
|
| 28 | 13-valent pneumococcal conjugated vaccine (PCV13) | - | - | - | - | [2] 96 96, 97 💬
|
| 29 | 1500mg mesalazine pellets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 30 | 15N2-tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 31 | 1: filgotinib 2: ustekinumab 3: vedolizumab 4: infliximab) | [4] Filgotinib Filgotinib, Infliximab, Ustekinumab, Vedolizumab | [5] Infliximab
Infliximab
,
Vedolizumab
,
Ustekinumab
,
Filgotinib
,
Filgotinib maleate
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 32 | 1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab | [4] Filgotinib Filgotinib, Infliximab, Ustekinumab, Vedolizumab | [5] Infliximab
Infliximab
,
Vedolizumab
,
Ustekinumab
,
Filgotinib
,
Filgotinib maleate
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 33 | 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib | [4] Filgotinib Filgotinib, Infliximab, Ustekinumab, Vedolizumab | [5] Infliximab
Infliximab
,
Vedolizumab
,
Ustekinumab
,
Filgotinib
,
Filgotinib maleate
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 34 | 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab | [4] Filgotinib Filgotinib, Infliximab, Ustekinumab, Vedolizumab | [5] Infliximab
Infliximab
,
Vedolizumab
,
Ustekinumab
,
Filgotinib
,
Filgotinib maleate
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 35 | 2 x 10 mg Natura-alpha capsules | - | - | - | - | [1] 97 97 💬
|
| 36 | 2'-Fucosyllactose | - | - | - | - | [2] 96 96, 97 💬
|
| 37 | 20 mg | - | - | - | - | [1] 97 97 💬
|
| 38 | 225mg SHP647 (PF-00547659) | - | - | - | - | [1] 97 97 💬
|
| 39 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | [2] 96 96, 97 💬
|
| 40 | 24mg bid TQH3906 capsule | - | - | - | - | [2] 96 96, 97 💬
|
| 41 | 25 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 42 | 250mg mesalazine pellets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 43 | 25mg adalimumab-680LT and 15/25 mg risankizumab-800CW | [2] Adalimumab Adalimumab, Risankizumab | [2] Adalimumab
Adalimumab
,
Risankizumab
💬
| [2] IL23A IL23A, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 44 | 2L polyethylene glycol/ascorbic acid | [2] Ascorbic acid Ascorbic acid, Polyethylene glycol | [4] Ascorbic acid
Ascorbic acid
,
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 97 97 💬
|
| 45 | 3 bottles of Lactulose oral solution | [1] Lactulose Lactulose | [1] Lactulose
Lactulose
💬
| - | - | [1] 97 97 💬
|
| 46 | 3 Servings of broccoli sprouts | [1] Broccoli Broccoli | - | - | - | [1] 97 97 💬
|
| 47 | 3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III) | - | - | - | - | [2] 96 96, 97 💬
|
| 48 | 32mg TQH3906 capsule | - | - | - | - | [2] 96 96, 97 💬
|
| 49 | 331731-18-1 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 50 | 39560 | - | - | - | - | [2] 96 96, 97 💬
|
| 51 | 3L-polyethylene glycol | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 97 97 💬
|
| 52 | 40 mg MSB11022 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 53 | 42942019 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 54 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | [1] 97 97 💬
|
| 55 | 5-amino salicylic acid | [1] Salicylic acid Salicylic acid | [4] Salicylic acid
Salicylic acid
,
Sodium salicylate
,
Choline magnesium trisalicylate
,
Diethylamine salicylate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 97 97 💬
|
| 56 | 5-amino salicylic acid (5-ASA) | [2] Mesalazine Mesalazine, Salicylic acid | [5] Salicylic acid
Salicylic acid
,
Mesalamine
,
Sodium salicylate
,
Choline magnesium trisalicylate
,
Diethylamine salicylate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 97 97 💬
|
| 57 | 5-amino-2-hydroxybenzoic acid | - | - | - | - | [1] 97 97 💬
|
| 58 | 5-Aminosalicyclic acid | - | - | - | - | [1] 97 97 💬
|
| 59 | 5-aminosalicylate (Pentasa, Ferring) | - | - | - | - | [2] 96 96, 97 💬
|
| 60 | 5-Aminosalicylic acid | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | [2] 96 96, 97 💬
|
| 61 | 5-Aminosalicylic acid (5-ASA) | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 62 | 5-Aminosalicylic acid(5-ASA) and/or Prednisone | [2] Aminosalicylic acid Aminosalicylic acid, Prednisone | [2] Aminosalicylic acid
Aminosalicylic acid
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 63 | 5-ASA | - | - | - | - | [1] 97 97 💬
|
| 64 | 5-ASA (5-Aminosalicylate) | - | - | - | - | [1] 97 97 💬
|
| 65 | 5-ASA MMx | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 66 | 5-HTP | - | - | - | - | [2] 96 96, 97 💬
|
| 67 | 50 mg | - | - | - | - | [1] 97 97 💬
|
| 68 | 500mg mesalazine pellets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 69 | 549-0261/F02-01 | - | - | - | - | [2] 96 96, 97 💬
|
| 70 | 6 Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 71 | 6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid | - | - | - | - | [1] 97 97 💬
|
| 72 | 6-Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [3] 96 96, 97, 164 💬
|
| 73 | 627 | - | - | - | - | [1] 97 97 💬
|
| 74 | 68125 | - | - | - | - | [2] 96 96, 97 💬
|
| 75 | 68Ga-FAPI | - | - | - | - | [4] 46 46, 53, 97, 300 💬
|
| 76 | 75 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 77 | 750mg mesalazine pellets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 78 | 75mg SHP647 (PF-00547659) | - | - | - | - | [1] 97 97 💬
|
| 79 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator | [3] Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 80 | 90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure | - | - | - | - | [1] 97 97 💬
|
| 81 | [124I]IB PF 06687234 | - | - | - | - | [2] 96 96, 97 💬
|
| 82 | [14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 83 | [18F]FSPG | - | - | - | - | [2] 96 96, 97 💬
|
| 84 | [90 mg idrocortisone acetato in supposta con appli | - | - | - | - | [1] 97 97 💬
|
| 85 | [ABBV-006] | - | - | - | - | [1] 97 97 💬
|
| 86 | [ABBV-066] | - | - | - | - | [2] 96 96, 97 💬
|
| 87 | [ABBV-323] | - | - | - | - | [1] 97 97 💬
|
| 88 | [ABT-494] | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 89 | [ABX464] | - | - | - | - | [1] 97 97 💬
|
| 90 | [AMG 592] | - | - | - | - | [2] 49 49, 97 💬
|
| 91 | [AMT-101] | [1] AMT-101 AMT-101 | - | - | - | [1] 97 97 💬
|
| 92 | [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2] 96 96, 97 💬
|
| 93 | [APD334] | - | - | - | - | [2] 96 96, 97 💬
|
| 94 | [BI 655130] | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 95 | [BMS-986165] | - | - | - | - | [2] 96 96, 97 💬
|
| 96 | [CC-10004] | - | - | - | - | [1] 97 97 💬
|
| 97 | [CNTO1275] | - | - | - | - | [2] 96 96, 97 💬
|
| 98 | [CNTO148] | - | - | - | - | [2] 96 96, 97 💬
|
| 99 | [CNTO1959] | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 100 | [CNTO312] | - | - | - | - | [1] 97 97 💬
|
| 101 | [CP-690, 550-10] | - | - | - | - | [2] 97 97, 107 💬
|
| 102 | [CT-P13] | - | - | - | - | [2] 96 96, 97 💬
|
| 103 | [FP-CYA-050] | - | - | - | - | [1] 97 97 💬
|
| 104 | [FP-CYA-053] | - | - | - | - | [1] 97 97 💬
|
| 105 | [GLPG0634] | - | - | - | - | [1] 97 97 💬
|
| 106 | [GS-4875] | - | - | - | - | [1] 97 97 💬
|
| 107 | [GS-6034] | - | - | - | - | [2] 96 96, 97 💬
|
| 108 | [LEVOVANOX] | - | - | - | - | [2] 94 94, 97 💬
|
| 109 | [LY3074828] | - | - | - | - | [2] 96 96, 97 💬
|
| 110 | [MEDI2070] | - | - | - | - | [2] 96 96, 97 💬
|
| 111 | [MT-1303] | - | - | - | - | [1] 97 97 💬
|
| 112 | [N.A.] | - | - | - | - | [1] 97 97 💬
|
| 113 | [n.d.] | - | - | - | - | [1] 97 97 💬
|
| 114 | [N/A] | - | - | - | - | [11] 2 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
|
| 115 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 116 | [PF-06480605] | - | - | - | - | [1] 97 97 💬
|
| 117 | [PF-06651600 10 mg] | - | - | - | - | [1] 97 97 💬
|
| 118 | [PF-06651600 50 mg] | - | - | - | - | [2] 96 96, 97 💬
|
| 119 | [PF-06687234] | - | - | - | - | [1] 97 97 💬
|
| 120 | [PF-06700841 25 mg] | - | - | - | - | [2] 96 96, 97 💬
|
| 121 | [PF-06700841 5 mg] | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 122 | [PN-943] | - | - | - | - | [1] 97 97 💬
|
| 123 | [PRA023] | - | - | - | - | [2] 51 51, 97 💬
|
| 124 | [Remsima (CT-P13)] | - | - | - | - | [1] 97 97 💬
|
| 125 | [RO7246311] | - | - | - | - | [1] 97 97 💬
|
| 126 | [SHP647] | - | - | - | - | [2] 96 96, 97 💬
|
| 127 | [STELARA] | - | - | - | - | [1] 97 97 💬
|
| 128 | [TD-1473] | - | - | - | - | [1] 97 97 💬
|
| 129 | [TEV-48574] | - | - | - | - | [2] 96 96, 97 💬
|
| 130 | [TOFACINITIB] | - | - | - | - | [1] 97 97 💬
|
| 131 | [UTTR1147A/RO7021610 (Active)] | - | - | - | - | [1] 97 97 💬
|
| 132 | [VTX002] | - | - | - | - | [1] 97 97 💬
|
| 133 | [VXT002] | - | - | - | - | [1] 97 97 💬
|
| 134 | A multistrain probiotic product (DSF) | - | - | - | - | [1] 97 97 💬
|
| 135 | A07DA03 | - | - | - | - | [1] 97 97 💬
|
| 136 | A: 1 dosis | - | - | - | - | [1] 97 97 💬
|
| 137 | AB (antibiotics) | - | - | - | - | [1] 97 97 💬
|
| 138 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 139 | Abatacept (ABA) | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 97 97 💬
|
| 140 | ABBV-006 | - | - | - | - | [1] 97 97 💬
|
| 141 | ABBV-066 | - | - | - | - | [2] 96 96, 97 💬
|
| 142 | ABBV-323 | - | - | - | - | [2] 53 53, 97 💬
|
| 143 | ABBV-323 Dose A | - | - | - | - | [1] 97 97 💬
|
| 144 | ABBV-323 Dose B | - | - | - | - | [1] 97 97 💬
|
| 145 | ABBV-668 | - | - | - | - | [1] 97 97 💬
|
| 146 | ABI-M201 | - | - | - | - | [1] 97 97 💬
|
| 147 | Abrilumab | [1] Abrilumab Abrilumab | [1] Abrilumab
Abrilumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 148 | ABT-494 | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 149 | ABT-Humira | - | - | - | - | [2] 46 46, 97 💬
|
| 150 | ABX464 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 151 | ABX464 100mg | - | - | - | - | [2] 46 46, 97 💬
|
| 152 | ABX464 25mg | - | - | - | - | [1] 97 97 💬
|
| 153 | ABX464 50mg | - | - | - | - | [2] 46 46, 97 💬
|
| 154 | AC-101 | - | - | - | - | [1] 97 97 💬
|
| 155 | Acacia | [1] Acacia Acacia | [1] Acacia
Acacia
💬
| - | - | [1] 97 97 💬
|
| 156 | Acacia Gum | [1] Acacia Acacia | [1] Acacia
Acacia
💬
| - | - | [1] 97 97 💬
|
| 157 | Accelerated 1 hour-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 158 | Accelerated 30 minutes-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 159 | Accelerated HBV Vaccine | - | - | - | - | [1] 97 97 💬
|
| 160 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 161 | ACETATO DI AMMONIO | - | - | - | - | [1] 97 97 💬
|
| 162 | Acetic acid | [1] Acetic acid Acetic acid | [1] Acetic acid, glacial
Acetic acid, glacial
💬
| - | - | [3] 21 21, 97, 296 💬
|
| 163 | Acetylcarnitine | [1] Acetylcarnitine Acetylcarnitine | - | - | - | [3] 2 2, 97, 265 💬
|
| 164 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 165 | Aclasta | - | - | - | - | [4] 13 13, 97, 271, 274 💬
|
| 166 | Actavis FERROUS SULPHATE TABLETS BP 200mg | - | - | - | - | [1] 97 97 💬
|
| 167 | Actonel Once a Week 35mg | - | - | - | - | [1] 97 97 💬
|
| 168 | Acupuncture | - | - | - | - | [3] 46 46, 70, 97 💬
|
| 169 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 170 | Adalimumab 40mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 171 | Adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab | [5] Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
💬
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 172 | Adalimumab-680LT | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 173 | Adalimumab-680LT 25mg | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 174 | Adalimumab-800CW | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 175 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 176 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 177 | Adipose-cord mesenchymal stromal cells (A-MSCs) | - | - | - | - | [1] 97 97 💬
|
| 178 | Adjuvanted Recombinant Zoster Vaccine (RZV) | - | - | - | - | [1] 97 97 💬
|
| 179 | Adrenomedullin | [1] Adrenomedullin Adrenomedullin | - | - | - | [3] 96 96, 97, 124 💬
|
| 180 | Advanced therapy | - | - | - | - | [1] 97 97 💬
|
| 181 | Advanced therapy only without dietary intervention | - | - | - | - | [1] 97 97 💬
|
| 182 | AEB071 | - | - | - | - | [1] 97 97 💬
|
| 183 | AEB071A | - | - | - | - | [1] 97 97 💬
|
| 184 | Aero-red 100 mg/ml gotas orales en solución | - | - | - | - | [2] 96 96, 97 💬
|
| 185 | Afimkibart | [1] Afimkibart Afimkibart | [1] Afimkibart
Afimkibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3] 46 46, 96, 97 💬
|
| 186 | AG011 | - | - | - | - | [1] 97 97 💬
|
| 187 | AG011 - Capsules | - | - | - | - | [1] 97 97 💬
|
| 188 | AG011 - Enema | - | - | - | - | [1] 97 97 💬
|
| 189 | AIN457 | - | - | - | - | [9] 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
| 190 | Air insufflation insertion | - | - | - | - | [1] 97 97 💬
|
| 191 | AIRE-2 Portable breath analyzer | - | - | - | - | [1] 97 97 💬
|
| 192 | AJM300 | - | - | - | - | [1] 97 97 💬
|
| 193 | AK101 IV | - | - | - | - | [1] 97 97 💬
|
| 194 | AK101 IV/AK101 SC | - | - | - | - | [1] 97 97 💬
|
| 195 | AK101 SC | - | - | - | - | [1] 97 97 💬
|
| 196 | Alanine | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [8] 6 6, 13, 70, 94, 97, 251, 298, 299 💬
|
| 197 | Aldesleukin | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 2 2, 49, 65, 96, 97 💬
|
| 198 | Alequel | - | - | - | - | [2] 96 96, 97 💬
|
| 199 | Alicaforsen | [1] Alicaforsen Alicaforsen | [1] Alicaforsen sodium
Alicaforsen sodium
💬
| [1] ICAM1 ICAM1 💬
| [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Influenza A, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Staphylococcus aureus infection, TNF signaling pathway, Viral myocarditis 💬 | [2] 96 96, 97 💬
|
| 200 | Alkaline Phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [4] 46 46, 93, 97, 172 💬
|
| 201 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 202 | Allogeneic bone marrow-derived mesenchymal stromal cells | - | - | - | - | [1] 97 97 💬
|
| 203 | Allopurinol | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [7] 6 6, 46, 57, 60, 66, 96, 97 💬
|
| 204 | ALLOPURINOL SODIUM | [1] Allopurinol Allopurinol | [2] Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 205 | AlloRx | - | - | - | - | [8] 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
| 206 | AloASC | - | - | - | - | [1] 97 97 💬
|
| 207 | Aloe Barbadensis Miller | - | - | - | - | [1] 97 97 💬
|
| 208 | Aloe vera gel | - | - | - | - | [1] 97 97 💬
|
| 209 | Also referred to as 'MEDI2070' | - | - | - | - | [2] 96 96, 97 💬
|
| 210 | Also referred to as 'MEDI2070'Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 1440- | - | - | - | - | [1] 97 97 💬
|
| 211 | Also referred to as 'MEDI2070'Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 240-Product Name: BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [1] 97 97 💬
|
| 212 | Also referred to as MEDI2070 | - | - | - | - | [2] 96 96, 97 💬
|
| 213 | ALTB-168 | - | - | - | - | [1] 97 97 💬
|
| 214 | ALTB-268 | - | - | - | - | [1] 97 97 💬
|
| 215 | ALTH12-1:4 | - | - | - | - | [1] 97 97 💬
|
| 216 | ALTH12-2:4 | - | - | - | - | [1] 97 97 💬
|
| 217 | AMG 181 | - | - | - | - | [2] 96 96, 97 💬
|
| 218 | AMG 592 | - | - | - | - | [3] 46 46, 49, 97 💬
|
| 219 | AMG181 | - | - | - | - | [1] 97 97 💬
|
| 220 | Amgevita | - | - | - | - | [2] 96 96, 97 💬
|
| 221 | AMGEVITA (Adalimumab biosimilar ) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 222 | Amgevita 40 mg Injektionslösung im Fertigpen | - | - | - | - | [2] 96 96, 97 💬
|
| 223 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | - | - | - | - | [2] 96 96, 97 💬
|
| 224 | Amgevita 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 💬
|
| 225 | AMGEVITA® | - | - | - | - | [2] 96 96, 97 💬
|
| 226 | Amino salicylic acid | [1] Salicylic acid Salicylic acid | [4] Salicylic acid
Salicylic acid
,
Sodium salicylate
,
Choline magnesium trisalicylate
,
Diethylamine salicylate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 97 97 💬
|
| 227 | AMINOSALICYLIC ACID | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [2] 96 96, 97 💬
|
| 228 | Amiselimod | [1] Amiselimod Amiselimod | [1] Amiselimod
Amiselimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 229 | AmiselimodProduct Code: MT-1303Pharmaceutical Form: CapsuleINN or Proposed INN: amiselimodOther descriptive name: MT-1303Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.2-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral useProduct Name: AmiselimodProduct Code: MT-1303Pharmaceutical Form: CapsuleINN or Proposed INN: amiselimodOther descriptive name: MT-1303Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.4-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use | - | - | - | - | [1] 97 97 💬
|
| 230 | Amitriptyline | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 96 96, 97, 226, 299 💬
|
| 231 | Amitriptyline hydrochloride | [1] Amitriptyline Amitriptyline | [2] Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 97 97 💬
|
| 232 | Amoxicillin | [1] Amoxicillin Amoxicillin | [3] Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | [9] 6 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
|
| 233 | Amoxicillin and doxycyclin | [2] Amoxicillin Amoxicillin, Doxycycline | [8] Amoxicillin
Amoxicillin
,
Doxycycline
,
Doxycycline hyclate
,
Amoxicillin sodium
,
Doxycycline calcium
,
Amoxicillin
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 234 | Amoxicillin, metronidazole and doxycycline | [3] Amoxicillin Amoxicillin, Doxycycline, Metronidazole | [10] Amoxicillin
Amoxicillin
,
Doxycycline
,
Metronidazole
,
Doxycycline hyclate
,
Amoxicillin sodium
,
Doxycycline calcium
,
Metronidazole hydrochloride
,
Amoxicillin
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 235 | Amphotericin B | [1] Amphotericin B Amphotericin B | [1] Amphotericin B
Amphotericin B
💬
| - | - | [3] 96 96, 97, 299 💬
|
| 236 | AMT-101 | [1] AMT-101 AMT-101 | - | - | - | [2] 46 46, 97 💬
|
| 237 | AMT-101 (oral) | [1] AMT-101 AMT-101 | - | - | - | [1] 97 97 💬
|
| 238 | Anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [22] 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
|
| 239 | AND (Andrographolide) | [1] Andrographolide Andrographolide | - | - | - | [1] 97 97 💬
|
| 240 | Andecaliximab | [1] Andecaliximab Andecaliximab | [1] Andecaliximab
Andecaliximab
💬
| [1] MMP9 MMP9 💬
| [16] Bladder cancer Bladder cancer, Diabetic cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Hepatitis B, IL-17 signaling pathway, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Pathways in cancer, Phagocytosis, Prostate cancer, Proteoglycans in cancer, Relaxin signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [5] 46 46, 96, 97, 272, 299 💬
|
| 241 | AndoSan | - | - | - | - | [2] 96 96, 97 💬
|
| 242 | ANDROGRAPHIS PANICULATA | - | - | - | - | [1] 97 97 💬
|
| 243 | ANDROGRAPHIS PANICULATA (ethanol extract) | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [1] 97 97 💬
|
| 244 | Andrographolide | [1] Andrographolide Andrographolide | - | - | - | [1] 97 97 💬
|
| 245 | ANHIDROUS SODIUM SULFATE | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 246 | ANHYDROUS SODIUM SULFATE | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 247 | Anrukinzumab | [1] Anrukinzumab Anrukinzumab | [1] Anrukinzumab
Anrukinzumab
💬
| [1] IL13 IL13 💬
| [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1] 97 97 💬
|
| 248 | Anti Beta7 | - | - | - | - | [1] 97 97 💬
|
| 249 | Anti CD3 monoclonal antibody | - | - | - | - | [1] 97 97 💬
|
| 250 | Anti TNF therapy including infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 251 | Anti-CD3 Monoclonal antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 252 | Anti-cytokine antibodies | - | - | - | - | [1] 97 97 💬
|
| 253 | Anti-integrin antibodies | - | - | - | - | [1] 97 97 💬
|
| 254 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 💬
|
| 255 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 256 | Anti-IP-10 Antibody | - | - | - | - | [1] 97 97 💬
|
| 257 | Anti-MAdCAM antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 258 | Anti-TL1A | - | - | - | - | [1] 97 97 💬
|
| 259 | Anti-TL1A monoclonal antibody, high dose | - | - | - | - | [2] 96 96, 97 💬
|
| 260 | Anti-TL1A monoclonal antibody, low dose | - | - | - | - | [2] 96 96, 97 💬
|
| 261 | Anti-TL1A monoclonal antibody, medium dose | - | - | - | - | [2] 96 96, 97 💬
|
| 262 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | [2] 96 96, 97 💬
|
| 263 | Anti-TNF Drug | - | - | - | - | [2] 96 96, 97 💬
|
| 264 | Anti-TNF therapy | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 265 | Anti-TNF: Infliximab (Infusion) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 266 | Anti-TNF:Adalimumab (Subcutaneus) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 267 | Anti-tumor necrosis factor alpha agents | - | - | - | - | [1] 97 97 💬
|
| 268 | Antibiotic cocktail | - | - | - | - | [1] 97 97 💬
|
| 269 | ANTIGENO SUPERFICIE HEPATITIS B | - | - | - | - | [1] 97 97 💬
|
| 270 | Antioxidant diet | - | - | - | - | [1] 97 97 💬
|
| 271 | AODG (Apigenin-7-O-glucuronide) | [1] Apigenin Apigenin | - | - | - | [1] 97 97 💬
|
| 272 | APD334 | - | - | - | - | [5] 93 93, 96, 97, 98, 269 💬
|
| 273 | APD334 L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 274 | Apigenin | [1] Apigenin Apigenin | - | - | - | [3] 6 6, 46, 97 💬
|
| 275 | Apixaban | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [6] 48 48, 96, 97, 222, 223, 279 💬
|
| 276 | Apixaban 2.5 milligram | [1] Apixaban Apixaban | [1] Apixaban
Apixaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 96 96, 97 💬
|
| 277 | APL-1401 | - | - | - | - | [1] 97 97 💬
|
| 278 | Appendectomy | - | - | - | - | [1] 97 97 💬
|
| 279 | Apremilast | [1] Apremilast Apremilast | [1] Apremilast
Apremilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [8] 36 36, 46, 50, 56, 97, 107, 162, 271 💬
|
| 280 | Apriso 0.375G ER CAP | - | - | - | - | [1] 97 97 💬
|
| 281 | APRISO 375 mg extended-release capsules | - | - | - | - | [1] 97 97 💬
|
| 282 | APVO210 | - | - | - | - | [1] 97 97 💬
|
| 283 | Aquamin | - | - | - | - | [1] 97 97 💬
|
| 284 | Aquamin® | - | - | - | - | [1] 97 97 💬
|
| 285 | AR401959 L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [3] 96 96, 97, 98 💬
|
| 286 | Arginine | [1] Arginine Arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [16] 2 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
|
| 287 | Arm 2 | - | - | - | - | [1] 97 97 💬
|
| 288 | Arm1 | - | - | - | - | [1] 97 97 💬
|
| 289 | ASACOL | - | - | - | - | [1] 97 97 💬
|
| 290 | Asacol (mesalamine) | - | - | - | - | [1] 97 97 💬
|
| 291 | Asacol (mesalamine) Delayed-release Tablets | - | - | - | - | [1] 97 97 💬
|
| 292 | Asacol 400 mg | - | - | - | - | [1] 97 97 💬
|
| 293 | Asacol 400 mg (mesalamine) | - | - | - | - | [1] 97 97 💬
|
| 294 | Asacol 400 mg tablet | - | - | - | - | [1] 97 97 💬
|
| 295 | Asacol 400mg tablet | - | - | - | - | [1] 97 97 💬
|
| 296 | Asacol 800 mg (mesalamine) | - | - | - | - | [1] 97 97 💬
|
| 297 | Asacol 800 mg tablet | - | - | - | - | [1] 97 97 💬
|
| 298 | Asacol 800mg tablet | - | - | - | - | [1] 97 97 💬
|
| 299 | Asacol Delayed Release Tablets | - | - | - | - | [1] 97 97 💬
|
| 300 | Asacol Delayed-Release Tablets | - | - | - | - | [1] 97 97 💬
|
| 301 | Asacol® | - | - | - | - | [1] 97 97 💬
|
| 302 | Asacol® 400 mg | - | - | - | - | [1] 97 97 💬
|
| 303 | ASC | - | - | - | - | [1] 97 97 💬
|
| 304 | Ascorbic acid | [1] Ascorbic acid Ascorbic acid | [1] Ascorbic acid
Ascorbic acid
💬
| - | - | [4] 10 10, 97, 206, 298 💬
|
| 305 | ASCs | - | - | - | - | [3] 53 53, 96, 97 💬
|
| 306 | ASCs (Cx401, company code) | - | - | - | - | [1] 97 97 💬
|
| 307 | ASCs:adipose derived stem cells | - | - | - | - | [1] 97 97 💬
|
| 308 | ASP015K | - | - | - | - | [2] 46 46, 97 💬
|
| 309 | ASP3291 | - | - | - | - | [1] 97 97 💬
|
| 310 | Aspergillus oryzae | [1] Aspergillus oryzae Aspergillus oryzae | - | - | - | [1] 97 97 💬
|
| 311 | Aspirin 81Mg Ec Tab | - | - | - | - | [2] 96 96, 97 💬
|
| 312 | Assessment of Biological factors | - | - | - | - | [1] 97 97 💬
|
| 313 | AST-120 | - | - | - | - | [2] 96 96, 97 💬
|
| 314 | ATH-063 | - | - | - | - | [2] 96 96, 97 💬
|
| 315 | ATL-2502 | - | - | - | - | [1] 97 97 💬
|
| 316 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 317 | Atorvastatin 80mg | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 97 97 💬
|
| 318 | ATORVASTATIN CALCIUM | [2] Atorvastatin Atorvastatin, Calcium | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [3] 79 79, 97, 265 💬
|
| 319 | AVONEX | - | - | - | - | [2] 13 13, 97 💬
|
| 320 | AVT02 (Alvotech Biosimilar to Adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 💬
|
| 321 | AVT16 | - | - | - | - | [1] 97 97 💬
|
| 322 | AVX 470 | - | - | - | - | [1] 97 97 💬
|
| 323 | AZA | - | - | - | - | [4] 11 11, 40, 96, 97 💬
|
| 324 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | [1] 97 97 💬
|
| 325 | AZAFOR 50mg | - | - | - | - | [1] 97 97 💬
|
| 326 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 327 | Azathioprine (AZA) | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [5] 13 13, 19, 49, 55, 97 💬
|
| 328 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 329 | Azathioprine (Imuran) 50 mg Overencapsulated Tablet | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 97 97 💬
|
| 330 | Azathioprine / Allopurinol | [2] Allopurinol Allopurinol, Azathioprine | [4] Allopurinol
Allopurinol
,
Azathioprine
,
Azathioprine sodium
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 97 97 💬
|
| 331 | Azathioprine and Allopurinol | [2] Allopurinol Allopurinol, Azathioprine | [4] Allopurinol
Allopurinol
,
Azathioprine
,
Azathioprine sodium
,
Allopurinol sodium
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [1] 97 97 💬
|
| 332 | AZATHIOPRINE BP | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 97 97 💬
|
| 333 | Azathioprine or 6-mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 96 96, 97 💬
|
| 334 | Azatioprina | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [2] 96 96, 97 💬
|
| 335 | B03A A07 | - | - | - | - | [1] 97 97 💬
|
| 336 | B03AC06 | - | - | - | - | [1] 97 97 💬
|
| 337 | B2-ASmedic | - | - | - | - | [1] 97 97 💬
|
| 338 | B: 2 dosis | - | - | - | - | [1] 97 97 💬
|
| 339 | Bacillus clausii | [1] Bacillus clausii Bacillus clausii | - | - | - | [1] 97 97 💬
|
| 340 | Bacteriotherapy | - | - | - | - | [2] 96 96, 97 💬
|
| 341 | Baitouweng Tang | - | - | - | - | [1] 97 97 💬
|
| 342 | Balinatunfib | [1] Balinatunfib Balinatunfib | [1] Balinatunfib
Balinatunfib
💬
| [2] TNFRSF1A TNFRSF1A, TNFRSF1B 💬
| [35] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, NF-kappa B signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TNF signaling pathway, Toxoplasmosis, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 343 | Balsalazide | [1] Balsalazide Balsalazide | [2] Balsalazide disodium
Balsalazide disodium
,
Balsalazide
💬
| - | - | [1] 97 97 💬
|
| 344 | Balsalazide Disodium | [1] Balsalazide Balsalazide | [2] Balsalazide disodium
Balsalazide disodium
,
Balsalazide
💬
| - | - | [1] 97 97 💬
|
| 345 | Baminercept | [1] Baminercept Baminercept | [1] Baminercept
Baminercept
💬
| [1] LTB LTB 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 13 13, 46, 53, 97 💬
|
| 346 | Barium | [1] Barium Barium | - | - | - | [5] 2 2, 6, 19, 97, 98 💬
|
| 347 | Bascial prescription plus or minus herbs depend on symptoms | - | - | - | - | [1] 97 97 💬
|
| 348 | Basiliximab | [1] Basiliximab Basiliximab | [1] Basiliximab
Basiliximab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 2 2, 50, 97, 222, 228 💬
|
| 349 | BB-TL1A-VIAL-HLE | - | - | - | - | [1] 97 97 💬
|
| 350 | BBT-401-1S | - | - | - | - | [1] 97 97 💬
|
| 351 | BBT-401-1S, Multiple doses | - | - | - | - | [1] 97 97 💬
|
| 352 | BBT-401-1S, Single dose | - | - | - | - | [1] 97 97 💬
|
| 353 | BCMA CAR-T or CD19 CAR-T or CD19×BCMA | - | - | - | - | [1] 97 97 💬
|
| 354 | BDHK-2009 Tablets | - | - | - | - | [2] 96 96, 97 💬
|
| 355 | Beclometasone | - | - | - | - | [1] 97 97 💬
|
| 356 | Beclometasone dipropionate | - | - | - | - | [2] 85 85, 97 💬
|
| 357 | Beclomethasone dipropionate | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [3] Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 97 97, 98 💬
|
| 358 | Beclomethasone diproprionate | - | - | - | - | [1] 97 97 💬
|
| 359 | Behavioral: AbbVie Care 2.0 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 360 | Behavioral: Acceptance and Commitment Therapy | - | - | - | - | [1] 97 97 💬
|
| 361 | Behavioral: Administration of probiotic (L. rhamnosus and L. acidophilus) | - | - | - | - | [1] 97 97 💬
|
| 362 | Behavioral: Assessment of quality of life | - | - | - | - | [2] 6 6, 97 💬
|
| 363 | Behavioral: Behavioral Counseling | - | - | - | - | [1] 97 97 💬
|
| 364 | Behavioral: Exercise Intervention | - | - | - | - | [1] 97 97 💬
|
| 365 | Behavioral: Habitual Diet | - | - | - | - | [1] 97 97 💬
|
| 366 | Behavioral: Increased dietary intake of salmon or cod | - | - | - | - | [1] 97 97 💬
|
| 367 | Behavioral: Mediterranean diet | - | - | - | - | [2] 96 96, 97 💬
|
| 368 | Behavioral: Physician-prescribed Exercise Programme | - | - | - | - | [1] 97 97 💬
|
| 369 | Behavioral: Quality of Life questionnaires | - | - | - | - | [2] 13 13, 97 💬
|
| 370 | Behavioral: Reduced Sulfur diet | - | - | - | - | [1] 97 97 💬
|
| 371 | Berberine | [1] Berberine Berberine | [1] Coptis rhizome
Coptis rhizome
💬
| - | - | [3] 46 46, 97, 265 💬
|
| 372 | Berberine Chloride | [1] Berberine Berberine | [1] Coptis rhizome
Coptis rhizome
💬
| - | - | [1] 97 97 💬
|
| 373 | Bertilimumab | [1] Bertilimumab Bertilimumab | - | - | - | [2] 97 97, 162 💬
|
| 374 | Best Medical Therapy | - | - | - | - | [1] 97 97 💬
|
| 375 | Beta-1,3/1,6-D-Glucan | - | - | - | - | [1] 97 97 💬
|
| 376 | Bezlotoxumab | [1] Bezlotoxumab Bezlotoxumab | [1] Bezlotoxumab
Bezlotoxumab
💬
| - | - | [2] 96 96, 97 💬
|
| 377 | BG9418 (interferon beta-1a) | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 13 13, 97 💬
|
| 378 | BG9924 | - | - | - | - | [2] 46 46, 97 💬
|
| 379 | BGP-014 | - | - | - | - | [1] 97 97 💬
|
| 380 | BGP-014 Capsules | - | - | - | - | [1] 97 97 💬
|
| 381 | BI 3032950 intravenous (Part A) | - | - | - | - | [1] 97 97 💬
|
| 382 | BI 3032950 subcutaneous (Part B) | - | - | - | - | [1] 97 97 💬
|
| 383 | BI 655130 | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 384 | Bi-PegLyte | - | - | - | - | [2] 96 96, 97 💬
|
| 385 | BIAP | - | - | - | - | [2] 46 46, 97 💬
|
| 386 | BICARBONATO DI SODIO | - | - | - | - | [1] 97 97 💬
|
| 387 | Bifidobacterium breve | [1] Bifidobacterium breve Bifidobacterium breve | - | - | - | [1] 97 97 💬
|
| 388 | Bifidobacterium infantis 35624 | - | - | - | - | [2] 96 96, 97 💬
|
| 389 | Bifidobacterium longum | [1] Bifidobacterium longum Bifidobacterium longum | - | - | - | [2] 13 13, 97 💬
|
| 390 | Bimekizumab | [1] Bimekizumab Bimekizumab | [1] Bimekizumab
Bimekizumab
💬
| [2] IL17A IL17A, IL17F 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [5] 37 37, 46, 97, 107, 271 💬
|
| 391 | Bio-enhanced Curcumin Soft Gelatin Capsule | [2] Curcumin Curcumin, Gelatin | [1] Gelatin
Gelatin
💬
| - | - | [1] 97 97 💬
|
| 392 | Biologic Agent | - | - | - | - | [2] 96 96, 97 💬
|
| 393 | Biologic therapy(eg:IFX,ADA,UST,VDZ) | - | - | - | - | [1] 97 97 💬
|
| 394 | Biological Drug | - | - | - | - | [4] 46 46, 96, 97, 107 💬
|
| 395 | Biological sampling | - | - | - | - | [2] 65 65, 97 💬
|
| 396 | Biologically active human fecal material, OpenBiome | - | - | - | - | [1] 97 97 💬
|
| 397 | Biologically active human fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 398 | Biologics | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 399 | Biopsies | - | - | - | - | [1] 97 97 💬
|
| 400 | Biopsy | - | - | - | - | [7] 28 28, 34, 51, 65, 97, 193, 285 💬
|
| 401 | Biopsy of Colon | - | - | - | - | [1] 97 97 💬
|
| 402 | Biosimilar | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 403 | Biosimilar Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 404 | Biospecimen Collection | - | - | - | - | [18] 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 405 | Bisacodyl | [1] Bisacodyl Bisacodyl | [1] Bisacodyl
Bisacodyl
💬
| - | - | [2] 13 13, 97 💬
|
| 406 | BITTER CANDYTUFT FRESH PLANT EXTRACT | - | - | - | - | [1] 97 97 💬
|
| 407 | Bitterschleifenblume-ganzpflanze 1,5ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 408 | BL-7040 | - | - | - | - | [1] 97 97 💬
|
| 409 | Blood and fecal samples | - | - | - | - | [2] 96 96, 97 💬
|
| 410 | Blood Draw/Data Collection | - | - | - | - | [1] 97 97 💬
|
| 411 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 412 | Blood sample - venous blood 10 ml. | - | - | - | - | [1] 97 97 💬
|
| 413 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 414 | Blood sampling | - | - | - | - | [15] 2 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
|
| 415 | Blood sampling, endoscopy | - | - | - | - | [1] 97 97 💬
|
| 416 | Blood test 4 EDTA tubes | - | - | - | - | [1] 97 97 💬
|
| 417 | Blueberry | [1] Blueberry Blueberry | - | - | - | [2] 96 96, 97 💬
|
| 418 | Blueberry-rich diet | [1] Blueberry Blueberry | - | - | - | [2] 96 96, 97 💬
|
| 419 | BMS-188667 | - | - | - | - | [10] 46 46, 49, 53, 65, 96, 97, 107, 222, 223, 271 💬
|
| 420 | BMS-936557 | - | - | - | - | [2] 96 96, 97 💬
|
| 421 | BMS-986165 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 422 | BMS-986166 | - | - | - | - | [1] 97 97 💬
|
| 423 | BMS-986184 | - | - | - | - | [1] 97 97 💬
|
| 424 | BMS986165 | - | - | - | - | [2] 96 96, 97 💬
|
| 425 | Boulardii | - | - | - | - | [2] 96 96, 97 💬
|
| 426 | Bovine intestinal alkaline phosphatase (BIAP) | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 97 97 💬
|
| 427 | Bovine-Calf Alkaline Phosphatase (BIAP) | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 97 97 💬
|
| 428 | Bovine-Calf Alkaline Phosphatase BIAP | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 97 97 💬
|
| 429 | BRAZIKUMAB | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 430 | Brazikumab Induction Dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 431 | Brazikumab Maintenance Dose | [1] Brazikumab Brazikumab | [1] Brazikumab
Brazikumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 432 | BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusion in pre-filled syringeINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [1] 97 97 💬
|
| 433 | Breast milk sampling | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 434 | Brepocitinib | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 49 49, 50, 84, 96, 97 💬
|
| 435 | Brepocitinib 25 mg | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 96 96, 97 💬
|
| 436 | Brepocitinib 5 mg | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 96 96, 97 💬
|
| 437 | Broccoli | [1] Broccoli Broccoli | - | - | - | [3] 36 36, 97, 299 💬
|
| 438 | Bromlein | - | - | - | - | [2] 94 94, 97 💬
|
| 439 | BRS201 | - | - | - | - | [2] 94 94, 97 💬
|
| 440 | BT-11 | - | - | - | - | [2] 96 96, 97 💬
|
| 441 | BT-11 (440 mg) | - | - | - | - | [1] 97 97 💬
|
| 442 | BT-11 (880 mg) | - | - | - | - | [1] 97 97 💬
|
| 443 | BT-11 1000mg | - | - | - | - | [2] 96 96, 97 💬
|
| 444 | BT-11 500 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 445 | BT051 200 mg | - | - | - | - | [1] 97 97 💬
|
| 446 | BT051 3200 mg | - | - | - | - | [1] 97 97 💬
|
| 447 | BT051 800 mg | - | - | - | - | [1] 97 97 💬
|
| 448 | Budenofalk 2mg rectal foam | - | - | - | - | [1] 97 97 💬
|
| 449 | Budenofalk 3mg | - | - | - | - | [2] 93 93, 97 💬
|
| 450 | Budenofalk rectal foam | - | - | - | - | [1] 97 97 💬
|
| 451 | Budenofalk® suppositories | - | - | - | - | [1] 97 97 💬
|
| 452 | Budenofalk® suppositories (BUS) | - | - | - | - | [1] 97 97 💬
|
| 453 | BUDESONIDE | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 66 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
|
| 454 | Budesonide (6 mg) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 455 | Budesonide (9 mg) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 456 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 457 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 458 | Budesonide 9 mg capsules, hard (BUX-PV) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 459 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 460 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 461 | Budesonide MMX | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 462 | Budesonide MMX 6 mg Tablet | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 463 | Budesonide MMX® | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 464 | Budesonide MMX® 6 mg | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 465 | Budesonide MMX® 9 mg | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 466 | Budesonide-MMX | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 467 | Budesonide-MMX® | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 468 | Budesonide-MMX® 6 mg | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 469 | Budesonide-MMX® 9 mg | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 470 | Budesonide-MMX™ | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 471 | Bupivacaine | [1] Bupivacaine Bupivacaine | [2] Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [10] 46 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬
|
| 472 | Bupropion | [1] Bupropion Bupropion | [3] Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [7] 8 8, 18, 21, 96, 97, 171, 298 💬
|
| 473 | Bupropion-SR | [1] Bupropion Bupropion | [3] Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 97 97 💬
|
| 474 | Butyrate | - | - | - | - | [2] 46 46, 97 💬
|
| 475 | BXD treatment | - | - | - | - | [1] 97 97 💬
|
| 476 | By demand | - | - | - | - | [2] 96 96, 97 💬
|
| 477 | Cabozantinib | [1] Cabozantinib Cabozantinib | [2] Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| [3] AXL AXL, KDR, MET 💬
| [28] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [9] 13 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
|
| 478 | CACIT D3 effervescent granules, 500 mg/440 IU | - | - | - | - | [1] 97 97 💬
|
| 479 | Caffeine | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
| 480 | Caffeine 100 mg | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 481 | Calcitonin nasal spray (salmon) | - | - | - | - | [2] 96 96, 97 💬
|
| 482 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 483 | Calcium carbonate | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [10] 13 13, 19, 46, 53, 71, 75, 96, 97, 235, 299 💬
|
| 484 | Calcium carbonate 600 mg once daily | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 97 97 💬
|
| 485 | Caltrate | - | - | - | - | [1] 97 97 💬
|
| 486 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [20] 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 487 | Cannabis, Medical | - | - | - | - | [5] 2 2, 6, 13, 96, 97 💬
|
| 488 | Captafer® | - | - | - | - | [1] 97 97 💬
|
| 489 | Carbon dioxide | [1] Carbon dioxide Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬
| - | - | [4] 50 50, 51, 97, 158 💬
|
| 490 | Carbon dioxide insufflation | [1] Carbon dioxide Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬
| - | - | [1] 97 97 💬
|
| 491 | CARBOSSIMALTOSIO FERRICO | - | - | - | - | [1] 97 97 💬
|
| 492 | Carotegrast methyl | [1] Carotegrast methyl Carotegrast methyl | [1] Carotegrast methyl
Carotegrast methyl
💬
| [3] ITGA4 ITGA4, ITGB1, ITGB7 💬
| [32] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagocytosis, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Transcriptional misregulation in cancer, Virion - Rotavirus, Yersinia infection 💬 | [1] 97 97 💬
|
| 493 | Carrageenan | - | - | - | - | [1] 97 97 💬
|
| 494 | CARVI EXTRACTUM FLUIDUM | - | - | - | - | [1] 97 97 💬
|
| 495 | Casein | [1] Casein Casein | - | - | - | [1] 97 97 💬
|
| 496 | Casein glycomacropeptide (CGMP) | [1] Casein Casein | - | - | - | [1] 97 97 💬
|
| 497 | CAT-354 | - | - | - | - | [1] 97 97 💬
|
| 498 | Catridecacog | [1] Catridecacog Catridecacog | [1] Catridecacog
Catridecacog
💬
| - | - | [1] 97 97 💬
|
| 499 | CB-01-02 | - | - | - | - | [1] 97 97 💬
|
| 500 | CB-01-05-MMX | - | - | - | - | [1] 97 97 💬
|
| 501 | CBD, synthetic form | - | - | - | - | [1] 97 97 💬
|
| 502 | CBP-307 | - | - | - | - | [1] 97 97 💬
|
| 503 | CC-10004 | - | - | - | - | [5] 46 46, 56, 97, 162, 271 💬
|
| 504 | CD7 CAR T-cells | - | - | - | - | [3] 50 50, 96, 97 💬
|
| 505 | Cefiderocol | [1] Cefiderocol Cefiderocol | [2] Cefiderocol sulfate tosylate
Cefiderocol sulfate tosylate
,
Cefiderocol
💬
| - | - | [3] 96 96, 97, 299 💬
|
| 506 | Cefmetazole | [1] Cefmetazole Cefmetazole | [2] Cefmetazole
Cefmetazole
,
Cefmetazole sodium
💬
| - | - | [2] 96 96, 97 💬
|
| 507 | Ceftriaxone | [1] Ceftriaxone Ceftriaxone | [2] Ceftriaxone sodium
Ceftriaxone sodium
,
Ceftriaxone
💬
| - | - | [4] 2 2, 6, 97, 299 💬
|
| 508 | Cefuroxime | [1] Cefuroxime Cefuroxime | [3] Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | [2] 97 97, 299 💬
|
| 509 | CELECOXIB | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [14] 2 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 510 | Certolizumab Pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [10] 37 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
|
| 511 | CGMP protein | - | - | - | - | [1] 97 97 💬
|
| 512 | Cherry | [1] Cherry Cherry | - | - | - | [1] 97 97 💬
|
| 513 | Chlorogenic Acid | [1] Chlorogenic Acid Chlorogenic Acid | - | - | - | [1] 97 97 💬
|
| 514 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 13 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
|
| 515 | Chronic- PF-06480605 150 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 516 | Chronic- PF-06480605 450 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 517 | Chronic- PF-06480605 50 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 518 | Ciclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 26 26, 46, 49, 50, 53, 60, 97, 226, 228, 269 💬
|
| 519 | CICLOSPORINA | - | - | - | - | [3] 49 49, 60, 97 💬
|
| 520 | CIMZIA | - | - | - | - | [7] 46 46, 48, 49, 96, 97, 107, 271 💬
|
| 521 | Ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [6] 2 2, 46, 60, 96, 97, 299 💬
|
| 522 | Cizutamig | - | - | - | - | [4] 11 11, 46, 49, 97 💬
|
| 523 | CLA (Chlorogenic acid) | [1] Chlorogenic Acid Chlorogenic Acid | - | - | - | [1] 97 97 💬
|
| 524 | Clarithromycin | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [10] 6 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
|
| 525 | ClaversalPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: Rectal foamINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Gastro-resistant granules for oral suspension in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: TabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: Granules for oral solution in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: MezavantPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: Mesalazine TevaPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: SalazopyrinePharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: SulfasalazineCAS Number: 599-79-1Trade Name: PentasaPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6 | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 526 | Clipper | - | - | - | - | [1] 97 97 💬
|
| 527 | Clipper 30 cpr 5mg R.M. | - | - | - | - | [1] 97 97 💬
|
| 528 | CLIPPER*30CPR 5MG R.M. | - | - | - | - | [1] 97 97 💬
|
| 529 | CLORURO DI POTASSIO | - | - | - | - | [1] 97 97 💬
|
| 530 | CLORURO DI SODIO | - | - | - | - | [1] 97 97 💬
|
| 531 | Clotrimazole | [1] Clotrimazole Clotrimazole | [1] Clotrimazole
Clotrimazole
💬
| - | - | [1] 97 97 💬
|
| 532 | CMTS0929 | - | - | - | - | [1] 97 97 💬
|
| 533 | CMV IgM, IgG in blood real time PCR for serum CMV DNA . | - | - | - | - | [1] 97 97 💬
|
| 534 | CNTO 148 | - | - | - | - | [4] 46 46, 84, 97, 271 💬
|
| 535 | CNTO-148 | - | - | - | - | [1] 97 97 💬
|
| 536 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 💬
|
| 537 | CNTO148 | - | - | - | - | [5] 46 46, 84, 96, 97, 107 💬
|
| 538 | CNTO1959 | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 539 | CNTO312 | - | - | - | - | [1] 97 97 💬
|
| 540 | Coamoxiclav | - | - | - | - | [1] 97 97 💬
|
| 541 | COBITOLIMOD | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 542 | Cobitolimod 250 mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 543 | Cobitolimod 500 mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 544 | Cobitolimod 500mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 545 | COFFEE COAL | - | - | - | - | [1] 97 97 💬
|
| 546 | COLAL PRED | - | - | - | - | [1] 97 97 💬
|
| 547 | COLAL-PRED | - | - | - | - | [1] 97 97 💬
|
| 548 | COLAL-PRED® | - | - | - | - | [1] 97 97 💬
|
| 549 | Colchicine | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [9] 2 2, 42, 46, 50, 56, 93, 97, 210, 266 💬
|
| 550 | Colecalciferol D3 (Vigantol Oil) | - | - | - | - | [2] 96 96, 97 💬
|
| 551 | Colectomy | - | - | - | - | [1] 97 97 💬
|
| 552 | Collection of blood, feces and urine. For UC: collection of 8 additional biopsies | - | - | - | - | [1] 97 97 💬
|
| 553 | Colon Endoscopy Procedure | - | - | - | - | [1] 97 97 💬
|
| 554 | Colon KCC Heptapeptide | - | - | - | - | [1] 97 97 💬
|
| 555 | Colon preparation for colonoscopy | - | - | - | - | [1] 97 97 💬
|
| 556 | Colonoscopy | - | - | - | - | [2] 96 96, 97 💬
|
| 557 | Colonoscopy after bowel cleansing | - | - | - | - | [1] 97 97 💬
|
| 558 | Colonoscopy with Indigo-Carmine chromoendoscopy | [1] Indigo Indigo | - | - | - | [1] 97 97 💬
|
| 559 | Colorectal biopsies | - | - | - | - | [1] 97 97 💬
|
| 560 | Coltect | - | - | - | - | [1] 97 97 💬
|
| 561 | Combination Oral Budesonide and Rectal Hydrocortisone | [2] Budesonide Budesonide, Hydrocortisone | [2] Hydrocortisone
Hydrocortisone
,
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 562 | Combination Product: 1.5g enriched pomegranate muffins | [1] Pomegranate Pomegranate | - | - | - | [1] 97 97 💬
|
| 563 | Combination Product: 3g enriched pomegranate muffins | [1] Pomegranate Pomegranate | - | - | - | [1] 97 97 💬
|
| 564 | Combination Product: Beclomethasone dipropionate in addition to MC-EVOO | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [3] Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 565 | Combination Product: Beclomethasone dipropionate in addition to refined oil | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [3] Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 566 | Combination Product: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 567 | Combination Product: Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 568 | Combination Product: Humira (adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 569 | Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator | [3] Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 570 | Companion blood samples with procedure | - | - | - | - | [4] 13 13, 51, 97, 271 💬
|
| 571 | Companion Diagnostic (CDx) Testing | - | - | - | - | [1] 97 97 💬
|
| 572 | Compressed oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 97 97 💬
|
| 573 | Control | - | - | - | - | [8] 2 2, 6, 46, 51, 90, 97, 168, 299 💬
|
| 574 | Control group: Mesalazine enema treatment | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 575 | Controlled-ileocolonic-release nicotinamide (CICR-NAM): 1000 mg/d | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 97 97 💬
|
| 576 | Controlled-ileocolonic-release nicotinamide (CICR-NAM): 500 mg/d | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 97 97 💬
|
| 577 | Conventional ibd medical treatment | - | - | - | - | [1] 97 97 💬
|
| 578 | Conventional Therapy | - | - | - | - | [5] 14 14, 49, 67, 97, 222 💬
|
| 579 | Conventional treatment | - | - | - | - | [1] 97 97 💬
|
| 580 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [2] 96 96, 97 💬
|
| 581 | Conventional white-light colonoscopy | - | - | - | - | [1] 97 97 💬
|
| 582 | Coolonic biopsies | - | - | - | - | [2] 96 96, 97 💬
|
| 583 | Cord Blood Stem Cell Transplantation | - | - | - | - | [1] 97 97 💬
|
| 584 | Corticosteroid | - | - | - | - | [12] 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
|
| 585 | Corticosteroids | - | - | - | - | [13] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
|
| 586 | Corticosteroids only | - | - | - | - | [1] 97 97 💬
|
| 587 | CortimentMMX 9 mg | - | - | - | - | [1] 97 97 💬
|
| 588 | CosmoFer | - | - | - | - | [2] 96 96, 97 💬
|
| 589 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | [2] 96 96, 97 💬
|
| 590 | Cotrimoxazole | - | - | - | - | [2] 85 85, 97 💬
|
| 591 | COVID-19 vaccine | - | - | - | - | [4] 46 46, 49, 51, 97 💬
|
| 592 | COVID-19 Vaccines at a 3-month interval | - | - | - | - | [2] 46 46, 97 💬
|
| 593 | COVID-19 Vaccines at a 6-month interval | - | - | - | - | [2] 46 46, 97 💬
|
| 594 | CP- 690 550 | - | - | - | - | [1] 97 97 💬
|
| 595 | CP-101 | - | - | - | - | [1] 97 97 💬
|
| 596 | CP-690,500 5 mg | - | - | - | - | [1] 97 97 💬
|
| 597 | CP-690,550 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 598 | CP-690,550 10 mg | - | - | - | - | [1] 97 97 💬
|
| 599 | CP-690,550-10 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 600 | CP690,550 | - | - | - | - | [2] 46 46, 97 💬
|
| 601 | Creatine | [1] Creatine Creatine | - | - | - | [18] 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
|
| 602 | Creatine Monohydrate | [1] Creatine Creatine | - | - | - | [5] 2 2, 8, 97, 113, 156 💬
|
| 603 | Creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [9] 2 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
|
| 604 | CS (corticosteroids) Only | - | - | - | - | [1] 97 97 💬
|
| 605 | CT-P13 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 606 | CT-P13 SC (Infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 607 | CU104 | - | - | - | - | [1] 97 97 💬
|
| 608 | Curcumin | [1] Curcumin Curcumin | - | - | - | [12] 2 2, 13, 34, 36, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
| 609 | Curcumin Supplementation | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬
|
| 610 | CurQD (Curcumin + QingDai combination) | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬
|
| 611 | Cyclosporin | - | - | - | - | [6] 53 53, 60, 97, 222, 223, 274 💬
|
| 612 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 613 | Cyclosporine (USAN) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 614 | Cyclosporine Injection (IV) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 615 | Cyclosporine Oral Product | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 97 💬
|
| 616 | CYCLOSPORINE VS INFLIXIMAB | [2] Cyclosporine Cyclosporine, Infliximab | [2] Cyclosporine
Cyclosporine
,
Infliximab
💬
| [6] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬
| [85] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 617 | CyCol | - | - | - | - | [1] 97 97 💬
|
| 618 | CyCol™ | - | - | - | - | [1] 97 97 💬
|
| 619 | Cytochrome P450 (CYP) Substrates | - | - | - | - | [2] 96 96, 97 💬
|
| 620 | Células troncales mesenquimales autólogas derivadas de tejido adiposo expandidas (ASC) | - | - | - | - | [1] 97 97 💬
|
| 621 | D-2570 | - | - | - | - | [2] 49 49, 97 💬
|
| 622 | D-Proline | [2] D-Proline D-Proline, Proline | [1] Proline
Proline
💬
| - | - | [1] 97 97 💬
|
| 623 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | [1] 97 97 💬
|
| 624 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | [1] 97 97 💬
|
| 625 | D3 VitaCaps® | - | - | - | - | [2] 96 96, 97 💬
|
| 626 | DACLIZUMAB | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [10] 13 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
|
| 627 | DACORTIN | - | - | - | - | [2] 97 97, 162 💬
|
| 628 | DAND (14-Deoxyandrographolide) | - | - | - | - | [1] 97 97 💬
|
| 629 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [16] 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 630 | Dapagliflozin 10mg Tab | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [4] 19 19, 97, 218, 222 💬
|
| 631 | DDAND (14-deoxy-11,12-didehydroandrographolide) | - | - | - | - | [1] 97 97 💬
|
| 632 | Decortin H 1 mg | - | - | - | - | [1] 97 97 💬
|
| 633 | Decortin H 10mg | - | - | - | - | [1] 97 97 💬
|
| 634 | Decortin H 20mg | - | - | - | - | [1] 97 97 💬
|
| 635 | Decortin H 50 mg | - | - | - | - | [1] 97 97 💬
|
| 636 | Decortin H 5mg | - | - | - | - | [1] 97 97 💬
|
| 637 | Dekavil | - | - | - | - | [2] 46 46, 97 💬
|
| 638 | Dekristol | - | - | - | - | [2] 13 13, 97 💬
|
| 639 | Delayed and extended release mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 640 | Deligoparin | - | - | - | - | [1] 97 97 💬
|
| 641 | Delmitide | [1] Delmitide Delmitide | - | - | - | [1] 97 97 💬
|
| 642 | Delmitide acetate | [2] Acetate Acetate, Delmitide | - | - | - | [1] 97 97 💬
|
| 643 | DELTACORTENE | - | - | - | - | [2] 43 43, 97 💬
|
| 644 | Deltacortene 10 cpr 25mg | - | - | - | - | [1] 97 97 💬
|
| 645 | Deltacortene 20 cpr 5mg | - | - | - | - | [1] 97 97 💬
|
| 646 | DELTACORTENE FORTE*10CPR 25MG | - | - | - | - | [2] 46 46, 97 💬
|
| 647 | DELTACORTENE*20CPR 5MG | - | - | - | - | [3] 49 49, 97, 113 💬
|
| 648 | DENSITYTM caplets (marketed as Amorphical) | - | - | - | - | [1] 97 97 💬
|
| 649 | Dersalazina sodica | - | - | - | - | [1] 97 97 💬
|
| 650 | Dersalazine | [1] Dersalazine Dersalazine | - | - | - | [1] 97 97 💬
|
| 651 | Dersalazine sodium | [1] Dersalazine Dersalazine | - | - | - | [1] 97 97 💬
|
| 652 | Desloratadine | [1] Desloratadine Desloratadine | [1] Desloratadine
Desloratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 46, 97 💬
|
| 653 | Deucravacitinib | [1] Deucravacitinib Deucravacitinib | [1] Deucravacitinib
Deucravacitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [10] 36 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
|
| 654 | Dex 21-P | - | - | - | - | [1] 97 97 💬
|
| 655 | Dexametasone sodium phosphate | - | - | - | - | [2] 96 96, 97 💬
|
| 656 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 657 | Dexamethasone (IV) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 96 96, 97 💬
|
| 658 | Dextran | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [5] 2 2, 62, 79, 96, 97 💬
|
| 659 | Dextran 1 | [2] Dextran Dextran, Dextran 1 | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 97 97 💬
|
| 660 | DEXTRAN 1 FOR INJECTION | [2] Dextran Dextran, Dextran 1 | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 97 97 💬
|
| 661 | Dextromethorphan | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [10] 2 2, 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
|
| 662 | Dextromethorphan 30 mg | [1] Dextromethorphan Dextromethorphan | [3] Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 96 96, 97 💬
|
| 663 | Diagnostic Test: Analysis of prouroguanyline and uroguanyline in full blood | - | - | - | - | [1] 97 97 💬
|
| 664 | Diagnostic Test: Antibodies to golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 665 | Diagnostic Test: Blood draw | - | - | - | - | [8] 34 34, 65, 85, 86, 96, 97, 240, 299 💬
|
| 666 | Diagnostic Test: Blood Routine Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 667 | Diagnostic Test: Blood Routine Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 668 | Diagnostic Test: Blood Routine Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 669 | Diagnostic Test: Blood sampling | - | - | - | - | [8] 49 49, 51, 65, 74, 97, 127, 231, 299 💬
|
| 670 | Diagnostic Test: C-reactive protein (CRP) | - | - | - | - | [1] 97 97 💬
|
| 671 | Diagnostic Test: C-reactive Protein Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 672 | Diagnostic Test: C-reactive Protein Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 673 | Diagnostic Test: C-reactive Protein Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 674 | Diagnostic Test: Calprotectin | - | - | - | - | [1] 97 97 💬
|
| 675 | Diagnostic Test: Colonoscopy | - | - | - | - | [1] 97 97 💬
|
| 676 | Diagnostic Test: Complete Blood Count | - | - | - | - | [2] 97 97, 107 💬
|
| 677 | Diagnostic Test: complete blood count (CBC) | - | - | - | - | [1] 97 97 💬
|
| 678 | Diagnostic Test: Coronal T1 weighted spin echo images | - | - | - | - | [2] 96 96, 97 💬
|
| 679 | Diagnostic Test: dry blood test | - | - | - | - | [2] 19 19, 97 💬
|
| 680 | Diagnostic Test: erythrocyte sedimentation rate (ESR) | - | - | - | - | [1] 97 97 💬
|
| 681 | Diagnostic Test: Erythrocyte Sedimentation Rate Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 682 | Diagnostic Test: Erythrocyte Sedimentation Rate Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 683 | Diagnostic Test: Erythrocyte Sedimentation Rate Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 684 | Diagnostic Test: Fecal Calprotectin | - | - | - | - | [1] 97 97 💬
|
| 685 | Diagnostic Test: Golimumab trough levels | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 686 | Diagnostic Test: Histology | - | - | - | - | [1] 97 97 💬
|
| 687 | Diagnostic Test: Infliximab level analysis in biological samples | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 688 | Diagnostic Test: Iron status testing | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 689 | Diagnostic Test: Kidney Function Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 690 | Diagnostic Test: Kidney Function Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 691 | Diagnostic Test: Kidney Function Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 692 | Diagnostic Test: Laboratory testing | - | - | - | - | [3] 84 84, 97, 271 💬
|
| 693 | Diagnostic Test: Leucine-rich a2-glycoprotein | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [2] 96 96, 97 💬
|
| 694 | Diagnostic Test: Liver Function Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 695 | Diagnostic Test: Liver Function Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 696 | Diagnostic Test: Liver Function Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 697 | Diagnostic Test: Magnetic resonance spectroscopy | - | - | - | - | [3] 96 96, 97, 299 💬
|
| 698 | Diagnostic Test: parasitological diagnostics (coproscopy) | - | - | - | - | [1] 97 97 💬
|
| 699 | Diagnostic Test: Rectosigmoidoscopy | - | - | - | - | [1] 97 97 💬
|
| 700 | Diagnostic Test: Serum 25(OH)D (Vitamin D3), C- reactive protein, Erthrocyte sedimentation rate | - | - | - | - | [1] 97 97 💬
|
| 701 | Diagnostic Test: serum albumin level | - | - | - | - | [1] 97 97 💬
|
| 702 | Diagnostic Test: serum calcium level | [1] Calcium Calcium | - | - | - | [1] 97 97 💬
|
| 703 | Diagnostic Test: serum creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [1] 97 97 💬
|
| 704 | Diagnostic Test: serum lactate | - | - | - | - | [1] 97 97 💬
|
| 705 | Diagnostic Test: serum leucine-rich alpha-2 glycoprotein (LRG) levels | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [2] 96 96, 97 💬
|
| 706 | Diagnostic Test: serum phosphurus level | - | - | - | - | [1] 97 97 💬
|
| 707 | Diagnostic Test: serum potassium level | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 97 97 💬
|
| 708 | Diagnostic Test: serum total 25 hydroxycholecalciferol 25(OH) vitamin D | [1] Vitamin D Vitamin D | - | - | - | [1] 97 97 💬
|
| 709 | Diagnostic Test: seum alanine aminotransferase | [1] Alanine Alanine | [1] Alanine
Alanine
💬
| - | - | [1] 97 97 💬
|
| 710 | Diagnostic Test: Spin-lattice relaxation (T1) | - | - | - | - | [2] 96 96, 97 💬
|
| 711 | Diagnostic Test: Stool | - | - | - | - | [2] 96 96, 97 💬
|
| 712 | Diagnostic Test: Stool Routine Test at 12-week | - | - | - | - | [1] 97 97 💬
|
| 713 | Diagnostic Test: Stool Routine Test at 4-week | - | - | - | - | [1] 97 97 💬
|
| 714 | Diagnostic Test: Stool Routine Test at 8-week | - | - | - | - | [1] 97 97 💬
|
| 715 | Diagnostic Test: Stool samplong | - | - | - | - | [1] 97 97 💬
|
| 716 | Diagnostic Test: Ultrasound | - | - | - | - | [2] 46 46, 97 💬
|
| 717 | Diet | - | - | - | - | [5] 86 86, 95, 97, 240, 299 💬
|
| 718 | Diet 1 | - | - | - | - | [2] 96 96, 97 💬
|
| 719 | Diet 2 | - | - | - | - | [2] 96 96, 97 💬
|
| 720 | Dietary Fiber Mixture | - | - | - | - | [1] 97 97 💬
|
| 721 | Dietary therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 722 | Dificlir | - | - | - | - | [1] 97 97 💬
|
| 723 | DIFICLIR - 200 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE -BLISTER (ALU/ALU) 2X10 COMPRESSE | - | - | - | - | [1] 97 97 💬
|
| 724 | DIFICLIR 200 mg compresse rivestite con film | - | - | - | - | [1] 97 97 💬
|
| 725 | DIFICLIR 200 mg film-coated tablets | - | - | - | - | [1] 97 97 💬
|
| 726 | DIMS0150 | - | - | - | - | [1] 97 97 💬
|
| 727 | Diosmin | [1] Diosmin Diosmin | [1] Diosmin
Diosmin
💬
| - | - | [4] 46 46, 51, 97, 265 💬
|
| 728 | Diphtheria booster vaccination | - | - | - | - | [1] 97 97 💬
|
| 729 | DISC-0974 | - | - | - | - | [1] 97 97 💬
|
| 730 | Discontinuation of thiopurines. | - | - | - | - | [1] 97 97 💬
|
| 731 | Doxycycline | [1] Doxycycline Doxycycline | [5] Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | [17] 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
|
| 732 | Dried Chicory Root | - | - | - | - | [1] 97 97 💬
|
| 733 | Dual biological therapy | - | - | - | - | [1] 97 97 💬
|
| 734 | Duloxetine | [1] Duloxetine Duloxetine | [2] Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [3] 6 6, 13, 97 💬
|
| 735 | Dupilumab | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [8] 51 51, 97, 98, 160, 162, 222, 300, 306 💬
|
| 736 | Duvakitug | [1] Duvakitug Duvakitug | [1] Duvakitug
Duvakitug
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 737 | E. coli Nissle | - | - | - | - | [1] 97 97 💬
|
| 738 | E. coli Nissle 1917 (Mutaflor®) | - | - | - | - | [1] 97 97 💬
|
| 739 | E400 elimination | - | - | - | - | [1] 97 97 💬
|
| 740 | E6007 | - | - | - | - | [1] 97 97 💬
|
| 741 | E6011 | - | - | - | - | [4] 46 46, 93, 96, 97 💬
|
| 742 | Ebetrex | - | - | - | - | [2] 96 96, 97 💬
|
| 743 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | [2] 96 96, 97 💬
|
| 744 | Echinacea | [1] Echinacea Echinacea | - | - | - | [1] 97 97 💬
|
| 745 | Echinacea Extract | [1] Echinacea Echinacea | - | - | - | [1] 97 97 💬
|
| 746 | Ecologic 825 | - | - | - | - | [1] 97 97 💬
|
| 747 | EFAVALEUKIN ALFA | [1] Efavaleukin alfa Efavaleukin alfa | [1] Efavaleukin alfa
Efavaleukin alfa
💬
| - | - | [2] 49 49, 97 💬
|
| 748 | Efmarodocokin alfa | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] Efmarodocokin alfa
Efmarodocokin alfa
💬
| [1] IL22 IL22 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 749 | EGF enema | - | - | - | - | [1] 97 97 💬
|
| 750 | Eicosapentaenoic acid | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 751 | Elemental 028 Extra | - | - | - | - | [1] 97 97 💬
|
| 752 | Elemental diet (ED) | - | - | - | - | [1] 97 97 💬
|
| 753 | Elemental formula (mBiota Elemental, Good LFE, Santa Monica, CA) | - | - | - | - | [1] 97 97 💬
|
| 754 | Eltrekibart | [1] Eltrekibart Eltrekibart | [1] Eltrekibart
Eltrekibart
💬
| [1] CXCR1 CXCR1 💬
| [6] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 97 97 💬
|
| 755 | EMEA/H/C/000240 | - | - | - | - | [2] 96 96, 97 💬
|
| 756 | EMEA/H/C/000481 | - | - | - | - | [1] 97 97 💬
|
| 757 | EMEA/H/C/002576 | - | - | - | - | [2] 96 96, 97 💬
|
| 758 | Empagliflozin | [1] Empagliflozin Empagliflozin | [1] Empagliflozin
Empagliflozin
💬
| - | - | [17] 28 28, 46, 57, 58, 65, 67, 72, 77, 86, 96, 97, 113, 222, 223, 257, 298, 299 💬
|
| 759 | Empagliflozin 10 MG | [1] Empagliflozin Empagliflozin | [1] Empagliflozin
Empagliflozin
💬
| - | - | [4] 58 58, 67, 86, 97 💬
|
| 760 | Emvistegrast | - | - | - | - | [1] 97 97 💬
|
| 761 | ENC1018 capsule administration group | - | - | - | - | [1] 97 97 💬
|
| 762 | Encapsulated faecal microbiota | - | - | - | - | [1] 97 97 💬
|
| 763 | Encapsulated faecal microbiota filtrate | - | - | - | - | [1] 97 97 💬
|
| 764 | Encapsulated Mesalamine Granules (eMG) | - | - | - | - | [1] 97 97 💬
|
| 765 | Enema | - | - | - | - | [1] 97 97 💬
|
| 766 | ENGERIX-B (HBV Vaccine) | - | - | - | - | [1] 97 97 💬
|
| 767 | ENGERIX-B 20µg / 1ml suspensión inyectable en jeringa precargada | - | - | - | - | [1] 97 97 💬
|
| 768 | Ensure Surgery Immunonutrition shakes | - | - | - | - | [1] 97 97 💬
|
| 769 | Entecavir | [1] Entecavir Entecavir | [2] Entecavir
Entecavir
,
Entecavir
💬
| - | - | [8] 46 46, 56, 96, 97, 107, 222, 223, 271 💬
|
| 770 | Entocort CR | - | - | - | - | [2] 96 96, 97 💬
|
| 771 | Entocort EC® 3 mg | - | - | - | - | [1] 97 97 💬
|
| 772 | Entocort® CR | - | - | - | - | [1] 97 97 💬
|
| 773 | Entyvio | - | - | - | - | [3] 94 94, 96, 97 💬
|
| 774 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU | - | - | - | - | [1] 97 97 💬
|
| 775 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 776 | ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | - | - | - | - | [1] 97 97 💬
|
| 777 | Entyvio 300 mg | - | - | - | - | [1] 97 97 💬
|
| 778 | Entyvio 300mg | - | - | - | - | [1] 97 97 💬
|
| 779 | Epaxal Berna (virosomal hepatitis A vaccine) | [1] Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [2] 96 96, 97 💬
|
| 780 | Epidermal growth factor | - | - | - | - | [1] 97 97 💬
|
| 781 | Epidermal growth factor enema | - | - | - | - | [1] 97 97 💬
|
| 782 | Epinephrine | [1] Epinephrine Epinephrine | [3] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Epinephrine bitartrate
💬
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 46 46, 70, 96, 97 💬
|
| 783 | Ergocalciferol | [1] Ergocalciferol Ergocalciferol | [1] Ergocalciferol
Ergocalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 46 46, 84, 96, 97, 299 💬
|
| 784 | ESKETAMINE | [1] Esketamine Esketamine | [2] Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [7] 2 2, 4, 6, 70, 96, 97, 156 💬
|
| 785 | Ethanol | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [8] 51 51, 58, 97, 144, 214, 278, 279, 280 💬
|
| 786 | Etrasimod | [1] Etrasimod Etrasimod | [2] Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 💬
|
| 787 | Etrasimod administration | [1] Etrasimod Etrasimod | [2] Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 788 | Etrasimod L-arginine | [3] Arginine Arginine, Etrasimod, L-arginine | [5] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
,
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 💬
|
| 789 | EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginine | [3] Arginine Arginine, Etrasimod, L-arginine | [5] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
,
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 790 | EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginine PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2- | [3] Arginine Arginine, Etrasimod, L-arginine | [5] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
,
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 791 | EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginineOther descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2- | [1] Etrasimod Etrasimod | [2] Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| [3] S1PR1 S1PR1, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 792 | ETROLIZUMAB | [1] Etrolizumab Etrolizumab | [1] Etrolizumab
Etrolizumab
💬
| [1] ITGB7 ITGB7 💬
| [13] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Integrin signaling, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | [2] 96 96, 97 💬
|
| 793 | EtrolizumabProduct Code: RO5490261/F04-02Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: EtrolizumabCAS Number: 1044758-60-2Current Sponsor code: RO5490261Other descriptive name: rhuMAb Beta7, Anti Beta7, PRO145223Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 105- | - | - | - | - | [1] 97 97 💬
|
| 794 | Etrozulimab | - | - | - | - | [1] 97 97 💬
|
| 795 | Evening Group | - | - | - | - | [1] 97 97 💬
|
| 796 | Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab | [5] Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
💬
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 797 | Exclusive Enteral Nutrition (EEN) | - | - | - | - | [1] 97 97 💬
|
| 798 | ExoFlo | - | - | - | - | [2] 96 96, 97 💬
|
| 799 | Exosomes derived from human umbilical cord mesenchymal stem cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 97 97 💬
|
| 800 | Exposed to IBD pharmacotherapy during pregnancy | - | - | - | - | [1] 97 97 💬
|
| 801 | Exposure to golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 802 | Eziclen | - | - | - | - | [1] 97 97 💬
|
| 803 | F8IL10 | - | - | - | - | [2] 46 46, 97 💬
|
| 804 | Faecal matter | - | - | - | - | [1] 97 97 💬
|
| 805 | Faecal Microbiota Transplant | - | - | - | - | [2] 94 94, 97 💬
|
| 806 | Faecal microbiota transplantation | - | - | - | - | [5] 46 46, 84, 96, 97, 271 💬
|
| 807 | FE 999301 | - | - | - | - | [2] 96 96, 97 💬
|
| 808 | Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's | - | - | - | - | [2] 96 96, 97 💬
|
| 809 | Febuxostat | [1] Febuxostat Febuxostat | [2] Febuxostat
Febuxostat
,
Febuxostat hydrate
💬
| [1] XDH XDH 💬
| [4] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | [5] 2 2, 6, 13, 67, 97 💬
|
| 810 | Fecal microbial l transplantation | - | - | - | - | [1] 97 97 💬
|
| 811 | Fecal Microbial transplant | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 812 | Fecal microbial transplantation | - | - | - | - | [3] 6 6, 96, 97 💬
|
| 813 | Fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [14] 2 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
|
| 814 | Fecal microbiota capsule | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 815 | Fecal Microbiota Enema | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 816 | Fecal Microbiota Transplant | [1] Fecal microbiota Fecal microbiota | - | - | - | [2] 96 96, 97 💬
|
| 817 | Fecal Microbiota Transplant (FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [2] 96 96, 97 💬
|
| 818 | Fecal microbiota transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [9] 2 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
|
| 819 | Fecal microbiota transplantation (FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [4] 94 94, 96, 97, 222 💬
|
| 820 | Fecal Microbiota Transplantation (FMT), OpenBiome | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 821 | Fecal Microbiota Transplantation by Intra-rectal enemas | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 822 | Fecal Microbiota Transplantation by Stool capsules | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 823 | Fecal transplantation | - | - | - | - | [1] 97 97 💬
|
| 824 | Fendrix | - | - | - | - | [2] 46 46, 97 💬
|
| 825 | FENDRIX, suspensión inyectable | - | - | - | - | [1] 97 97 💬
|
| 826 | Fenofibrate | [1] Fenofibrate Fenofibrate | [1] Fenofibrate
Fenofibrate
💬
| [1] PPARA PPARA 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [6] 8 8, 79, 93, 94, 97, 265 💬
|
| 827 | Fenofibrate 160mg | [1] Fenofibrate Fenofibrate | [1] Fenofibrate
Fenofibrate
💬
| [1] PPARA PPARA 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 97 97 💬
|
| 828 | Fentanyl | [1] Fentanyl Fentanyl | [3] Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [6] 46 46, 70, 97, 215, 231, 298 💬
|
| 829 | Fentanyl B. Braun | [1] Fentanyl Fentanyl | [3] Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 830 | Feraccru | - | - | - | - | [1] 97 97 💬
|
| 831 | Feramyl | - | - | - | - | [1] 97 97 💬
|
| 832 | Ferinject | - | - | - | - | [3] 86 86, 97, 299 💬
|
| 833 | FERINJECT - 50 MG/ML SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO IN VETRO DA 10 ML | - | - | - | - | [1] 97 97 💬
|
| 834 | Ferinject 50 mg /ml. Solución inyectable y para perfusión | - | - | - | - | [1] 97 97 💬
|
| 835 | Ferinject 50 mg Eisen/ml | - | - | - | - | [1] 97 97 💬
|
| 836 | FERINJECT 50 mg iron/ml solution for injection and infusion | - | - | - | - | [1] 97 97 💬
|
| 837 | FERINJECT® (Ferric carboxymaltose) | [1] Ferric carboxymaltose Ferric carboxymaltose | [1] Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | [1] 97 97 💬
|
| 838 | FERLIXIT - 62.5 MG/5 ML SOLUZIONE PER USO ORALE E USO ENDOVENOSO 5 FIALE DA 5 ML | - | - | - | - | [1] 97 97 💬
|
| 839 | Ferracru | - | - | - | - | [1] 97 97 💬
|
| 840 | Ferric Carboxy Maltose | [1] Maltose Maltose | [1] Maltose
Maltose
💬
| - | - | [2] 96 96, 97 💬
|
| 841 | FERRIC CARBOXYMALTOSE | [1] Ferric carboxymaltose Ferric carboxymaltose | [1] Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | [4] 86 86, 96, 97, 299 💬
|
| 842 | Ferric derisomaltose | [1] Ferric derisomaltose Ferric derisomaltose | [1] Ferric derisomaltose
Ferric derisomaltose
💬
| - | - | [1] 97 97 💬
|
| 843 | Ferric Gluconate | - | - | - | - | [1] 97 97 💬
|
| 844 | Ferric Maltol | [1] Ferric maltol Ferric maltol | [1] Ferric maltol
Ferric maltol
💬
| - | - | [2] 96 96, 97 💬
|
| 845 | Ferric trimaltol | - | - | - | - | [1] 97 97 💬
|
| 846 | FERRISAT | - | - | - | - | [1] 97 97 💬
|
| 847 | FERRISAT 50mg/ml | - | - | - | - | [1] 97 97 💬
|
| 848 | Ferro Duretter, prolonged release | - | - | - | - | [1] 97 97 💬
|
| 849 | Ferro Duretter, prolonged release tablet | - | - | - | - | [1] 97 97 💬
|
| 850 | Ferro e.v. (come carbossimaltoso ferrico) - FERINJECT | - | - | - | - | [1] 97 97 💬
|
| 851 | Ferro e.v. (come gluconato ferrico) | - | - | - | - | [1] 97 97 💬
|
| 852 | Ferrofumaraat | - | - | - | - | [1] 97 97 💬
|
| 853 | Ferrofumaraat Apotex | - | - | - | - | [1] 97 97 💬
|
| 854 | Ferrofumaraat TEVA | - | - | - | - | [1] 97 97 💬
|
| 855 | FERROUS FUMARATE | [1] Ferrous fumarate Ferrous fumarate | - | - | - | [1] 97 97 💬
|
| 856 | Ferrous Fumarate Syrup | [1] Ferrous fumarate Ferrous fumarate | - | - | - | [1] 97 97 💬
|
| 857 | Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron) | [1] Ferrous fumarate Ferrous fumarate | - | - | - | [1] 97 97 💬
|
| 858 | Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron) | [1] Ferrous fumarate Ferrous fumarate | - | - | - | [1] 97 97 💬
|
| 859 | Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron) | [1] Ferrous fumarate Ferrous fumarate | - | - | - | [1] 97 97 💬
|
| 860 | Ferrous sulfate | [1] Ferrous sulfate anhydrous Ferrous sulfate anhydrous | [1] Ferrous sulfate
Ferrous sulfate
💬
| - | - | [2] 97 97, 299 💬
|
| 861 | Ferrous Sulfate tablets | [1] Ferrous sulfate anhydrous Ferrous sulfate anhydrous | [1] Ferrous sulfate
Ferrous sulfate
💬
| - | - | [1] 97 97 💬
|
| 862 | Ferrous sulphate | - | - | - | - | [2] 96 96, 97 💬
|
| 863 | Ferrous sulphate with 65 mg iron++ per tablet | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 864 | Fibrin | [1] Fibrin Fibrin | - | - | - | [3] 96 96, 97, 279 💬
|
| 865 | Fibrin adhesive | [1] Fibrin Fibrin | - | - | - | [1] 97 97 💬
|
| 866 | FIDAXOMICIN | [1] Fidaxomicin Fidaxomicin | [1] Fidaxomicin
Fidaxomicin
💬
| - | - | [1] 97 97 💬
|
| 867 | Fidaxomicina | [1] Fidaxomicin Fidaxomicin | [1] Fidaxomicin
Fidaxomicin
💬
| - | - | [1] 97 97 💬
|
| 868 | FILGOTINIB | [1] Filgotinib Filgotinib | [2] Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [10] 46 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
| 869 | Filgotinib Maleate | [1] Filgotinib Filgotinib | [2] Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 97 💬
|
| 870 | Film-coated tablet | - | - | - | - | [1] 97 97 💬
|
| 871 | First-line biologic:IFX | - | - | - | - | [1] 97 97 💬
|
| 872 | First-line biologic:VDZ | - | - | - | - | [1] 97 97 💬
|
| 873 | FITC-Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 874 | Flagyl | - | - | - | - | [2] 96 96, 97 💬
|
| 875 | Flaxseed lignan-enriched complex (FLC) | - | - | - | - | [1] 97 97 💬
|
| 876 | Flixabi | - | - | - | - | [2] 96 96, 97 💬
|
| 877 | Fluorescein | [1] Fluorescein Fluorescein | [2] Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | [4] 19 19, 22, 41, 97 💬
|
| 878 | Fluorescence Imaging | - | - | - | - | [2] 46 46, 97 💬
|
| 879 | Fluorescence molecular imaging procedure using vedolizumab-800CW | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 880 | Fluoropyrimidine | - | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 881 | Flupentixol | [1] Flupentixol Flupentixol | [3] Flupentixol
Flupentixol
,
Flupentixol dihydrochloride
,
Flupentixol decanoate
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 97 97 💬
|
| 882 | FMT | - | - | - | - | [3] 96 96, 97, 271 💬
|
| 883 | FMT enema | - | - | - | - | [1] 97 97 💬
|
| 884 | FMT infusions | - | - | - | - | [1] 97 97 💬
|
| 885 | FMT oral | - | - | - | - | [1] 97 97 💬
|
| 886 | FMT Protocol | - | - | - | - | [1] 97 97 💬
|
| 887 | Folacin | - | - | - | - | [2] 96 96, 97 💬
|
| 888 | Folic acid | [1] Folic acid Folic acid | [2] Folic acid
Folic acid
,
Folate sodium
💬
| - | - | [9] 6 6, 46, 49, 50, 84, 97, 118, 172, 296 💬
|
| 889 | Fosfomycin | [1] Fosfomycin Fosfomycin | [3] Fosfomycin tromethamine
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
💬
| - | - | [2] 96 96, 97 💬
|
| 890 | FP-110 | - | - | - | - | [1] 97 97 💬
|
| 891 | FP-CYA-050 | - | - | - | - | [1] 97 97 💬
|
| 892 | FP-CYA-053 | - | - | - | - | [1] 97 97 💬
|
| 893 | Freeze dried grape powder | [1] Grape Grape | - | - | - | [2] 96 96, 97 💬
|
| 894 | Freeze-dried black raspberry powder | [1] Raspberry Raspberry | [1] Raspberry
Raspberry
💬
| - | - | [1] 97 97 💬
|
| 895 | Frondanol | - | - | - | - | [1] 97 97 💬
|
| 896 | Fructose | [1] Fructose Fructose | [1] Fructose
Fructose
💬
| - | - | [2] 97 97, 257 💬
|
| 897 | Fructose Sachet | [1] Fructose Fructose | [1] Fructose
Fructose
💬
| - | - | [1] 97 97 💬
|
| 898 | Fully human IgG1 monoclonal antibody specific for TL1A | - | - | - | - | [2] 96 96, 97 💬
|
| 899 | G1567970 | - | - | - | - | [3] 46 46, 53, 97 💬
|
| 900 | G321605 | - | - | - | - | [3] 85 85, 96, 97 💬
|
| 901 | Ganciclovir | [1] Ganciclovir Ganciclovir | [2] Ganciclovir
Ganciclovir
,
Ganciclovir sodium
💬
| - | - | [3] 28 28, 60, 97 💬
|
| 902 | Gardasil vaccine | - | - | - | - | [1] 97 97 💬
|
| 903 | Gastro-resistant phosphatidylcholine granules | - | - | - | - | [1] 97 97 💬
|
| 904 | Gastroscopy | - | - | - | - | [1] 97 97 💬
|
| 905 | GB004 | - | - | - | - | [1] 97 97 💬
|
| 906 | GB004-HCl | - | - | - | - | [1] 97 97 💬
|
| 907 | GED-0301 | - | - | - | - | [2] 96 96, 97 💬
|
| 908 | GED-0507-34-LEVO | [1] GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1] 97 97 💬
|
| 909 | GED-0507-34-Levo 160 mg | [1] GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1] 97 97 💬
|
| 910 | GED-0507-34-Levo 80 mg | [1] GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1] 97 97 💬
|
| 911 | GED0507 | - | - | - | - | [1] 97 97 💬
|
| 912 | Gelatin | [1] Gelatin Gelatin | [1] Gelatin
Gelatin
💬
| - | - | [7] 28 28, 47, 62, 70, 71, 97, 269 💬
|
| 913 | Genetic: 2ml peripheral venous blood was collected to detect genetic genes | - | - | - | - | [1] 97 97 💬
|
| 914 | Genetic: Assessment of Genetics | - | - | - | - | [1] 97 97 💬
|
| 915 | Genetic: Blood or saliva sample collection | - | - | - | - | [3] 96 96, 97, 299 💬
|
| 916 | Genetic: Genomic DNA | - | - | - | - | [1] 97 97 💬
|
| 917 | Genetic: genotyping for three genes (TPMT, NUDT15 and FTO) | - | - | - | - | [1] 97 97 💬
|
| 918 | Genetic: HLADQA1*05A>G screening | - | - | - | - | [2] 96 96, 97 💬
|
| 919 | Genetic: Microbiome | - | - | - | - | [1] 97 97 💬
|
| 920 | Genetic: PCR-RFLP | - | - | - | - | [1] 97 97 💬
|
| 921 | Genetic: PGx-guided post-operative pain management | - | - | - | - | [2] 96 96, 97 💬
|
| 922 | Genetic: Pre-genotype NUDT15 and optimize azathioprine dosage | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 97 97 💬
|
| 923 | Genetic: RNA analysis | - | - | - | - | [3] 28 28, 60, 97 💬
|
| 924 | Genetic: TPMT genotyping | - | - | - | - | [2] 96 96, 97 💬
|
| 925 | Genetic: transcriptomic analysis | - | - | - | - | [1] 97 97 💬
|
| 926 | GI-270384 | - | - | - | - | [1] 97 97 💬
|
| 927 | GlobiFer Forte | - | - | - | - | [1] 97 97 💬
|
| 928 | GLPG0634 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 929 | GLPG0974 | - | - | - | - | [1] 97 97 💬
|
| 930 | GLPG1205 | - | - | - | - | [3] 85 85, 96, 97 💬
|
| 931 | GLPG3970 | - | - | - | - | [3] 46 46, 53, 97 💬
|
| 932 | Gluconato ferrico sodico | - | - | - | - | [1] 97 97 💬
|
| 933 | Glutamine | [1] L-Glutamine L-Glutamine | [1] Glutamine
Glutamine
💬
| - | - | [7] 87 87, 89, 96, 97, 113, 245, 299 💬
|
| 934 | Gluten free diet | - | - | - | - | [1] 97 97 💬
|
| 935 | Gluten-free diet | - | - | - | - | [2] 94 94, 97 💬
|
| 936 | Glycyrrhiza glabra | [1] Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [1] 97 97 💬
|
| 937 | GLYCYRRHIZA GLABRA ROOT | [1] Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [1] 97 97 💬
|
| 938 | GM-CSF, fosfomycin and metronidazole | [2] Fosfomycin Fosfomycin, Metronidazole | [5] Metronidazole
Metronidazole
,
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
,
Metronidazole hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 939 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 940 | GOLIMUMAB | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 46 46, 56, 84, 96, 97, 107, 270, 271 💬
|
| 941 | Golimumab (GLM) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 942 | Golimumab (Optimization) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 943 | Golimumab 1 mg per kg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 944 | Golimumab 100 mg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 945 | Golimumab 2 mg per kg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 946 | Golimumab 200 mg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 947 | Golimumab 4 mg per kg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 948 | Golimumab 400 mg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 949 | Golimumab 50 mg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 950 | Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 951 | Golimumab Dose 1 | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 952 | Golimumab Dose 2 | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 953 | Golimumab Liquid in prefilled syringe | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 84, 97, 107 💬
|
| 954 | Golimumab Liquid in Vial | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 97, 271 💬
|
| 955 | Golimumab Prefilled Syringe | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 956 | Golimumab treatment optimization. | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 957 | Gralise | - | - | - | - | [2] 97 97, 226 💬
|
| 958 | GRANOCYTE 34 | - | - | - | - | [1] 97 97 💬
|
| 959 | Granulated mesalamine | - | - | - | - | [1] 97 97 💬
|
| 960 | Grape | [1] Grape Grape | - | - | - | [2] 96 96, 97 💬
|
| 961 | Grape Seed Extracts | [1] Grape Grape | - | - | - | [1] 97 97 💬
|
| 962 | Grapefruit | [1] Grapefruit Grapefruit | - | - | - | [5] 6 6, 46, 50, 83, 97 💬
|
| 963 | Group 1 of patients will receive Adalimumab while Group 1 will receive ustekinumab | [2] Adalimumab Adalimumab, Ustekinumab | [2] Adalimumab
Adalimumab
,
Ustekinumab
💬
| [4] IL12A IL12A, IL12B, IL23A, TNF 💬
| [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 964 | Group 1- Control Diet | - | - | - | - | [1] 97 97 💬
|
| 965 | Group 2 ustekinumab 130 mg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 966 | Group 2- UCD Diet | - | - | - | - | [1] 97 97 💬
|
| 967 | Group 3: ustekinumab approximately 6 mg/kg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 968 | Growth Hormone | - | - | - | - | [10] 19 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
|
| 969 | GS-4875 | - | - | - | - | [1] 97 97 💬
|
| 970 | GS-5745 | [1] GS-5745 GS-5745 | - | - | - | [4] 46 46, 96, 97, 299 💬
|
| 971 | GS-5745 IV | [1] GS-5745 GS-5745 | - | - | - | [1] 97 97 💬
|
| 972 | GS-5745 SC | [1] GS-5745 GS-5745 | - | - | - | [1] 97 97 💬
|
| 973 | GS-6034 | - | - | - | - | [4] 46 46, 53, 96, 97 💬
|
| 974 | GSK1399686 | - | - | - | - | [1] 97 97 💬
|
| 975 | GSK1605786 | - | - | - | - | [2] 96 96, 97 💬
|
| 976 | GSK1605786A | - | - | - | - | [2] 96 96, 97 💬
|
| 977 | GSK2586184 400mg | - | - | - | - | [1] 97 97 💬
|
| 978 | GSK2831781 | - | - | - | - | [1] 97 97 💬
|
| 979 | GSK2831781 - Double Blind Phase | - | - | - | - | [1] 97 97 💬
|
| 980 | GSK2831781 - Open Label phase | - | - | - | - | [1] 97 97 💬
|
| 981 | GSK2982772 | - | - | - | - | [2] 46 46, 97 💬
|
| 982 | GSK2982772A, where A denotes the free base | - | - | - | - | [2] 46 46, 97 💬
|
| 983 | Guselkum | - | - | - | - | [1] 97 97 💬
|
| 984 | GUSELKUMAB | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [7] 37 37, 41, 51, 96, 97, 161, 269 💬
|
| 985 | Guselkumab (GUS) | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 986 | Guselkumab (GUS), JAK inhibitors (such as upadacitinib/tofacitinib) | [3] Guselkumab Guselkumab, Tofacitinib, Upadacitinib | [6] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
,
Guselkumab
,
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [5] IL23A IL23A, JAK1, JAK2, JAK3, TYK2 💬
| [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, C-type lectin receptor signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 987 | Guselkumab (Tremfya) | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 988 | Guselkumab Dose 1 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 💬
|
| 989 | Guselkumab Dose 2 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 💬
|
| 990 | Guselkumab Dose 3 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 991 | Guselkumab Intravenous | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 97 97 💬
|
| 992 | Guselkumab Subcutaneous | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 993 | GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: GuselkumabProduct Code: CNTO1959Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: GuselkumabCurrent Sponsor code: CNTO1959Other descriptive name: GUSELKUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 97 97 💬
|
| 994 | Gut Microbial Transplantation | - | - | - | - | [1] 97 97 💬
|
| 995 | GWP42003 | - | - | - | - | [1] 97 97 💬
|
| 996 | H021 | - | - | - | - | [1] 97 97 💬
|
| 997 | H02AB | - | - | - | - | [1] 97 97 💬
|
| 998 | HE3286 | - | - | - | - | [2] 46 46, 97 💬
|
| 999 | Hemay005 tablet | - | - | - | - | [1] 97 97 💬
|
| 1000 | Hemay005 tablets | - | - | - | - | [1] 97 97 💬
|
| 1001 | Hemay007 | - | - | - | - | [1] 97 97 💬
|
| 1002 | Hepatitis A Vaccine | [1] Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [3] 46 46, 96, 97 💬
|
| 1003 | Hepatitis B vaccine | - | - | - | - | [1] 97 97 💬
|
| 1004 | Herbal treatment (SA100) | - | - | - | - | [1] 97 97 💬
|
| 1005 | Hextend | - | - | - | - | [2] 96 96, 97 💬
|
| 1006 | HF2 | - | - | - | - | [1] 97 97 💬
|
| 1007 | Hgd40 | - | - | - | - | [1] 97 97 💬
|
| 1008 | HGS1025 | - | - | - | - | [1] 97 97 💬
|
| 1009 | High dose | - | - | - | - | [1] 97 97 💬
|
| 1010 | High Dose Budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1011 | High dose budesonide rectal foam | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1012 | High dose influenza vaccine (HDIV) | - | - | - | - | [1] 97 97 💬
|
| 1013 | High Dose MT-1303 | - | - | - | - | [1] 97 97 💬
|
| 1014 | High gluten diet | - | - | - | - | [1] 97 97 💬
|
| 1015 | High Protein and Low Fiber Diet | - | - | - | - | [1] 97 97 💬
|
| 1016 | High-Dose CICR-NAM | - | - | - | - | [1] 97 97 💬
|
| 1017 | High-dose MH002 | - | - | - | - | [1] 97 97 💬
|
| 1018 | HM201 | - | - | - | - | [2] 96 96, 97 💬
|
| 1019 | HMPL-004 | - | - | - | - | [2] 96 96, 97 💬
|
| 1020 | HMPL-004 1800 mg/day | - | - | - | - | [1] 97 97 💬
|
| 1021 | HMPL-004 2400 mg/day | - | - | - | - | [1] 97 97 💬
|
| 1022 | HMPL-004 high dose | - | - | - | - | [1] 97 97 💬
|
| 1023 | HMPL-004 low dose | - | - | - | - | [1] 97 97 💬
|
| 1024 | HMPL004-6599 | - | - | - | - | [2] 96 96, 97 💬
|
| 1025 | Hospital-Based Vaccination Pathway | - | - | - | - | [1] 97 97 💬
|
| 1026 | HRS-7085 | - | - | - | - | [1] 97 97 💬
|
| 1027 | HRS-7085 tablets | - | - | - | - | [1] 97 97 💬
|
| 1028 | HSK47388 | - | - | - | - | [1] 97 97 💬
|
| 1029 | Hulio | - | - | - | - | [2] 96 96, 97 💬
|
| 1030 | HuM291 | - | - | - | - | [2] 96 96, 97 💬
|
| 1031 | HuM291) | - | - | - | - | [1] 97 97 💬
|
| 1032 | Human anti-IP10 monoclonal antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 1033 | Human Anti-TNF IgG1 Monoclonal Antibody | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 1034 | Human anti-TNF-alpha monoclonal antibody | - | - | - | - | [3] 46 46, 97, 107 💬
|
| 1035 | Human Anti-TNFalfa | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 1036 | Human Papillomavirus Vaccine | - | - | - | - | [1] 97 97 💬
|
| 1037 | Human Umbilical Cord Mesenchymal Stem Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [5] 13 13, 96, 97, 113, 271 💬
|
| 1038 | Humanized recombinant IgG4 monoclonal antibody against CD-127 | - | - | - | - | [1] 97 97 💬
|
| 1039 | HUMIRA | - | - | - | - | [9] 46 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
|
| 1040 | Humira (adalimumab original) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1041 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER | - | - | - | - | [2] 56 56, 97 💬
|
| 1042 | Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL) | - | - | - | - | [1] 97 97 💬
|
| 1043 | Humira 40 mg solution for injection in pre-filled syringe | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1044 | Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL) | - | - | - | - | [1] 97 97 💬
|
| 1045 | Humira 40 mg solution for injection in pre-filled syringes | - | - | - | - | [1] 97 97 💬
|
| 1046 | Humira 40 mg/0.8 ml solution for injection | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1047 | Humira 40 mg/0.8 ml solution for injection for paediatric use | - | - | - | - | [1] 97 97 💬
|
| 1048 | HUMIRA 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 💬
|
| 1049 | Humira 40mg/0.4ml pre-filled syringe | - | - | - | - | [2] 96 96, 97 💬
|
| 1050 | Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL) | - | - | - | - | [1] 97 97 💬
|
| 1051 | HUMIRA ® | - | - | - | - | [2] 96 96, 97 💬
|
| 1052 | Humira® | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 1053 | HW201877 capsules | - | - | - | - | [1] 97 97 💬
|
| 1054 | Hydrocortisone | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
|
| 1055 | HYDROCORTISONE ACETATE | [3] Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1056 | HYDROCORTISONE SODIUM SUCCINATE | [3] Hydrocortisone Hydrocortisone, Hydrocortisone succinate, Succinic acid | [3] Hydrocortisone
Hydrocortisone
,
Hydrocortisone sodium succinate
,
Hydrocortisone succinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 81 81, 83, 97 💬
|
| 1057 | Hydrogen | [1] Hydrogen Hydrogen | - | - | - | [8] 5 5, 6, 13, 17, 83, 97, 226, 238 💬
|
| 1058 | Hydroxocobalamin | [1] Hydroxocobalamin Hydroxocobalamin | [2] Hydroxocobalamin
Hydroxocobalamin
,
Hydroxocobalamin acetate
💬
| - | - | [3] 97 97, 246, 337 💬
|
| 1059 | Hydroxocobalamin with Butyrate | [1] Hydroxocobalamin Hydroxocobalamin | [2] Hydroxocobalamin
Hydroxocobalamin
,
Hydroxocobalamin acetate
💬
| - | - | [1] 97 97 💬
|
| 1060 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 1061 | Hydroxyethyl Starch | [1] Hydroxyethyl Starch Hydroxyethyl Starch | [1] Hetastarch
Hetastarch
💬
| - | - | [1] 97 97 💬
|
| 1062 | Hyperbaric Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [3] 46 46, 97, 269 💬
|
| 1063 | Hyperbaric oxygen treatment (HBOT) | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [6] 13 13, 15, 36, 96, 97, 269 💬
|
| 1064 | IBD98-M | - | - | - | - | [1] 97 97 💬
|
| 1065 | IBD98-M Delayed-release Capsules | - | - | - | - | [1] 97 97 💬
|
| 1066 | Iberogast N | - | - | - | - | [1] 97 97 💬
|
| 1067 | ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T | - | - | - | - | [1] 97 97 💬
|
| 1068 | Icotrokinra | [1] Icotrokinra Icotrokinra | [1] Icotrokinra
Icotrokinra
💬
| [1] IL23R IL23R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 1069 | Identical Tacrolimus-free Lipid Suspension for Enema | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1070 | IDOFORM®Travel | - | - | - | - | [1] 97 97 💬
|
| 1071 | IDROCORTISONE ACETATO | - | - | - | - | [1] 97 97 💬
|
| 1072 | IGG2 ANTIBODIES | - | - | - | - | [2] 96 96, 97 💬
|
| 1073 | IM90838 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1074 | Imolope | - | - | - | - | [1] 97 97 💬
|
| 1075 | Imraldi | - | - | - | - | [2] 96 96, 97 💬
|
| 1076 | IMU-838 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1077 | Imuran | - | - | - | - | [2] 96 96, 97 💬
|
| 1078 | Imurek 25mg Filmtabletten | - | - | - | - | [1] 97 97 💬
|
| 1079 | Imurek 50mg Filmtabletten | - | - | - | - | [1] 97 97 💬
|
| 1080 | IMUREL | - | - | - | - | [7] 13 13, 44, 45, 46, 54, 96, 97 💬
|
| 1081 | Inactivated influenza vaccine (IIV) at baseline | - | - | - | - | [2] 46 46, 97 💬
|
| 1082 | Inactivated influenza vaccine at Month 1 | - | - | - | - | [2] 46 46, 97 💬
|
| 1083 | INCB039110 | - | - | - | - | [3] 51 51, 97, 228 💬
|
| 1084 | Indigo | [1] Indigo Indigo | - | - | - | [3] 97 97, 289, 300 💬
|
| 1085 | Indigo-carmine 0.2% using a spray catheter | [1] Indigo Indigo | - | - | - | [1] 97 97 💬
|
| 1086 | Induction- PF-06480605 150 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 1087 | Induction- PF-06480605 450 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 1088 | Induction- PF-06480605 50 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 1089 | Inflectra | - | - | - | - | [4] 46 46, 56, 96, 97 💬
|
| 1090 | Inflectra 100 mg | - | - | - | - | [1] 97 97 💬
|
| 1091 | Inflectra 100 mg powder for concentrate for solution for infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 1092 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 1093 | Infliximab (IFX) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1094 | Infliximab 10 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 1095 | Infliximab 5 mg/kg | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1096 | Infliximab [infliximab biosimilar 3] | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 37 37, 46, 96, 97 💬
|
| 1097 | Infliximab Adalimumab y Golimumab | [3] Adalimumab Adalimumab, Golimumab, Infliximab | [3] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1098 | Infliximab and adalimumab | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1099 | Infliximab at weeks 0 and 8 | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1100 | Infliximab at weeks 0,2, and 6 | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1101 | Infliximab at weeks 0,4, and 8 | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1102 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib | [6] Adalimumab Adalimumab, Golimumab, Infliximab, Tofacitinib, Ustekinumab, Vedolizumab | [7] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
,
Tofacitinib citrate
,
Tofacitinib
💬
| [10] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TNF, TYK2 💬
| [97] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1103 | Infliximab therapeutic drug monitoring | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1104 | Infliximab Treatment | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1105 | Infliximab, adalimumab, certolizumab pegol | [3] Adalimumab Adalimumab, Certolizumab pegol, Infliximab | [3] Adalimumab
Adalimumab
,
Infliximab
,
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1106 | Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab | [5] Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5] Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
💬
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Insulin resistance, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1107 | Infliximab-Biosimilar | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1108 | Infliximab-Innovator | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1109 | Influenza vaccination | - | - | - | - | [2] 97 97, 299 💬
|
| 1110 | Influenza vaccine | - | - | - | - | [6] 11 11, 13, 46, 51, 84, 97 💬
|
| 1111 | Infusion of Saline | - | - | - | - | [1] 97 97 💬
|
| 1112 | Injectafer | - | - | - | - | [1] 97 97 💬
|
| 1113 | Injectafer /ferinject. | - | - | - | - | [1] 97 97 💬
|
| 1114 | Injectafer 50 mg ijzer / ml oplossing voor injectie/infusie | - | - | - | - | [1] 97 97 💬
|
| 1115 | Injection of CNK-UT009 | - | - | - | - | [2] 96 96, 97 💬
|
| 1116 | Innovator infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 1117 | Inositol | [1] Inositol Inositol | [1] Inositol
Inositol
💬
| - | - | [3] 96 96, 97, 118 💬
|
| 1118 | INT-210 Capsule | - | - | - | - | [1] 97 97 💬
|
| 1119 | Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM) | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 97 97 💬
|
| 1120 | INTERFERON BETA-1A | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [2] Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 13 13, 14, 26, 96, 97 💬
|
| 1121 | Interferon-beta-1a, 44 microgram | - | - | - | - | [1] 97 97 💬
|
| 1122 | Interferon-beta-1a, 66 microgram | - | - | - | - | [1] 97 97 💬
|
| 1123 | Interleukin 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
|
| 1124 | Interleukin 23 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1125 | Interleukin-2 (aldesleukin). | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 96 96, 97 💬
|
| 1126 | Interleukin-23 Inhibitors (IL-23i) | - | - | - | - | [1] 97 97 💬
|
| 1127 | Intestinal biopsies | - | - | - | - | [2] 96 96, 97 💬
|
| 1128 | Intestinal flora capsule | - | - | - | - | [1] 97 97 💬
|
| 1129 | Intravenous (IV) infusions | - | - | - | - | [2] 13 13, 97 💬
|
| 1130 | Intravenous iron | - | - | - | - | [1] 97 97 💬
|
| 1131 | Intravenous iron sucrose | [2] Iron sucrose Iron sucrose, Sucrose | [2] Sucrose
Sucrose
,
Iron sucrose
💬
| - | - | [1] 97 97 💬
|
| 1132 | Intravenous Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 97, 145 💬
|
| 1133 | Intravenous midazolam (3 mg initially, with optional 3 mg boluses) plus fentanyl (100 mcg) for procedural sedation. | [2] Fentanyl Fentanyl, Midazolam | [6] Fentanyl
Fentanyl
,
Midazolam
,
Midazolam hydrochloride
,
Fentanyl citrate
,
Midazolam maleate
,
Fentanyl hydrochloride
💬
| [17] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, OPRM1 💬
| [11] Cadherin signaling Cadherin signaling, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1134 | Intravenous remimazolam (5 mg initially, with optional 2.5 mg boluses) plus fentanyl (100 mcg) for procedural sedation. | [2] Fentanyl Fentanyl, Remimazolam | [5] Fentanyl
Fentanyl
,
Fentanyl citrate
,
Remimazolam besylate
,
Fentanyl hydrochloride
,
Remimazolam
💬
| [17] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, OPRM1 💬
| [11] Cadherin signaling Cadherin signaling, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1135 | Inulin | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [5] 6 6, 96, 97, 156, 299 💬
|
| 1136 | Inulin Sachet | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [1] 97 97 💬
|
| 1137 | Inulin/Inulin C13 | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [2] 96 96, 97 💬
|
| 1138 | INV-101 | - | - | - | - | [1] 97 97 💬
|
| 1139 | IPG11406 | - | - | - | - | [1] 97 97 💬
|
| 1140 | Ipilimumab | [1] Ipilimumab Ipilimumab | [1] Ipilimumab
Ipilimumab
💬
| [1] CTLA4 CTLA4 💬
| [4] Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | [9] 13 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
|
| 1141 | Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [7] 18 18, 60, 96, 97, 238, 254, 284 💬
|
| 1142 | Iron (III) hydroxide hydroxyethyl starch glucopheptonic acid complex | [2] Hydroxyethyl Starch Hydroxyethyl Starch, Iron | [2] Ferrous fumarate
Ferrous fumarate
,
Hetastarch
💬
| - | - | [1] 97 97 💬
|
| 1143 | Iron Dextran | [3] Dextran Dextran, Iron, Iron Dextran | [7] Dextran 1
Dextran 1
,
Ferrous fumarate
,
Dextran sulfate sodium
,
Iron dextran
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [2] 62 62, 97 💬
|
| 1144 | Iron HES Complex | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1145 | Iron integrated haemolysed haemoglobin powderequal to 18 mg Fe++ | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1146 | Iron isomalto-oligosaccharide complex | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1147 | Iron Isomaltoside | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1148 | IRON ISOMALTOSIDE 1000 | [2] Iron Iron, Iron isomaltoside 1000 | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1149 | Iron isomaltoside complex - Iron Isomaltoside 1000 | [2] Iron Iron, Iron isomaltoside 1000 | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1150 | Iron oligosaccharide complex | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1151 | Iron sucrose | [3] Iron Iron, Iron sucrose, Sucrose | [3] Sucrose
Sucrose
,
Ferrous fumarate
,
Iron sucrose
💬
| - | - | [3] 62 62, 96, 97 💬
|
| 1152 | Iron Sucrose. | [3] Iron Iron, Iron sucrose, Sucrose | [3] Sucrose
Sucrose
,
Ferrous fumarate
,
Iron sucrose
💬
| - | - | [1] 97 97 💬
|
| 1153 | Iron Sulfate | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1154 | Iron sulphate | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 1155 | Iron sulphate 200mg coated tablets | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 1156 | Iron supplement 300-600 mg/day | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 96 96, 97 💬
|
| 1157 | Iron trivalent | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1158 | IRON(III) ISOMALTOSIDE 1000 | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1159 | Iron(III)- hydroxide dextran complex | [2] Dextran Dextran, Iron | [6] Dextran 1
Dextran 1
,
Ferrous fumarate
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1160 | IRON(III)-HYDROXIDE DEXTRAN COMPLEX | [1] Dextran Dextran | [5] Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| [2] LIPC LIPC, LPL 💬
| [4] Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | [1] 97 97 💬
|
| 1161 | ISM5411 tablets | - | - | - | - | [1] 97 97 💬
|
| 1162 | Isoflavone | [1] Isoflavone Isoflavone | - | - | - | [2] 96 96, 97 💬
|
| 1163 | Itacitinib | [1] Itacitinib Itacitinib | [2] Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 51, 97, 228 💬
|
| 1164 | ITACITINIB ADIPATE | [1] Itacitinib Itacitinib | [2] Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 97 97, 228 💬
|
| 1165 | Itraconazole | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [13] 2 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
|
| 1166 | IV Corticosteroid | - | - | - | - | [1] 97 97 💬
|
| 1167 | IV Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 1168 | IZINOVA | - | - | - | - | [1] 97 97 💬
|
| 1169 | JAK inhibitor | - | - | - | - | [4] 46 46, 50, 97, 325 💬
|
| 1170 | Janus Kinase Inhibitor | - | - | - | - | [4] 46 46, 97, 110, 162 💬
|
| 1171 | JNJ-54781532 150 mg once daily | - | - | - | - | [1] 97 97 💬
|
| 1172 | JNJ-54781532 25 mg once daily | - | - | - | - | [1] 97 97 💬
|
| 1173 | JNJ-54781532 75 mg once daily | - | - | - | - | [1] 97 97 💬
|
| 1174 | JNJ-54781532 75 mg twice daily | - | - | - | - | [1] 97 97 💬
|
| 1175 | JNJ-54781532-AAD-10 mg | - | - | - | - | [1] 97 97 💬
|
| 1176 | JNJ-54781532-AAD-30 mg | - | - | - | - | [1] 97 97 💬
|
| 1177 | JNJ-54781532-AAD-5 mg | - | - | - | - | [1] 97 97 💬
|
| 1178 | JNJ-64841829 | - | - | - | - | [1] 97 97 💬
|
| 1179 | JNJ-64841842 | - | - | - | - | [1] 97 97 💬
|
| 1180 | JNJ-64841855 | - | - | - | - | [1] 97 97 💬
|
| 1181 | JNJ-64841894 | - | - | - | - | [1] 97 97 💬
|
| 1182 | JNJ-64841907 | - | - | - | - | [1] 97 97 💬
|
| 1183 | JNJ-64841920 | - | - | - | - | [1] 97 97 💬
|
| 1184 | JNJ-64841933 | - | - | - | - | [1] 97 97 💬
|
| 1185 | JNJ-64841946 | - | - | - | - | [1] 97 97 💬
|
| 1186 | JNJ-66525433 | - | - | - | - | [1] 97 97 💬
|
| 1187 | JNJ-72537634 | - | - | - | - | [1] 97 97 💬
|
| 1188 | JNJ-77242113 | - | - | - | - | [2] 37 37, 97 💬
|
| 1189 | JNJ-78934804 | - | - | - | - | [2] 96 96, 97 💬
|
| 1190 | Jyseleca | - | - | - | - | [2] 46 46, 97 💬
|
| 1191 | K(D)PT | - | - | - | - | [1] 97 97 💬
|
| 1192 | Kamillenblüten 3ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 1193 | Kappaproct | - | - | - | - | [1] 97 97 💬
|
| 1194 | KBL697 | - | - | - | - | [1] 97 97 💬
|
| 1195 | KdPT | - | - | - | - | [1] 97 97 💬
|
| 1196 | KHK4083 | - | - | - | - | [1] 97 97 💬
|
| 1197 | KLEAN PREP - POLVERE PER SOLUZIONE ORALE 4 BUSTINE DA 69 G | - | - | - | - | [1] 97 97 💬
|
| 1198 | KLEAN-PREP | - | - | - | - | [1] 97 97 💬
|
| 1199 | KleanLyte | - | - | - | - | [2] 96 96, 97 💬
|
| 1200 | Kremezin | - | - | - | - | [2] 96 96, 97 💬
|
| 1201 | Kremezin®, Spherical Adsorptive Carbon | - | - | - | - | [2] 96 96, 97 💬
|
| 1202 | KRP203 | - | - | - | - | [1] 97 97 💬
|
| 1203 | KRP203A | - | - | - | - | [1] 97 97 💬
|
| 1204 | KSP-0243 | - | - | - | - | [1] 97 97 💬
|
| 1205 | Kyo-Dophilus | - | - | - | - | [1] 97 97 💬
|
| 1206 | Kümmel 2ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 1207 | L-arginine | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [10] 2 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
|
| 1208 | L-Lysyl-D-Prolyl-L-Threonine Acetate | [2] Acetate Acetate, Threonine | [1] Threonine
Threonine
💬
| - | - | [1] 97 97 💬
|
| 1209 | L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate | [1] Acetate Acetate | - | - | - | [1] 97 97 💬
|
| 1210 | Lactated Ringers | - | - | - | - | [2] 96 96, 97 💬
|
| 1211 | Lactobacillus casei | [1] Lactobacillus casei Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬
| - | - | [3] 6 6, 97, 296 💬
|
| 1212 | Lactobacillus casei DG | [1] Lactobacillus casei Lactobacillus casei | [1] Lactobacillus casei
Lactobacillus casei
💬
| - | - | [1] 97 97 💬
|
| 1213 | Lactobacillus GG | - | - | - | - | [1] 97 97 💬
|
| 1214 | Lactobacillus plantarum | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [3] 6 6, 97, 156 💬
|
| 1215 | LACTOBACILLUS REUTERI | [1] Lactobacillus reuteri Lactobacillus reuteri | - | - | - | [2] 97 97, 299 💬
|
| 1216 | Lactobacillus rhamnosus CALM 607(LR607) | - | - | - | - | [1] 97 97 💬
|
| 1217 | Lactobacillus rhamnosus GG ATCC 53103 | - | - | - | - | [1] 97 97 💬
|
| 1218 | Lactobacillus salivarius UCC118 | - | - | - | - | [2] 96 96, 97 💬
|
| 1219 | Lactobacilus acidophilus & bifidobacterium animalis/lactis | - | - | - | - | [1] 97 97 💬
|
| 1220 | Lactoferrin | [1] Lactoferrin Lactoferrin | - | - | - | [1] 97 97 💬
|
| 1221 | Lactose | [1] Lactose Lactose | [2] Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [8] 2 2, 6, 13, 21, 97, 107, 228, 310 💬
|
| 1222 | Lactose in water | [2] Lactose Lactose, Water | [3] Water
Water
,
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [1] 97 97 💬
|
| 1223 | Lactose Sachet | [1] Lactose Lactose | [2] Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [1] 97 97 💬
|
| 1224 | Lactulose | [1] Lactulose Lactulose | [1] Lactulose
Lactulose
💬
| - | - | [5] 6 6, 13, 96, 97, 291 💬
|
| 1225 | Lap TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
💬
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1226 | LC51-0255 | - | - | - | - | [1] 97 97 💬
|
| 1227 | LDP-02 | - | - | - | - | [2] 96 96, 97 💬
|
| 1228 | Lenograstim | [1] Lenograstim Lenograstim | [1] Lenograstim
Lenograstim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [8] 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
| 1229 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [13] 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 1230 | LEVOCARNITINE | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [3] 3 3, 53, 97 💬
|
| 1231 | Levocarnitine propyl hydrochloride | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1232 | Levotonine | - | - | - | - | [1] 97 97 💬
|
| 1233 | LEVOVANOX | - | - | - | - | [2] 94 94, 97 💬
|
| 1234 | LH VIOLA Supplementation | - | - | - | - | [2] 96 96, 97 💬
|
| 1235 | Linaclotide | [1] Linaclotide Linaclotide | [2] Linaclotide acetate
Linaclotide acetate
,
Linaclotide
💬
| [1] GUCY2C GUCY2C 💬
| [2] Hormone signaling Hormone signaling, Purine metabolism 💬 | [3] 6 6, 97, 299 💬
|
| 1236 | Lipoic acid | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [6] 2 2, 5, 13, 14, 20, 97 💬
|
| 1237 | Liposomal Curcumin | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬
|
| 1238 | LIV001 | - | - | - | - | [1] 97 97 💬
|
| 1239 | Live SK08 powder | - | - | - | - | [1] 97 97 💬
|
| 1240 | LIXACOL | - | - | - | - | [1] 97 97 💬
|
| 1241 | LMT503 | - | - | - | - | [2] 96 96, 97 💬
|
| 1242 | Loperamide | [1] Loperamide Loperamide | [2] Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 13 13, 97 💬
|
| 1243 | Loperamide hydrochloride | [1] Loperamide Loperamide | [2] Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1244 | Losartan | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [20] 17 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
|
| 1245 | LOVOLDYL*30CPR RIV 5MG | - | - | - | - | [1] 97 97 💬
|
| 1246 | Low dose | - | - | - | - | [1] 97 97 💬
|
| 1247 | Low Dose Budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1248 | Low dose budesonide rectal foam | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1249 | Low Dose MT-1303 | - | - | - | - | [1] 97 97 💬
|
| 1250 | Low dose naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1251 | Low FODMAP | - | - | - | - | [1] 97 97 💬
|
| 1252 | Low FODMAP diet | - | - | - | - | [1] 97 97 💬
|
| 1253 | Low Protein and High Fiber Diet | - | - | - | - | [1] 97 97 💬
|
| 1254 | Low-Dose CICR-NAM | - | - | - | - | [1] 97 97 💬
|
| 1255 | Low-dose MH002 | - | - | - | - | [1] 97 97 💬
|
| 1256 | LT-02 | - | - | - | - | [1] 97 97 💬
|
| 1257 | LT-02 (modified-release PC pellets) | - | - | - | - | [1] 97 97 💬
|
| 1258 | LUBIPROSTONE | [1] Lubiprostone Lubiprostone | [1] Lubiprostone
Lubiprostone
💬
| [1] CLCN2 CLCN2 💬
| [1] Mineral absorption Mineral absorption 💬 | [5] 6 6, 13, 97, 290, 299 💬
|
| 1259 | Lumbar puncture | - | - | - | - | [9] 2 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
|
| 1260 | Lusvertikimab | [1] Lusvertikimab Lusvertikimab | [1] Lusvertikimab
Lusvertikimab
💬
| [1] IL7R IL7R 💬
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, FoxO signaling pathway, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency 💬 | [1] 97 97 💬
|
| 1261 | Lutikizumab | [1] Lutikizumab Lutikizumab | [1] Lutikizumab
Lutikizumab
💬
| [2] IL1A IL1A, IL1B 💬
| [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [3] 46 46, 96, 97 💬
|
| 1262 | LX1606 | - | - | - | - | [1] 97 97 💬
|
| 1263 | LY3074828 | - | - | - | - | [2] 96 96, 97 💬
|
| 1264 | LY3471851 | - | - | - | - | [2] 49 49, 97 💬
|
| 1265 | LY4268989 | - | - | - | - | [1] 97 97 💬
|
| 1266 | LY4395089 | - | - | - | - | [2] 96 96, 97 💬
|
| 1267 | LYC-30937 | - | - | - | - | [1] 97 97 💬
|
| 1268 | LYC-30937-EC | - | - | - | - | [1] 97 97 💬
|
| 1269 | LYNC-101 | - | - | - | - | [1] 97 97 💬
|
| 1270 | Lyophilized fecal microbiota (LFMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 1271 | LYS006 | - | - | - | - | [1] 97 97 💬
|
| 1272 | Lysine | [1] Lysine Lysine | [4] Lysine acetate
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [4] 13 13, 97, 228, 299 💬
|
| 1273 | Lysine-D-Proline-Threonine | [4] D-Proline D-Proline, Lysine, Proline, Threonine | [6] Proline
Proline
,
Threonine
,
Lysine acetate
,
Lysine hydrochloride
,
Lysine
,
Lysine hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1274 | Macrogol | - | - | - | - | [1] 97 97 💬
|
| 1275 | MACROGOL 3350 | - | - | - | - | [1] 97 97 💬
|
| 1276 | MAGNESIO SOLFATO EPTAIDRATO | [1] Magnesium Magnesium | - | - | - | [1] 97 97 💬
|
| 1277 | Magnesium | [1] Magnesium Magnesium | - | - | - | [23] 3 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
|
| 1278 | Magnesium citrate | [2] Magnesium Magnesium, Magnesium citrate | [1] Magnesium citrate
Magnesium citrate
💬
| - | - | [1] 97 97 💬
|
| 1279 | Magnesium sulfate | [2] Magnesium Magnesium, Magnesium sulfate | [1] Magnesium sulfate
Magnesium sulfate
💬
| - | - | [4] 11 11, 97, 296, 297 💬
|
| 1280 | MAGNESIUM SULFATE HEPTAHYDRATE | [2] Magnesium Magnesium, Magnesium sulfate | [1] Magnesium sulfate
Magnesium sulfate
💬
| - | - | [1] 97 97 💬
|
| 1281 | MAGNESIUM SULPHATE HEPTAHYDRATE | [2] Magnesium Magnesium, Magnesium sulfate | [1] Magnesium sulfate
Magnesium sulfate
💬
| - | - | [1] 97 97 💬
|
| 1282 | MAGNESIUM SULPHATE HEPTAYDRATE | [1] Magnesium Magnesium | - | - | - | [1] 97 97 💬
|
| 1283 | Maltodextrin | [1] Maltodextrin Maltodextrin | [1] Maltodextrin
Maltodextrin
💬
| - | - | [4] 6 6, 13, 96, 97 💬
|
| 1284 | Maltose | [1] Maltose Maltose | [1] Maltose
Maltose
💬
| - | - | [2] 96 96, 97 💬
|
| 1285 | Mango | [1] Mango Mango | - | - | - | [2] 96 96, 97 💬
|
| 1286 | Mango polyphenolics | [1] Mango Mango | - | - | - | [2] 96 96, 97 💬
|
| 1287 | Mare´s milk | - | - | - | - | [2] 96 96, 97 💬
|
| 1288 | MATRICARIA FLOWER | - | - | - | - | [1] 97 97 💬
|
| 1289 | MATRICARIA RECUTITA L. FLOS | - | - | - | - | [1] 97 97 💬
|
| 1290 | Maximal oral 5ASA | - | - | - | - | [1] 97 97 💬
|
| 1291 | MB-001 | - | - | - | - | [1] 97 97 💬
|
| 1292 | MB310 | - | - | - | - | [1] 97 97 💬
|
| 1293 | MDX-1100 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1294 | MDX-1100 (anti-CXCL10 human monoclonal antibody) | - | - | - | - | [1] 97 97 💬
|
| 1295 | Mebendazole | [1] Mebendazole Mebendazole | [1] Mebendazole
Mebendazole
💬
| - | - | [1] 97 97 💬
|
| 1296 | MEDI2070 | - | - | - | - | [2] 96 96, 97 💬
|
| 1297 | MEDI7183 high dose | - | - | - | - | [1] 97 97 💬
|
| 1298 | MEDI7183 low dose | - | - | - | - | [1] 97 97 💬
|
| 1299 | MEDI7183 medium dose | - | - | - | - | [1] 97 97 💬
|
| 1300 | Medical Cannabis | [1] Medical Cannabis Medical Cannabis | [1] Cannabis
Cannabis
💬
| - | - | [3] 6 6, 96, 97 💬
|
| 1301 | Mediterranean Diet | - | - | - | - | [4] 13 13, 77, 97, 265 💬
|
| 1302 | Medium chain triglycerides | - | - | - | - | [2] 96 96, 97 💬
|
| 1303 | Melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [18] 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 1304 | MELISSAE FOLII DRY AQUEOUS EXTRACT | - | - | - | - | [1] 97 97 💬
|
| 1305 | Melissenblätter 15ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 1306 | Melitracen | [1] Melitracen Melitracen | [1] Melitracen
Melitracen
💬
| - | - | [1] 97 97 💬
|
| 1307 | Menatetrenone | [1] Menatetrenone Menatetrenone | [1] Menatetrenone
Menatetrenone
💬
| - | - | [2] 66 66, 97 💬
|
| 1308 | MENTHA × PIPERITA L. FOLIUM | - | - | - | - | [1] 97 97 💬
|
| 1309 | Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [4] 65 65, 96, 97, 164 💬
|
| 1310 | Mercaptopurine (Puri-Nethol) | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 97 97 💬
|
| 1311 | Mercaptopurine (Purinethol) | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 97 97 💬
|
| 1312 | Mesalamin | - | - | - | - | [1] 97 97 💬
|
| 1313 | Mesalamine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [3] 96 96, 97, 164 💬
|
| 1314 | Mesalamine and alpha-lipoic acid | [1] Lipoic acid Lipoic acid | [1] Thioctic acid
Thioctic acid
💬
| - | - | [1] 97 97 💬
|
| 1315 | Mesalamine and probiotics (Bacillus Clausii) | [1] Bacillus clausii Bacillus clausii | - | - | - | [1] 97 97 💬
|
| 1316 | Mesalamine Delayed Release Tablets 400mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1317 | Mesalamine Enema | - | - | - | - | [1] 97 97 💬
|
| 1318 | Mesalamine Granules | - | - | - | - | [1] 97 97 💬
|
| 1319 | Mesalamine Once-Daily | - | - | - | - | [1] 97 97 💬
|
| 1320 | Mesalamine Twice-Daily | - | - | - | - | [1] 97 97 💬
|
| 1321 | Mesalamine, 5-aminosalicylic acid [5-ASA] | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] Aminosalicylic acid
Aminosalicylic acid
,
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1322 | Mesalamine, 5-ASA | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1323 | MESALAZINA | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1324 | Mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [3] 46 46, 96, 97 💬
|
| 1325 | Mesalazine (3,600 mg) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1326 | Mesalazine (Asacol®) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1327 | Mesalazine - TID 1000 mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1328 | Mesalazine - TID 2x 500 mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1329 | Mesalazine 1000 mg gastro-resistant tablets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1330 | Mesalazine 250Mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1331 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet | [2] Mesalazine Mesalazine, Nitazoxanide | [2] Mesalamine
Mesalamine
,
Nitazoxanide
💬
| - | - | [1] 97 97 💬
|
| 1332 | Mesalazine 4G Enema | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1333 | Mesalazine 500 mg gastro-resistant tablets (Salofa | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1334 | Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1335 | Mesalazine Enema | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1336 | Mesalazine liquid enema | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1337 | Mesalazine slow-release granules | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1338 | Mesalazine Suppository Treatment | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1339 | Mesalazine with hydrocortisone sodium succinate | [4] Hydrocortisone Hydrocortisone, Hydrocortisone succinate, Mesalazine, Succinic acid | [4] Hydrocortisone
Hydrocortisone
,
Mesalamine
,
Hydrocortisone sodium succinate
,
Hydrocortisone succinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1340 | Mesalazinum | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1341 | MESENCHYMAL CELLS | - | - | - | - | [1] 97 97 💬
|
| 1342 | Mesenchymal stem cells (MSCs) | - | - | - | - | [4] 13 13, 36, 96, 97 💬
|
| 1343 | Mesenchymal stromal cells | - | - | - | - | [7] 36 36, 51, 96, 97, 107, 274, 284 💬
|
| 1344 | MET-2 | - | - | - | - | [1] 97 97 💬
|
| 1345 | Metformin | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [31] 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 1346 | Metformin 500 mg TID Oral Tablet | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1347 | Methalazine suppository was given rectally once a day | - | - | - | - | [1] 97 97 💬
|
| 1348 | Methane | [1] Methane Methane | - | - | - | [2] 2 2, 97 💬
|
| 1349 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 1350 | Methotrexate bellon | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 97 97 💬
|
| 1351 | Methotrexate bellon 25mg/ml | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 97 97 💬
|
| 1352 | METHOTREXATE DISODIUM | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [5] 46 46, 96, 97, 107, 271 💬
|
| 1353 | Methotrexate injection | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [2] 96 96, 97 💬
|
| 1354 | METHYLENE BLUE | [1] Methylene blue Methylene blue | [2] Methylene blue
Methylene blue
,
Methylthioninium chloride hydrate
💬
| - | - | [2] 97 97, 235 💬
|
| 1355 | Methylene blue 25mg tablets | [1] Methylene blue Methylene blue | [2] Methylene blue
Methylene blue
,
Methylthioninium chloride hydrate
💬
| - | - | [1] 97 97 💬
|
| 1356 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 1357 | METHYLPREDNISOLONE SODIUM HEMISUCCINATE | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 85, 97 💬
|
| 1358 | METOJECT | - | - | - | - | [6] 41 41, 46, 96, 97, 107, 271 💬
|
| 1359 | Metotrexat | - | - | - | - | [3] 50 50, 96, 97 💬
|
| 1360 | METRONIDAZOLE | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [7] 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 1361 | MetroNIDAZOLE 500 MG Oral Tablet [Flagyl] | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1362 | Metronidazole capsule 50 mg | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1363 | MetronidazoleProduct Name: MetronidazolePharmaceutical Form: Solution for infusionINN or Proposed INN: METRONIDAZOLECAS Number: 443-48-1Other descriptive name: MetronidazoleConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Trade Name: FosfomycinProduct Name: InfectofosPharmaceutical Form: Powder for infusionINN or Proposed INN: Fosfomycin disodiumCAS Number: 78964-85-9Other descriptive name: FOSFOMYCIN DISODIUMConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 40- | [1] Fosfomycin Fosfomycin | [3] Fosfomycin tromethamine
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
💬
| - | - | [1] 97 97 💬
|
| 1364 | MEZAVANT | - | - | - | - | [1] 97 97 💬
|
| 1365 | Mezavant 1200 mg magensaftresistente Retardtabletten | - | - | - | - | [1] 97 97 💬
|
| 1366 | Mezavant Gastro-resistant, prolonged release tablets | - | - | - | - | [1] 97 97 💬
|
| 1367 | Mezavant XL | - | - | - | - | [1] 97 97 💬
|
| 1368 | Mezavant XL 1200 mg gastro-resistant prolonged release tablets | - | - | - | - | [1] 97 97 💬
|
| 1369 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets | - | - | - | - | [1] 97 97 💬
|
| 1370 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets. | - | - | - | - | [1] 97 97 💬
|
| 1371 | Mezavant XL 1200mg gastro-resistant, prolonged release tablets | - | - | - | - | [1] 97 97 💬
|
| 1372 | Mezavant XL Gastro-resistant, prolonged release tablets | - | - | - | - | [1] 97 97 💬
|
| 1373 | MH002 | - | - | - | - | [1] 97 97 💬
|
| 1374 | Microbiome-Targeting Nutraceutical | - | - | - | - | [1] 97 97 💬
|
| 1375 | Microbiota capsule | - | - | - | - | [1] 97 97 💬
|
| 1376 | Microbiota suspension | - | - | - | - | [1] 97 97 💬
|
| 1377 | Microbiote fécal | - | - | - | - | [1] 97 97 💬
|
| 1378 | Microcrystalline Cellulose | [1] Microcrystalline cellulose Microcrystalline cellulose | [2] Microcrystalline cellulose
Microcrystalline cellulose
,
Rayon, purified
💬
| - | - | [1] 97 97 💬
|
| 1379 | Midazolam | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [14] 2 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
|
| 1380 | Midazolam 2 mg | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 96 96, 97 💬
|
| 1381 | Midazolam B. Braun | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1382 | Midazolam B.Braun | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1383 | Minocycline | [1] Minocycline Minocycline | [2] Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | [14] 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
| 1384 | Mirikizumab | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 37 37, 96, 97 💬
|
| 1385 | Mirikizumab - Intravenous (IV) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1386 | Mirikizumab - Subcutaneous (SC) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1387 | Mirikizumab IV | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 97 97 💬
|
| 1388 | Mirikizumab SC | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 97 97 💬
|
| 1389 | Mirtazapine | [1] Mirtazapine Mirtazapine | [1] Mirtazapine
Mirtazapine
💬
| [11] ADRA2A ADRA2A, ADRA2B, ADRA2C, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | [4] 6 6, 85, 97, 156 💬
|
| 1390 | MitoQ | - | - | - | - | [3] 2 2, 6, 97 💬
|
| 1391 | MK-6194 | - | - | - | - | [2] 49 49, 97 💬
|
| 1392 | MK-8259 | - | - | - | - | [1] 97 97 💬
|
| 1393 | MK-8690 | - | - | - | - | [1] 97 97 💬
|
| 1394 | MLN0002 | - | - | - | - | [3] 94 94, 96, 97 💬
|
| 1395 | MLN0002 SC | - | - | - | - | [2] 96 96, 97 💬
|
| 1396 | MLN002 | - | - | - | - | [2] 96 96, 97 💬
|
| 1397 | MMX Mesalamine | - | - | - | - | [1] 97 97 💬
|
| 1398 | MMX mesalamine/ mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1399 | MMX Mesalamine/Mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1400 | MMX Mesalamine/Mesalazine (High Dose) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1401 | MMX Mesalamine/Mesalazine (Low Dose) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1402 | MODAFINIL | [1] Modafinil Modafinil | [1] Modafinil
Modafinil
💬
| - | - | [6] 6 6, 13, 49, 93, 96, 97 💬
|
| 1403 | Modified Gegen Qinlian Decoction | - | - | - | - | [1] 97 97 💬
|
| 1404 | Modified-release phosphatidylcholine | - | - | - | - | [1] 97 97 💬
|
| 1405 | Mongersen | [1] Mongersen Mongersen | [1] Mongersen
Mongersen
💬
| [1] SMAD7 SMAD7 💬
| [2] Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1406 | MONOCLONAL ANTIBODY ANTI-IGG1 | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 1407 | MonoFer | [1] Iron isomaltoside 1000 Iron isomaltoside 1000 | - | - | - | [1] 97 97 💬
|
| 1408 | Monofer (iron isomaltoside 1000) | [1] Iron isomaltoside 1000 Iron isomaltoside 1000 | - | - | - | [1] 97 97 💬
|
| 1409 | MonoFer 100 mg/ml | - | - | - | - | [1] 97 97 💬
|
| 1410 | Monofer 100mg/ml | - | - | - | - | [1] 97 97 💬
|
| 1411 | Montmorency tart cherry | [1] Cherry Cherry | - | - | - | [1] 97 97 💬
|
| 1412 | MORF-057 | [1] MORF-057 MORF-057 | - | - | - | [2] 96 96, 97 💬
|
| 1413 | Morning Group | - | - | - | - | [1] 97 97 💬
|
| 1414 | Moviprep polvo para solución oral | - | - | - | - | [2] 96 96, 97 💬
|
| 1415 | Moviprep Sabor Naranja | - | - | - | - | [1] 97 97 💬
|
| 1416 | MRNA COVD19 vaccine | - | - | - | - | [4] 49 49, 53, 97, 271 💬
|
| 1417 | MS-20 oral solution | - | - | - | - | [1] 97 97 💬
|
| 1418 | MSC | - | - | - | - | [5] 51 51, 60, 96, 97, 271 💬
|
| 1419 | MT-1303 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1420 | MT-201 | - | - | - | - | [2] 96 96, 97 💬
|
| 1421 | MT-501 | - | - | - | - | [2] 96 96, 97 💬
|
| 1422 | MTX 12.5 | - | - | - | - | [1] 97 97 💬
|
| 1423 | MTX 25 | - | - | - | - | [1] 97 97 💬
|
| 1424 | Multi-Strain Probiotics | - | - | - | - | [1] 97 97 💬
|
| 1425 | Multiple dose- Group B | - | - | - | - | [1] 97 97 💬
|
| 1426 | Multiple dose-Group B | - | - | - | - | [1] 97 97 💬
|
| 1427 | MultiStem | - | - | - | - | [1] 97 97 💬
|
| 1428 | MultiStem high dose | - | - | - | - | [1] 97 97 💬
|
| 1429 | MultiStem low dose | - | - | - | - | [1] 97 97 💬
|
| 1430 | Mupirocin | [1] Mupirocin Mupirocin | [2] Mupirocin
Mupirocin
,
Mupirocin calcium
💬
| - | - | [4] 35 35, 97, 227, 299 💬
|
| 1431 | Mycodigest supplement | - | - | - | - | [2] 96 96, 97 💬
|
| 1432 | MYRRH | [1] Myrrh Myrrh | [1] Myrrh
Myrrh
💬
| - | - | [1] 97 97 💬
|
| 1433 | Myrrhinil-Intest® | - | - | - | - | [1] 97 97 💬
|
| 1434 | N.a. | - | - | - | - | [11] 3 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
|
| 1435 | NABILONE | [1] Nabilone Nabilone | [1] Nabilone
Nabilone
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 6 6, 13, 97, 127 💬
|
| 1436 | Naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [14] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
|
| 1437 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
| 1438 | NAND (Neoandrographolide) | - | - | - | - | [1] 97 97 💬
|
| 1439 | Nanocort | - | - | - | - | [3] 13 13, 46, 97 💬
|
| 1440 | Nd | - | - | - | - | [6] 2 2, 6, 13, 46, 51, 97 💬
|
| 1441 | Neomycin | [1] Neomycin Neomycin | [3] Neomycin sulfate
Neomycin sulfate
,
Neomycin palmitate
,
Neomycin
💬
| - | - | [3] 96 96, 97, 296 💬
|
| 1442 | Neoral | - | - | - | - | [3] 60 60, 97, 222 💬
|
| 1443 | Neoral Soft Gelatin Capsules | [1] Gelatin Gelatin | [1] Gelatin
Gelatin
💬
| - | - | [2] 97 97, 269 💬
|
| 1444 | Nestle IMPACT Immunonutrition | - | - | - | - | [1] 97 97 💬
|
| 1445 | Niclosamide | [1] Niclosamide Niclosamide | [1] Niclosamide
Niclosamide
💬
| - | - | [2] 46 46, 97 💬
|
| 1446 | Nicolon | - | - | - | - | [1] 97 97 💬
|
| 1447 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 1448 | Nicotinamide Mononucleotide | [2] Nicotinamide Nicotinamide, Nicotinamide Mononucleotide | [1] Niacinamide
Niacinamide
💬
| - | - | [2] 63 63, 97 💬
|
| 1449 | Nicotinamide riboside | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [14] 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
|
| 1450 | Nicotinamide Riboside Chloride | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 97 97 💬
|
| 1451 | Nifuroxazide | [1] Nifuroxazide Nifuroxazide | [1] Nifuroxazide
Nifuroxazide
💬
| - | - | [1] 97 97 💬
|
| 1452 | NIRS | - | - | - | - | [1] 97 97 💬
|
| 1453 | Nitazoxanide | [1] Nitazoxanide Nitazoxanide | [1] Nitazoxanide
Nitazoxanide
💬
| - | - | [3] 46 46, 96, 97 💬
|
| 1454 | Nitazoxanide 500Mg Oral Tablet | [1] Nitazoxanide Nitazoxanide | [1] Nitazoxanide
Nitazoxanide
💬
| - | - | [2] 46 46, 97 💬
|
| 1455 | Nitric Oxide | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [12] 46 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
|
| 1456 | Nivolumab | [1] Nivolumab Nivolumab | [1] Nivolumab
Nivolumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 1457 | Nolpitantium Besylate | - | - | - | - | [1] 97 97 💬
|
| 1458 | Non as of yet | - | - | - | - | [1] 97 97 💬
|
| 1459 | Non-Interventional Study | - | - | - | - | [1] 97 97 💬
|
| 1460 | None | - | - | - | - | [14] 13 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
|
| 1461 | None given | - | - | - | - | [1] 97 97 💬
|
| 1462 | Nordiet | - | - | - | - | [1] 97 97 💬
|
| 1463 | Norditropin SimpleXx | - | - | - | - | [5] 3 3, 97, 107, 193, 195 💬
|
| 1464 | Norditropin® SimpleXx® 5mg/1.5ml | - | - | - | - | [1] 97 97 💬
|
| 1465 | Normal dietetic scheme | - | - | - | - | [1] 97 97 💬
|
| 1466 | Normal Saline | - | - | - | - | [20] 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
|
| 1467 | Normal Saline (0.9% NaCl) | - | - | - | - | [1] 97 97 💬
|
| 1468 | Normal Saline Enema | - | - | - | - | [1] 97 97 💬
|
| 1469 | NP-201 acetate injection (Part A) | [1] Acetate Acetate | - | - | - | [1] 97 97 💬
|
| 1470 | Nutrition supplement | - | - | - | - | [1] 97 97 💬
|
| 1471 | Nutritional dietary intervention | - | - | - | - | [2] 96 96, 97 💬
|
| 1472 | Nuvion®) | - | - | - | - | [1] 97 97 💬
|
| 1473 | NX-13 250 mg | - | - | - | - | [1] 97 97 💬
|
| 1474 | NX-13 250mg | - | - | - | - | [1] 97 97 💬
|
| 1475 | NX-13 250mg IR | - | - | - | - | [1] 97 97 💬
|
| 1476 | NX-13 500mg IR | - | - | - | - | [1] 97 97 💬
|
| 1477 | NX-13 500mg MR | - | - | - | - | [1] 97 97 💬
|
| 1478 | NX-13 750mg | - | - | - | - | [1] 97 97 💬
|
| 1479 | Oats | - | - | - | - | [1] 97 97 💬
|
| 1480 | Obefazimod | [1] Obefazimod Obefazimod | [1] Obefazimod
Obefazimod
💬
| [3] NCBP1 NCBP1, NCBP2, NCBP2L 💬
| [4] Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Nucleocytoplasmic transport, Spliceosome, mRNA surveillance pathway 💬 | [2] 96 96, 97 💬
|
| 1481 | OD-07656 | - | - | - | - | [3] 96 96, 97, 110 💬
|
| 1482 | Oligofructose-enriched Inulin OI | [1] Inulin Inulin | [1] Inulin
Inulin
💬
| - | - | [1] 97 97 💬
|
| 1483 | Olimel Parenteral Nutrition | - | - | - | - | [1] 97 97 💬
|
| 1484 | Olive oil | [1] Olive oil Olive oil | [1] Olive oil
Olive oil
💬
| - | - | [10] 13 13, 34, 35, 46, 49, 53, 97, 124, 162, 271 💬
|
| 1485 | Omeprazole | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [18] 6 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
|
| 1486 | Omeprazole 20 mg | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [2] 96 96, 97 💬
|
| 1487 | Ondansetron | [1] Ondansetron Ondansetron | [2] Ondansetron
Ondansetron
,
Ondansetron hydrochloride hydrate
💬
| [5] HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | [5] 6 6, 97, 98, 107, 231 💬
|
| 1488 | Ondansetron hydrochloride dihydrate | [1] Ondansetron Ondansetron | [2] Ondansetron
Ondansetron
,
Ondansetron hydrochloride hydrate
💬
| [5] HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | [2] 6 6, 97 💬
|
| 1489 | Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 1490 | OPC-6535 | - | - | - | - | [2] 96 96, 97 💬
|
| 1491 | OPC-6535 Tablets (drug) | - | - | - | - | [1] 97 97 💬
|
| 1492 | OPC-6535(Tetomilast) | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 💬
|
| 1493 | Open-Label | - | - | - | - | [1] 97 97 💬
|
| 1494 | OPRX-106 | - | - | - | - | [1] 97 97 💬
|
| 1495 | OPRX-106 (plant cells expressing TNFR-Fc) 2mg | - | - | - | - | [1] 97 97 💬
|
| 1496 | OPRX-106 (plant cells expressing TNFR-Fc) 8mg | - | - | - | - | [1] 97 97 💬
|
| 1497 | Optimized Treatment (OPT) | - | - | - | - | [2] 96 96, 97 💬
|
| 1498 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1499 | Oral Budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 97 97, 98 💬
|
| 1500 | Oral cholera vaccine | - | - | - | - | [1] 97 97 💬
|
| 1501 | Oral corticosteroids | - | - | - | - | [4] 13 13, 46, 97, 251 💬
|
| 1502 | Oral ferrous sulfate | [1] Ferrous sulfate anhydrous Ferrous sulfate anhydrous | [1] Ferrous sulfate
Ferrous sulfate
💬
| - | - | [1] 97 97 💬
|
| 1503 | Oral Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [2] 97 97, 254 💬
|
| 1504 | Oral liposomal iron | - | - | - | - | [1] 97 97 💬
|
| 1505 | Oral OKT3 | - | - | - | - | [1] 97 97 💬
|
| 1506 | Oral prednisolone Taper | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1507 | Oral Prednisone - Hospital Dose Steroids | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1508 | Oral Upadacitinib | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 1509 | Oral Vancomycin | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [3] 94 94, 97, 296 💬
|
| 1510 | Ordinary meat diet | - | - | - | - | [1] 97 97 💬
|
| 1511 | ORE1001 | - | - | - | - | [1] 97 97 💬
|
| 1512 | ORENCIA | - | - | - | - | [16] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
|
| 1513 | Originator (legacy) drug | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1514 | OSE-127 | - | - | - | - | [2] 53 53, 97 💬
|
| 1515 | Oseltamivir | [1] Oseltamivir Oseltamivir | [2] Oseltamivir phosphate
Oseltamivir phosphate
,
Oseltamivir
💬
| - | - | [3] 63 63, 97, 299 💬
|
| 1516 | OST-122 | - | - | - | - | [1] 97 97 💬
|
| 1517 | Other Biologic Therapies | - | - | - | - | [2] 96 96, 97 💬
|
| 1518 | Other: 100% pomegranate juice | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 💬
|
| 1519 | Other: A plant based high fiber diet that mimics fasting (FMD) plus advanced therapy | - | - | - | - | [1] 97 97 💬
|
| 1520 | Other: Additional Therapies | - | - | - | - | [1] 97 97 💬
|
| 1521 | Other: Advanced therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 1522 | Other: amino acid mixture beverage | - | - | - | - | [1] 97 97 💬
|
| 1523 | Other: Anti inflammatory diet | - | - | - | - | [1] 97 97 💬
|
| 1524 | Other: Anti-Inflammatory Diet | - | - | - | - | [1] 97 97 💬
|
| 1525 | Other: Anxiety/Depression Questionnaires | - | - | - | - | [1] 97 97 💬
|
| 1526 | Other: Arm B- Standard of Care | - | - | - | - | [1] 97 97 💬
|
| 1527 | Other: Assessment of Psychophysiological factors | - | - | - | - | [1] 97 97 💬
|
| 1528 | Other: Autologous Platelet-poor Plasma (PPP) and Thrombin Coagulum Treatment | [1] Thrombin Thrombin | [1] Thrombin
Thrombin
💬
| - | - | [1] 97 97 💬
|
| 1529 | Other: Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment | [1] Thrombin Thrombin | [1] Thrombin
Thrombin
💬
| - | - | [1] 97 97 💬
|
| 1530 | Other: Blood and stool sample | - | - | - | - | [2] 96 96, 97 💬
|
| 1531 | Other: Blood and urine collection | - | - | - | - | [1] 97 97 💬
|
| 1532 | Other: Blood draw | - | - | - | - | [17] 2 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
|
| 1533 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 1534 | Other: blood specimen | - | - | - | - | [4] 43 43, 96, 97, 329 💬
|
| 1535 | Other: Blood, fecal, saliva | - | - | - | - | [1] 97 97 💬
|
| 1536 | Other: Calprotectin | - | - | - | - | [1] 97 97 💬
|
| 1537 | Other: carbon dioxide insufflation during colonoscopy | [1] Carbon dioxide Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬
| - | - | [1] 97 97 💬
|
| 1538 | Other: Clinical follow-up | - | - | - | - | [2] 96 96, 97 💬
|
| 1539 | Other: co-transplantation of FMT and pectin | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [1] 97 97 💬
|
| 1540 | Other: Collect of blood, urines, and intestinal biopsies | - | - | - | - | [1] 97 97 💬
|
| 1541 | Other: collection of gut biopsies collection of blood samples | - | - | - | - | [2] 94 94, 97 💬
|
| 1542 | Other: Collection of stool and blood samples | - | - | - | - | [1] 97 97 💬
|
| 1543 | Other: colonoscopy | - | - | - | - | [2] 96 96, 97 💬
|
| 1544 | Other: Colored water | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 97 97 💬
|
| 1545 | Other: Control | - | - | - | - | [12] 6 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
|
| 1546 | Other: Control Diet | - | - | - | - | [2] 96 96, 97 💬
|
| 1547 | Other: Control group(Normal saline) | - | - | - | - | [1] 97 97 💬
|
| 1548 | Other: Conventional drugs | - | - | - | - | [1] 97 97 💬
|
| 1549 | Other: dietary intervention with no-carrageenan diet | - | - | - | - | [1] 97 97 💬
|
| 1550 | Other: Discontinuation of 5-ASA | - | - | - | - | [2] 96 96, 97 💬
|
| 1551 | Other: e-Monitoring | - | - | - | - | [1] 97 97 💬
|
| 1552 | Other: Environmental factor monitoring | - | - | - | - | [1] 97 97 💬
|
| 1553 | Other: Evaluate the blood level of NTproBNP | - | - | - | - | [1] 97 97 💬
|
| 1554 | Other: Faecal bacterial transplantation | - | - | - | - | [1] 97 97 💬
|
| 1555 | Other: Fecal Microbial Transplantation | - | - | - | - | [2] 96 96, 97 💬
|
| 1556 | Other: Fecal microbiota transplant | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 1557 | Other: Fecal Microbiota transplant (FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 1558 | Other: Fecal Microbiota Transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [3] 96 96, 97, 271 💬
|
| 1559 | Other: Fecal Microbiota Transplantation (FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [2] 13 13, 97 💬
|
| 1560 | Other: Fecal Microbiota Transplantation Capsules | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 1561 | Other: Fluorescence molecular imaging procedure without prior administration of vedolizumab-800CW | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1562 | Other: food questionnaire | - | - | - | - | [4] 46 46, 49, 96, 97 💬
|
| 1563 | Other: free diet | - | - | - | - | [1] 97 97 💬
|
| 1564 | Other: glucose-based sports drink | - | - | - | - | [1] 97 97 💬
|
| 1565 | Other: habitual diet -> pomegranate juice | [1] Pomegranate Pomegranate | - | - | - | [1] 97 97 💬
|
| 1566 | Other: Hyperbaric Oxygen Therapy | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [2] 97 97, 226 💬
|
| 1567 | Other: Infusion rate of infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1568 | Other: Intensify treatment with the existing drug | - | - | - | - | [2] 96 96, 97 💬
|
| 1569 | Other: intestinal content samples and biopsies | - | - | - | - | [1] 97 97 💬
|
| 1570 | Other: Laboratory Biomarker Analysis | - | - | - | - | [22] 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 1571 | Other: Lyophilized Fecal Microbiota Transplantation (LFMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 1572 | Other: Measurement of drug (Adalimumab/Infliximab) | [2] Adalimumab Adalimumab, Infliximab | [2] Adalimumab
Adalimumab
,
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1573 | Other: Mediterranean Diet | - | - | - | - | [2] 97 97, 299 💬
|
| 1574 | Other: Mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1575 | Other: No intervention | - | - | - | - | [5] 6 6, 70, 96, 97, 201 💬
|
| 1576 | Other: Non-exposed group | - | - | - | - | [1] 97 97 💬
|
| 1577 | Other: non-genotyping | - | - | - | - | [1] 97 97 💬
|
| 1578 | Other: normal diet | - | - | - | - | [2] 96 96, 97 💬
|
| 1579 | Other: normal saline | - | - | - | - | [5] 13 13, 97, 222, 226, 280 💬
|
| 1580 | Other: Nutrition specialist | - | - | - | - | [1] 97 97 💬
|
| 1581 | Other: Other Biologic Agents | - | - | - | - | [2] 96 96, 97 💬
|
| 1582 | Other: Pain questionnaires | - | - | - | - | [1] 97 97 💬
|
| 1583 | Other: Partial enteral nutrition (PEN) | - | - | - | - | [1] 97 97 💬
|
| 1584 | Other: PENTASA (mesalamine/ 5-Aminosalicylic acid (5-ASA) | [1] Aminosalicylic acid Aminosalicylic acid | [1] Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | [1] 97 97 💬
|
| 1585 | Other: Personalized B-fructan diet | - | - | - | - | [1] 97 97 💬
|
| 1586 | Other: Personalized pectin diet | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [1] 97 97 💬
|
| 1587 | Other: PK microsampling of blood | - | - | - | - | [4] 6 6, 8, 13, 97 💬
|
| 1588 | Other: pomegranate juice -> habitual diet | [1] Pomegranate Pomegranate | - | - | - | [1] 97 97 💬
|
| 1589 | Other: pretreatment antibiotics | - | - | - | - | [1] 97 97 💬
|
| 1590 | Other: Questionnaire Administration | - | - | - | - | [7] 16 16, 28, 34, 51, 60, 97, 298 💬
|
| 1591 | Other: Randomized B-fructan diet | - | - | - | - | [1] 97 97 💬
|
| 1592 | Other: Registry | - | - | - | - | [4] 6 6, 8, 13, 97 💬
|
| 1593 | Other: Removal of blood | - | - | - | - | [2] 96 96, 97 💬
|
| 1594 | Other: Saline | - | - | - | - | [8] 2 2, 6, 46, 97, 98, 256, 274, 301 💬
|
| 1595 | Other: sample blood and fecal collection | - | - | - | - | [1] 97 97 💬
|
| 1596 | Other: Sham Diet | - | - | - | - | [2] 96 96, 97 💬
|
| 1597 | Other: Sham transplantation | - | - | - | - | [2] 96 96, 97 💬
|
| 1598 | Other: single fecal microbiota transplantation | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 97 97 💬
|
| 1599 | Other: Standard medical treatment | - | - | - | - | [6] 13 13, 96, 97, 149, 153, 171 💬
|
| 1600 | Other: Standard of Care | - | - | - | - | [11] 13 13, 49, 57, 64, 79, 85, 95, 96, 97, 245, 246 💬
|
| 1601 | Other: stool collection | - | - | - | - | [2] 46 46, 97 💬
|
| 1602 | Other: Stool samples | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 1603 | Other: Therapy Education | - | - | - | - | [1] 97 97 💬
|
| 1604 | Other: Threonine | [1] Threonine Threonine | [1] Threonine
Threonine
💬
| - | - | [2] 96 96, 97 💬
|
| 1605 | Other: Ulcerative Colitis Diet | - | - | - | - | [1] 97 97 💬
|
| 1606 | Other: Ulcerative colitis Exclusion Diet | - | - | - | - | [1] 97 97 💬
|
| 1607 | Other: VOCs profile | - | - | - | - | [2] 96 96, 97 💬
|
| 1608 | Other: Water or milk | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 97 97 💬
|
| 1609 | Overencapsulated Azathioprine (Imuran) 50 mg Tablet | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 97 97 💬
|
| 1610 | Overencapsulated mesalazine tablets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1611 | OXITRIPTAN | [1] Oxitriptan Oxitriptan | [1] Oxitriptan
Oxitriptan
💬
| - | - | [1] 97 97 💬
|
| 1612 | Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [30] 6 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
|
| 1613 | Oxygen Gas for Inhalation | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [2] 96 96, 97 💬
|
| 1614 | Oxygen Medicinal Gas SOL 100% v/v medicinal gas, compressed | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 97 97 💬
|
| 1615 | Ozanimod | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 1616 | Ozanimod HCL | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 1617 | Ozanimod hydrochloride | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 1618 | Ozanimod Oral Capsule | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 97 💬
|
| 1619 | PALI-2108 | - | - | - | - | [2] 96 96, 97 💬
|
| 1620 | Palmitoleic Acid | [1] Palmitoleic Acid Palmitoleic Acid | - | - | - | [2] 96 96, 97 💬
|
| 1621 | Palmitoylethanolamide (PEA) | - | - | - | - | [1] 97 97 💬
|
| 1622 | Pancrelipase | [1] Pancrelipase Pancrelipase | [2] Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | [4] 96 96, 97, 298, 299 💬
|
| 1623 | Parnaparin | [1] Parnaparin Parnaparin | [1] Parnaparin sodium
Parnaparin sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 97 97 💬
|
| 1624 | PARNAPARIN SODIUM | [1] Parnaparin Parnaparin | [1] Parnaparin sodium
Parnaparin sodium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 97 97 💬
|
| 1625 | Patient switched from IV vedolizumab to subcutaneous vedolizumab as part of normal patient care | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 💬
|
| 1626 | PBF-677 | - | - | - | - | [1] 97 97 💬
|
| 1627 | PCT (PureCell Technologies Complex) | - | - | - | - | [1] 97 97 💬
|
| 1628 | Pectin | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [2] 96 96, 97 💬
|
| 1629 | PEG low volume with bisacodyl | [1] Bisacodyl Bisacodyl | [1] Bisacodyl
Bisacodyl
💬
| - | - | [1] 97 97 💬
|
| 1630 | PEG-liposomal Prednisolone Sodium Phosphate | [2] Prednisolone Prednisolone, Prednisolone phosphate | [2] Prednisolone
Prednisolone
,
Prednisolone sodium phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 97 💬
|
| 1631 | Pembrolizumab | [1] Pembrolizumab Pembrolizumab | [1] Pembrolizumab
Pembrolizumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [3] 25 25, 97, 285 💬
|
| 1632 | Pending | - | - | - | - | [7] 6 6, 13, 19, 96, 97, 113, 302 💬
|
| 1633 | Pentasa | - | - | - | - | [2] 96 96, 97 💬
|
| 1634 | Pentasa 2g sachet prolonged release granules (95%) | - | - | - | - | [1] 97 97 💬
|
| 1635 | Pentasa 500 mg Retardtabletten | - | - | - | - | [1] 97 97 💬
|
| 1636 | Pentasa Compact 2g, granulate with prolonged release | - | - | - | - | [1] 97 97 💬
|
| 1637 | Pentasa Compact 4g, granulate with prolonged release | - | - | - | - | [1] 97 97 💬
|
| 1638 | Pentasa enema | - | - | - | - | [1] 97 97 💬
|
| 1639 | Pentasa prolonged release granules 2g | - | - | - | - | [1] 97 97 💬
|
| 1640 | PENTASA Sachet | - | - | - | - | [2] 96 96, 97 💬
|
| 1641 | Pentasa Sachet 1 g | - | - | - | - | [2] 96 96, 97 💬
|
| 1642 | Pentasa Sachet 1g | - | - | - | - | [1] 97 97 💬
|
| 1643 | Pentasa Sachet 2 g | - | - | - | - | [1] 97 97 💬
|
| 1644 | Pentoxifylline | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline
Pentoxifylline
💬
| - | - | [13] 6 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
|
| 1645 | Pentoxifylline 400 MG | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline
Pentoxifylline
💬
| - | - | [2] 6 6, 97 💬
|
| 1646 | Period 1 IBI112 dose 1 | - | - | - | - | [1] 97 97 💬
|
| 1647 | Period 1 IBI112 dose 2 | - | - | - | - | [1] 97 97 💬
|
| 1648 | Period 2 IBI112 dose 3 | - | - | - | - | [1] 97 97 💬
|
| 1649 | Period 2 IBI112 dose 4 | - | - | - | - | [1] 97 97 💬
|
| 1650 | PF 06687234 | - | - | - | - | [2] 96 96, 97 💬
|
| 1651 | PF-00547659 | - | - | - | - | [2] 96 96, 97 💬
|
| 1652 | PF-00547659 SC injection | - | - | - | - | [2] 96 96, 97 💬
|
| 1653 | PF-05230917 | - | - | - | - | [1] 97 97 💬
|
| 1654 | PF-05285401 | - | - | - | - | [1] 97 97 💬
|
| 1655 | PF-06480605 | - | - | - | - | [1] 97 97 💬
|
| 1656 | PF-06480605 100 mg/ml | - | - | - | - | [1] 97 97 💬
|
| 1657 | PF-06651600 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1658 | PF-06651600 10 mg | - | - | - | - | [1] 97 97 💬
|
| 1659 | PF-06651600 50 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1660 | PF-06651600-15 | - | - | - | - | [2] 96 96, 97 💬
|
| 1661 | PF-06687234 | - | - | - | - | [1] 97 97 💬
|
| 1662 | PF-06700841 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1663 | PF-06700841 25 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1664 | PF-06700841 5 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 1665 | PF-06700841-15 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1666 | PF-06826647 | - | - | - | - | [1] 97 97 💬
|
| 1667 | PF-06826647 100 mg QD | - | - | - | - | [1] 97 97 💬
|
| 1668 | PF-06826647 300 mg QD | - | - | - | - | [1] 97 97 💬
|
| 1669 | PF-06826647 600 mg QD | - | - | - | - | [1] 97 97 💬
|
| 1670 | PF-07054894 | - | - | - | - | [1] 97 97 💬
|
| 1671 | PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2- | [2] Arginine Arginine, L-arginine | [3] Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 1672 | PF-6826647 400 mg QD | - | - | - | - | [1] 97 97 💬
|
| 1673 | Pfefferminzblätter 1ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 1674 | Pfizer Comirnaty vaccine | - | - | - | - | [1] 97 97 💬
|
| 1675 | Phentermine | [1] Phentermine Phentermine | [2] Phentermine
Phentermine
,
Phentermine hydrochloride
💬
| [5] MAOA MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬
| [16] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 97 97 💬
|
| 1676 | Phentermine-Topiramate | [2] Phentermine Phentermine, Topiramate | [3] Topiramate
Topiramate
,
Phentermine
,
Phentermine hydrochloride
💬
| [42] CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, MAOA, MAOB, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SLC6A2, SLC6A3, SLC6A4 💬
| [65] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Cadherin signaling, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, IgSF CAM signaling, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1677 | Phosphatidylcholine | - | - | - | - | [1] 97 97 💬
|
| 1678 | Photodynamic therapy with Gliolan | - | - | - | - | [1] 97 97 💬
|
| 1679 | PK-model to decide when to dose Vedolizumab and Ustekinumab | [2] Ustekinumab Ustekinumab, Vedolizumab | [2] Vedolizumab
Vedolizumab
,
Ustekinumab
💬
| [5] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7 💬
| [45] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1680 | PL8177 | - | - | - | - | [1] 97 97 💬
|
| 1681 | Platinum | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 1682 | Platinum Compound | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 1683 | Platinum Doublet | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 1684 | PN-10884A | - | - | - | - | [1] 97 97 💬
|
| 1685 | PN-943 | - | - | - | - | [1] 97 97 💬
|
| 1686 | PNEUMO 23 | - | - | - | - | [2] 65 65, 97 💬
|
| 1687 | Pneumococcal Pneumonia vaccine | - | - | - | - | [1] 97 97 💬
|
| 1688 | Polaprezinc | [1] Polaprezinc Polaprezinc | [1] Polaprezinc
Polaprezinc
💬
| - | - | [2] 96 96, 97 💬
|
| 1689 | POLIETILENGLICOLE | - | - | - | - | [1] 97 97 💬
|
| 1690 | Polyethylene glycol | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [8] 6 6, 50, 96, 97, 195, 235, 276, 299 💬
|
| 1691 | Polyethylene glycol (PEG) | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 97 97 💬
|
| 1692 | Polyethylene Glycols | - | - | - | - | [1] 97 97 💬
|
| 1693 | Polyphenon E® | - | - | - | - | [1] 97 97 💬
|
| 1694 | Pomegranate | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 💬
|
| 1695 | POTASSIO SOLFATO | - | - | - | - | [1] 97 97 💬
|
| 1696 | Potassium | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [17] 36 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
|
| 1697 | POTASSIUM CHLORIDE | [2] Potassium Potassium, Potassium chloride | [2] Potassium chloride
Potassium chloride
,
Potassium
💬
| - | - | [1] 97 97 💬
|
| 1698 | POTASSIUM SULPHATE | [1] Potassium Potassium | [1] Potassium
Potassium
💬
| - | - | [1] 97 97 💬
|
| 1699 | PRA023 | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 1700 | PRA023Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: Not yet assignedCAS Number: 2648504-55-4Current Sponsor code: PRA023Other descriptive name: PRA023Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 60-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 97 97 💬
|
| 1701 | PRD5973697 | - | - | - | - | [1] 97 97 💬
|
| 1702 | Pre-packaged low-residue diet for bowel preparation | - | - | - | - | [1] 97 97 💬
|
| 1703 | Prebiotic | - | - | - | - | [2] 96 96, 97 💬
|
| 1704 | Prebiotics | - | - | - | - | [2] 96 96, 97 💬
|
| 1705 | PRECISION dosing Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1706 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 1707 | Prednisolon Jenapharm | - | - | - | - | [2] 96 96, 97 💬
|
| 1708 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 1709 | Prednisolone sodium metasulphobenzoate | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1710 | PREDNISOLONE SODIUM PHOSPHATE | [2] Prednisolone Prednisolone, Prednisolone phosphate | [2] Prednisolone
Prednisolone
,
Prednisolone sodium phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 3 3, 13, 97 💬
|
| 1711 | Prednisolone Tablets B.P. 5mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1712 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 1713 | Prednisone Oral Product | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1714 | Prefilled Syringe delivery of Golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1715 | Prevenar 13 | - | - | - | - | [5] 13 13, 46, 96, 97, 223 💬
|
| 1716 | Previously referred to as MEDI2070 and AMG 139 | - | - | - | - | [2] 96 96, 97 💬
|
| 1717 | PRIM-DJ2727 | - | - | - | - | [3] 6 6, 51, 97 💬
|
| 1718 | PRIM-DJ2727 - CAPSULES | - | - | - | - | [1] 97 97 💬
|
| 1719 | PRIM-DJ2727 - FROZEN | - | - | - | - | [1] 97 97 💬
|
| 1720 | PRO145223 | - | - | - | - | [1] 97 97 💬
|
| 1721 | PRO145223 (RO5490261) | - | - | - | - | [1] 97 97 💬
|
| 1722 | Probiotic | - | - | - | - | [10] 2 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
|
| 1723 | Probiotic - VSL#3 | - | - | - | - | [2] 96 96, 97 💬
|
| 1724 | Probiotic Formula Capsule | - | - | - | - | [1] 97 97 💬
|
| 1725 | Probiotic Mixture | - | - | - | - | [2] 96 96, 97 💬
|
| 1726 | Probiotics | - | - | - | - | [6] 6 6, 94, 96, 97, 206, 291 💬
|
| 1727 | Probiotics (Bacillus Clausii) | [1] Bacillus clausii Bacillus clausii | - | - | - | [1] 97 97 💬
|
| 1728 | Probiotics 6600 | - | - | - | - | [1] 97 97 💬
|
| 1729 | Procedure: endoscopic biopsy | - | - | - | - | [1] 97 97 💬
|
| 1730 | Products containing aminosalicylate | - | - | - | - | [1] 97 97 💬
|
| 1731 | Products containing azathioprine or 6-mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] Mercaptopurine
Mercaptopurine
,
Azathioprine
,
Azathioprine sodium
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 97 97 💬
|
| 1732 | Prolife | - | - | - | - | [1] 97 97 💬
|
| 1733 | Proline | [1] Proline Proline | [1] Proline
Proline
💬
| - | - | [3] 66 66, 94, 97 💬
|
| 1734 | Promiten | - | - | - | - | [1] 97 97 💬
|
| 1735 | PROPIONYL L-CARNITINE | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1736 | PROPIONYL L-CARNITINE HYDROCHLORIDE | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1737 | Propionyl-L-Carnitine | [1] Levocarnitine Levocarnitine | [2] Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | [1] 97 97 💬
|
| 1738 | Propionylcarnitinhydrochlorid | - | - | - | - | [1] 97 97 💬
|
| 1739 | Propofol | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [10] 3 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
|
| 1740 | Propofol B. Braun | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1741 | Protein hydrolysate | [1] Protein hydrolysate Protein hydrolysate | [1] Protein hydrolysate
Protein hydrolysate
💬
| - | - | [1] 97 97 💬
|
| 1742 | PRV-300 | - | - | - | - | [1] 97 97 💬
|
| 1743 | Psyllium Husk Powder | - | - | - | - | [1] 97 97 💬
|
| 1744 | PTG-100 | - | - | - | - | [1] 97 97 💬
|
| 1745 | PUR 0110 | - | - | - | - | [1] 97 97 💬
|
| 1746 | PUR 0110 Rectal Enema | - | - | - | - | [1] 97 97 💬
|
| 1747 | PUR 0110 Rectal Enema 1000 mg | - | - | - | - | [1] 97 97 💬
|
| 1748 | PUR 0110 Rectal Enema 250 mg | - | - | - | - | [1] 97 97 💬
|
| 1749 | PUR 0110 Rectal Enema 500 mg | - | - | - | - | [1] 97 97 💬
|
| 1750 | Pure give pectin 20g/d for five days | [1] Pectin Pectin | [1] Pectin
Pectin
💬
| - | - | [1] 97 97 💬
|
| 1751 | Puri Nethol | - | - | - | - | [2] 96 96, 97 💬
|
| 1752 | Puri-Nethol | - | - | - | - | [3] 86 86, 96, 97 💬
|
| 1753 | PVT401 | - | - | - | - | [1] 97 97 💬
|
| 1754 | Pyrrolidine | [1] Pyrrolidine Pyrrolidine | - | - | - | [2] 28 28, 97 💬
|
| 1755 | QBECO | - | - | - | - | [2] 96 96, 97 💬
|
| 1756 | QBECO SSI | - | - | - | - | [1] 97 97 💬
|
| 1757 | QD (Qing Dai) | - | - | - | - | [1] 97 97 💬
|
| 1758 | Quadrivalent HPV vaccine | - | - | - | - | [2] 97 97, 107 💬
|
| 1759 | Quercetin | [1] Quercetin Quercetin | - | - | - | [10] 13 13, 46, 65, 84, 85, 97, 192, 271, 285, 299 💬
|
| 1760 | R-3750 | - | - | - | - | [1] 97 97 💬
|
| 1761 | Radiation: Magnetic resonance imaging scanning | - | - | - | - | [1] 97 97 💬
|
| 1762 | Ramosetron | [1] Ramosetron Ramosetron | [2] Ramosetron hydrochloride
Ramosetron hydrochloride
,
Ramosetron
💬
| [5] HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | [1] 97 97 💬
|
| 1763 | Ranolazine | [1] Ranolazine Ranolazine | [2] Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | [8] 2 2, 57, 58, 86, 96, 97, 113, 114 💬
|
| 1764 | Raspberry | [1] Raspberry Raspberry | [1] Raspberry
Raspberry
💬
| - | - | [1] 97 97 💬
|
| 1765 | Ravagalimab | [1] Ravagalimab Ravagalimab | [1] Ravagalimab
Ravagalimab
💬
| [1] CD40 CD40 💬
| [17] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [3] 46 46, 53, 97 💬
|
| 1766 | RCTB-401 | - | - | - | - | [2] 96 96, 97 💬
|
| 1767 | RD06-05 CART Cell Infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 1768 | RDP58 | [1] RDP58 RDP58 | - | - | - | [1] 97 97 💬
|
| 1769 | Rebamipide | [1] Rebamipide Rebamipide | [1] Rebamipide
Rebamipide
💬
| - | - | [5] 46 46, 53, 56, 97, 271 💬
|
| 1770 | Recombinant Factor XIII (rFXIII) | - | - | - | - | [1] 97 97 💬
|
| 1771 | Recombinant Human Interleukin-11 (rhIL-11) | - | - | - | - | [2] 96 96, 97 💬
|
| 1772 | Rectal dialysis | - | - | - | - | [1] 97 97 💬
|
| 1773 | Rectal tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1774 | Rectosigmoidoscopy | - | - | - | - | [1] 97 97 💬
|
| 1775 | Regular treatment | - | - | - | - | [1] 97 97 💬
|
| 1776 | Regulatory T cells | - | - | - | - | [2] 95 95, 97 💬
|
| 1777 | Remestemcel-L | [1] Remestemcel-L Remestemcel-L | [1] Remestemcel-L
Remestemcel-L
💬
| - | - | [2] 96 96, 97 💬
|
| 1778 | REMICADE | - | - | - | - | [9] 46 46, 49, 56, 84, 85, 96, 97, 223, 271 💬
|
| 1779 | REMICADE (INFLIXIMAB) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 1780 | Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten | - | - | - | - | [1] 97 97 💬
|
| 1781 | Remicade 100 mg powder for concentrate for solution for infusion. | - | - | - | - | [2] 96 96, 97 💬
|
| 1782 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1783 | RemicadePharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: INFLIXIMABCAS Number: 170277-31-3Current Sponsor code: RO6897845Other descriptive name: INFLIXIMABConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-Trade Name: XeljanzPharmaceutical Form: Film-coated tabletINN or Proposed INN: TOFACITINIBCAS Number: 477600-75-2Current Sponsor code: Ro 516-9503Other descriptive name: TOFACITINIBConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Trade Name: XeljanzPharmaceutical Form: Film-coated tabletINN or Proposed INN: TOFACITINIBCAS Number: 477600-75-2Current Sponsor code: Ro 516-9503Other descriptive name: TOFACITINIBConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Trade Name: StelaraPharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: USTEKINUMABCAS Number: 815610-63-0Current Sponsor code: Ro 723-3920Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Trade Name: StelaraPharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: USTEKINUMABCAS Number: 815610-63-0Current Sponsor code: Ro 723-3920Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentra | - | - | - | - | [1] 97 97 💬
|
| 1784 | Remimazolam | [1] Remimazolam Remimazolam | [2] Remimazolam besylate
Remimazolam besylate
,
Remimazolam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [3] 6 6, 22, 97 💬
|
| 1785 | REMSIMA | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1786 | Remsima (CT-P13) | - | - | - | - | [1] 97 97 💬
|
| 1787 | Remsima (infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 💬
|
| 1788 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1789 | Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1790 | Remsima and Inflectra | - | - | - | - | [2] 96 96, 97 💬
|
| 1791 | RepomolPharmaceutical Form: Solution for infusionINN or Proposed INN: MolgramostimCAS Number: 99283-10-0Concentration unit: µg/ml microgram(s)/millilitreConcentration type: equalConcentration number: 250- | - | - | - | - | [1] 97 97 💬
|
| 1792 | Resveratrol | [1] Resveratrol Resveratrol | - | - | - | [10] 2 2, 6, 8, 18, 46, 57, 89, 97, 113, 299 💬
|
| 1793 | Resveratrol Supplementation | [1] Resveratrol Resveratrol | - | - | - | [1] 97 97 💬
|
| 1794 | Retarded release phosphatidylcholine | - | - | - | - | [1] 97 97 💬
|
| 1795 | Retarded Release Phosphatidylcholine (rPC) | - | - | - | - | [1] 97 97 💬
|
| 1796 | RhIL-11 | - | - | - | - | [2] 63 63, 97 💬
|
| 1797 | RhuMAb Beta7 | - | - | - | - | [1] 97 97 💬
|
| 1798 | RhuMAb Beta7, Anti Beta 7, PRO145223 | - | - | - | - | [1] 97 97 💬
|
| 1799 | RhuMAb Beta7, Anti Beta7, PRO145223 | - | - | - | - | [1] 97 97 💬
|
| 1800 | Riboflavin | [1] Riboflavin Riboflavin | [1] Riboflavin
Riboflavin
💬
| - | - | [8] 13 13, 38, 46, 96, 97, 162, 168, 265 💬
|
| 1801 | Rifaximin | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [8] 6 6, 65, 93, 96, 97, 99, 296, 299 💬
|
| 1802 | Risankizumab | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [4] 37 37, 96, 97, 271 💬
|
| 1803 | Risankizumab IV | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1804 | Risankizumab SC | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1805 | Risankizumab-800CW 15 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1806 | Risankizumab-800CW 15 mg/25 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1807 | Risankizumab-800CW 25 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1808 | Risankizumab-800CW 4.5 mg | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1809 | Risankizumab-800CW optimal dose | [1] Risankizumab Risankizumab | [1] Risankizumab
Risankizumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 1810 | RisankizumabProduct Code: ABBV-006Pharmaceutical Form: Solution for infusionINN or Proposed INN: RISANKIZUMABCurrent Sponsor code: ABBV-066Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 90-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous useProduct Name: RisankizumabProduct Code: ABBV-066Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: RISANKIZUMABCurrent Sponsor code: ABBV-066Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 90-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: RisankizumabProduct Code: ABBV-006Pharmaceutical Form: Solution for infusionINN or Proposed INN: RISANKIZUMABCurrent Sponsor code: ABBV-066Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 60- | - | - | - | - | [1] 97 97 💬
|
| 1811 | Ritlecitinib | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [3] 46 46, 96, 97 💬
|
| 1812 | Ritlecitinib 10 mg | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 1813 | Ritlecitinib 5 mg | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 1814 | Ritlecitinib 50 mg | [1] Ritlecitinib Ritlecitinib | [1] Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| [1] JAK3 JAK3 💬
| [15] Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | [2] 96 96, 97 💬
|
| 1815 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 1816 | Rivenprost | [1] Rivenprost Rivenprost | - | - | - | [1] 97 97 💬
|
| 1817 | Rivenprost (drug) | [1] Rivenprost Rivenprost | - | - | - | [1] 97 97 💬
|
| 1818 | Ro 549-0261/F04 | - | - | - | - | [1] 97 97 💬
|
| 1819 | RO5490261 / F02 | - | - | - | - | [1] 97 97 💬
|
| 1820 | RO5490261/F02 | - | - | - | - | [1] 97 97 💬
|
| 1821 | RO7049665 | - | - | - | - | [2] 95 95, 97 💬
|
| 1822 | RO7246311 | - | - | - | - | [1] 97 97 💬
|
| 1823 | RO7837195 | - | - | - | - | [1] 97 97 💬
|
| 1824 | Roflumilast | [1] Roflumilast Roflumilast | [1] Roflumilast
Roflumilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [5] 46 46, 84, 97, 206, 299 💬
|
| 1825 | Roflumilast 500 MCG Oral Tablet [DALIRESP] | [1] Roflumilast Roflumilast | [1] Roflumilast
Roflumilast
💬
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 97 97 💬
|
| 1826 | Ropivacaine | [1] Ropivacaine Ropivacaine | [2] Ropivacaine hydrochloride
Ropivacaine hydrochloride
,
Ropivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [7] 22 22, 36, 46, 63, 70, 71, 97 💬
|
| 1827 | Rosemary | [1] Rosemary Rosemary | - | - | - | [5] 13 13, 46, 51, 97, 271 💬
|
| 1828 | Rosiglitazone | [1] Rosiglitazone Rosiglitazone | [2] Rosiglitazone maleate
Rosiglitazone maleate
,
Rosiglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [7] 46 46, 57, 75, 77, 97, 222, 265 💬
|
| 1829 | Rosnilimab | [1] Rosnilimab Rosnilimab | [1] Rosnilimab
Rosnilimab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [2] 46 46, 97 💬
|
| 1830 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [16] 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 1831 | Rosuvastatin 10mg | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 97 97 💬
|
| 1832 | ROSUVASTATIN CALCIUM | [2] Calcium Calcium, Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [4] 49 49, 79, 97, 299 💬
|
| 1833 | Rosuvastatine EG | - | - | - | - | [1] 97 97 💬
|
| 1834 | RPC1063 | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 1835 | RTNV148B IgG | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 1836 | Rupatadine | [1] Rupatadine Rupatadine | [2] Rupatadine
Rupatadine
,
Rupatadine fumarate
💬
| [2] HRH1 HRH1, PTAFR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | [2] 46 46, 97 💬
|
| 1837 | Rutin | [1] Rutin Rutin | [1] Rutoside
Rutoside
💬
| - | - | [3] 46 46, 97, 271 💬
|
| 1838 | Rutin 500 MG | [1] Rutin Rutin | [1] Rutoside
Rutoside
💬
| - | - | [1] 97 97 💬
|
| 1839 | Rutin 500 MG Oral Tablet | [1] Rutin Rutin | [1] Rutoside
Rutoside
💬
| - | - | [1] 97 97 💬
|
| 1840 | RVG 114681 | - | - | - | - | [2] 96 96, 97 💬
|
| 1841 | RVG 116648 | - | - | - | - | [2] 96 96, 97 💬
|
| 1842 | RVG00859 | - | - | - | - | [2] 96 96, 97 💬
|
| 1843 | RYAH-Medtech Inhaler | - | - | - | - | [5] 2 2, 6, 13, 96, 97 💬
|
| 1844 | Saffron | - | - | - | - | [1] 97 97 💬
|
| 1845 | Saffron 100 | - | - | - | - | [1] 97 97 💬
|
| 1846 | Saffron 50 | - | - | - | - | [1] 97 97 💬
|
| 1847 | Saffron supplement for IBD | - | - | - | - | [1] 97 97 💬
|
| 1848 | Salicylic acid | [1] Salicylic acid Salicylic acid | [4] Salicylic acid
Salicylic acid
,
Sodium salicylate
,
Choline magnesium trisalicylate
,
Diethylamine salicylate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 97 97 💬
|
| 1849 | Saline | - | - | - | - | [12] 2 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
|
| 1850 | Saline +5% albumin | - | - | - | - | [1] 97 97 💬
|
| 1851 | Salofalk | - | - | - | - | [2] 96 96, 97 💬
|
| 1852 | Salofalk 1000mg Granu-Stix | - | - | - | - | [1] 97 97 💬
|
| 1853 | Salofalk 1000mg Granu-Stix® | - | - | - | - | [1] 97 97 💬
|
| 1854 | Salofalk 3g gastro-resistant prolonged-release granules | - | - | - | - | [1] 97 97 💬
|
| 1855 | Salofalk 4g/60ml Klysma | - | - | - | - | [1] 97 97 💬
|
| 1856 | Salofalk Granu-Stix 500 mg | - | - | - | - | [1] 97 97 💬
|
| 1857 | Salofalk® 1000mg Granu-Stix® | - | - | - | - | [1] 97 97 💬
|
| 1858 | Salofalk® 500 mg gastro-resistant tablet | - | - | - | - | [1] 97 97 💬
|
| 1859 | Salofalk® 500 mg tablets | - | - | - | - | [1] 97 97 💬
|
| 1860 | Salofalk® 500mg | - | - | - | - | [1] 97 97 💬
|
| 1861 | Salofalk® 500mg Granu-Stix® | - | - | - | - | [1] 97 97 💬
|
| 1862 | Sampling | - | - | - | - | [1] 97 97 💬
|
| 1863 | Sandimmum | - | - | - | - | [1] 97 97 💬
|
| 1864 | Sandimmun | - | - | - | - | [2] 97 97, 226 💬
|
| 1865 | Sandimmun 50 mg/ml, infuusiokonsentraatti | - | - | - | - | [1] 97 97 💬
|
| 1866 | Sandimmun Neoral | - | - | - | - | [5] 54 54, 60, 97, 222, 226 💬
|
| 1867 | SANDINUM | - | - | - | - | [1] 97 97 💬
|
| 1868 | SAR339658 | - | - | - | - | [2] 13 13, 97 💬
|
| 1869 | SAR441566 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 1870 | SAR442970 | - | - | - | - | [2] 96 96, 97 💬
|
| 1871 | SAR443122 | [1] SAR443122 SAR443122 | [1] Eclitasertib
Eclitasertib
💬
| [1] RIPK1 RIPK1 💬
| [16] Alcoholic liver disease Alcoholic liver disease, Apoptosis, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis C, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, RIG-I-like receptor signaling pathway, Salmonella infection, Shigellosis, TNF signaling pathway, Toll-like receptor signaling pathway 💬 | [1] 97 97 💬
|
| 1872 | SB-656933 | - | - | - | - | [1] 97 97 💬
|
| 1873 | SB-656933 Tablets | - | - | - | - | [2] 97 97, 299 💬
|
| 1874 | SB012 | - | - | - | - | [1] 97 97 💬
|
| 1875 | SB5 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 1876 | SC Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 1877 | SC12267 | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬
|
| 1878 | SC12267 (4SC-101) | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬
|
| 1879 | SCH 900050 | - | - | - | - | [1] 97 97 💬
|
| 1880 | Sci-B-Vac | - | - | - | - | [1] 97 97 💬
|
| 1881 | Selenium | [1] Selenium Selenium | - | - | - | [5] 13 13, 96, 97, 278, 298 💬
|
| 1882 | Selenium supplementation | [1] Selenium Selenium | - | - | - | [1] 97 97 💬
|
| 1883 | SELG*OS POLV 4BUST 70G 1LT | - | - | - | - | [1] 97 97 💬
|
| 1884 | Semi-vegetarian diet | - | - | - | - | [1] 97 97 💬
|
| 1885 | Sequential FMT | - | - | - | - | [1] 97 97 💬
|
| 1886 | SER-287 | [1] SER-287 SER-287 | - | - | - | [1] 97 97 💬
|
| 1887 | Serum and fecal measurements | - | - | - | - | [1] 97 97 💬
|
| 1888 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 💬
|
| 1889 | SF257 C59 | - | - | - | - | [1] 97 97 💬
|
| 1890 | Sham acupuncture | - | - | - | - | [1] 97 97 💬
|
| 1891 | Sham Hyperbaric Air | - | - | - | - | [1] 97 97 💬
|
| 1892 | Shingrix | - | - | - | - | [6] 41 41, 46, 49, 51, 96, 97 💬
|
| 1893 | SHP647 | - | - | - | - | [2] 96 96, 97 💬
|
| 1894 | SHR-1139 intravenous injection. | - | - | - | - | [1] 97 97 💬
|
| 1895 | SHR0302 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1896 | SHR0302 Tablets | - | - | - | - | [2] 46 46, 97 💬
|
| 1897 | Sigmoidoscopy | - | - | - | - | [1] 97 97 💬
|
| 1898 | Sigmoidoscopy and biopsy, blood work | - | - | - | - | [1] 97 97 💬
|
| 1899 | Silymarin | - | - | - | - | [3] 6 6, 46, 97 💬
|
| 1900 | SIMPONI | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 1901 | Simponi (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 1902 | SIMPONI 100 mg | - | - | - | - | [1] 97 97 💬
|
| 1903 | SIMPONI 50 mg | - | - | - | - | [1] 97 97 💬
|
| 1904 | Simponi® | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 1905 | Simponi® (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1906 | Simulect | - | - | - | - | [3] 66 66, 97, 223 💬
|
| 1907 | Single dose-group A | - | - | - | - | [1] 97 97 💬
|
| 1908 | Single FMT | - | - | - | - | [1] 97 97 💬
|
| 1909 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 1910 | SM17 | - | - | - | - | [1] 97 97 💬
|
| 1911 | Smartject Device delivery of Golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1912 | Smoking cigarettes | - | - | - | - | [2] 96 96, 97 💬
|
| 1913 | Smoking of cannabis | - | - | - | - | [2] 96 96, 97 💬
|
| 1914 | SODIO SOLFATO ANIDRO | - | - | - | - | [1] 97 97 💬
|
| 1915 | SODIUM | - | - | - | - | [1] 97 97 💬
|
| 1916 | Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate | [1] Pyrrolidine Pyrrolidine | - | - | - | [1] 97 97 💬
|
| 1917 | SODIUM ASCORBATE | [2] Ascorbic acid Ascorbic acid, Sodium ascorbate | [2] Ascorbic acid
Ascorbic acid
,
Sodium ascorbate
💬
| - | - | [1] 97 97 💬
|
| 1918 | Sodium bicarbonate | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [4] 67 67, 97, 226, 299 💬
|
| 1919 | SODIUM BICARBONATE BP | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [2] 97 97, 299 💬
|
| 1920 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 1921 | Sodium hyaluronate | [1] Hyaluronic acid Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [6] 46 46, 53, 70, 97, 226, 279 💬
|
| 1922 | Sodium Picosulfate/Magnesium Citrate Laxative | [2] Magnesium Magnesium, Magnesium citrate | [1] Magnesium citrate
Magnesium citrate
💬
| - | - | [1] 97 97 💬
|
| 1923 | Sodium propionate | [1] Propanoic acid Propanoic acid | [3] Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | [1] 97 97 💬
|
| 1924 | Sodium succinate | [1] Succinic acid Succinic acid | - | - | - | [11] 13 13, 46, 49, 50, 51, 81, 83, 95, 97, 211, 222 💬
|
| 1925 | Sodium sulfate | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [2] 28 28, 97 💬
|
| 1926 | SODIUM SULFATE ANHYDROUS | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 1927 | SODIUM SULPHATE ANHYDROUS | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 1928 | SOLFATO DI SODIO ANIDRO | - | - | - | - | [1] 97 97 💬
|
| 1929 | Solu-Medrol | - | - | - | - | [5] 13 13, 51, 53, 97, 211 💬
|
| 1930 | Soluble protein hydrolysate (SPHi) | [1] Protein hydrolysate Protein hydrolysate | [1] Protein hydrolysate
Protein hydrolysate
💬
| - | - | [1] 97 97 💬
|
| 1931 | Somatropin | - | - | - | - | [14] 3 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
|
| 1932 | SonoVue | - | - | - | - | [2] 96 96, 97 💬
|
| 1933 | SOR102 | - | - | - | - | [1] 97 97 💬
|
| 1934 | Sorbitol | [1] Sorbitol Sorbitol | [1] Sorbitol solution
Sorbitol solution
💬
| - | - | [2] 10 10, 97 💬
|
| 1935 | Sorbitol Sachet | [1] Sorbitol Sorbitol | [1] Sorbitol solution
Sorbitol solution
💬
| - | - | [1] 97 97 💬
|
| 1936 | Sotrastaurin | [1] Sotrastaurin Sotrastaurin | [2] Sotrastaurin
Sotrastaurin
,
Sotrastaurin acetate
💬
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
| [30] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagosome formation, GnRH signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1937 | Sotrastaurin (INN) acetate | [2] Acetate Acetate, Sotrastaurin | [2] Sotrastaurin
Sotrastaurin
,
Sotrastaurin acetate
💬
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
| [30] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagosome formation, GnRH signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1938 | Soybean | [1] Soybean Soybean | - | - | - | [1] 97 97 💬
|
| 1939 | SOYBEAN PHOSPHATIDYLCHOLINE | [1] Soybean Soybean | - | - | - | [1] 97 97 💬
|
| 1940 | SPD476 | - | - | - | - | [1] 97 97 💬
|
| 1941 | SPD476 (mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1942 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1943 | Spesolimab | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [5] 37 37, 96, 97, 160, 269 💬
|
| 1944 | Spesolimab IV infusion | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 💬
|
| 1945 | Spesolimab SC solution for injection | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 💬
|
| 1946 | SPH3127 | - | - | - | - | [1] 97 97 💬
|
| 1947 | SPH3127 Tablets with Dose A | - | - | - | - | [1] 97 97 💬
|
| 1948 | SPH3127 Tablets with Dose B | - | - | - | - | [1] 97 97 💬
|
| 1949 | SPH7854 | - | - | - | - | [1] 97 97 💬
|
| 1950 | SPY001 | - | - | - | - | [1] 97 97 💬
|
| 1951 | SPY002 | - | - | - | - | [1] 97 97 💬
|
| 1952 | SPY003 | - | - | - | - | [1] 97 97 💬
|
| 1953 | SR140333B | - | - | - | - | [1] 97 97 💬
|
| 1954 | SRT2104 | - | - | - | - | [1] 97 97 💬
|
| 1955 | ST 261 | - | - | - | - | [1] 97 97 💬
|
| 1956 | ST-0529 | - | - | - | - | [1] 97 97 💬
|
| 1957 | ST10 | - | - | - | - | [2] 96 96, 97 💬
|
| 1958 | ST10-021 | - | - | - | - | [2] 96 96, 97 💬
|
| 1959 | ST261 | - | - | - | - | [1] 97 97 💬
|
| 1960 | Standard 2 hours-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 1961 | Standard dose Influenza vaccine (SDIV) | - | - | - | - | [1] 97 97 💬
|
| 1962 | Standard hepatitis B vaccine | - | - | - | - | [1] 97 97 💬
|
| 1963 | Standard intravenous omeprazole therapy (40 mg IV once daily at 6:00 AM). | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 97 97 💬
|
| 1964 | Standard of Care | - | - | - | - | [18] 6 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
|
| 1965 | Standard therapy | - | - | - | - | [5] 49 49, 51, 58, 97, 195 💬
|
| 1966 | Standardized anthocyanin-rich extract | - | - | - | - | [1] 97 97 💬
|
| 1967 | Standardized FMT | - | - | - | - | [1] 97 97 💬
|
| 1968 | Standardized FODMAP | - | - | - | - | [1] 97 97 💬
|
| 1969 | Stelara | - | - | - | - | [6] 49 49, 56, 96, 97, 269, 271 💬
|
| 1970 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 1971 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | - | - | - | - | [2] 96 96, 97 💬
|
| 1972 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 1973 | STELARA® | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1974 | STELARA®Product Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injectionINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: up toConcentration number: 200-Trade Name: STELARA®Product Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: up toConcentration number: 200- | - | - | - | - | [2] 96 96, 97 💬
|
| 1975 | Sterile saline for injection | - | - | - | - | [1] 97 97 💬
|
| 1976 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬
|
| 1977 | STNM01 | - | - | - | - | [1] 97 97 💬
|
| 1978 | STNM01 1.84 mg | - | - | - | - | [1] 97 97 💬
|
| 1979 | Stool samples | - | - | - | - | [2] 97 97, 160 💬
|
| 1980 | Stool sampling | - | - | - | - | [2] 97 97, 98 💬
|
| 1981 | STW5-II | - | - | - | - | [1] 97 97 💬
|
| 1982 | STW5-II (Iberogast N, BAY98-7410) | - | - | - | - | [1] 97 97 💬
|
| 1983 | SUB20016 | - | - | - | - | [2] 96 96, 97 💬
|
| 1984 | Subcutaneous infliximab CT-P13 Remsima®SC | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 1985 | Sucrose | [1] Sucrose Sucrose | [1] Sucrose
Sucrose
💬
| - | - | [4] 62 62, 96, 97, 127 💬
|
| 1986 | Sucrosomial Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1987 | Sugar Extract | - | - | - | - | [2] 96 96, 97 💬
|
| 1988 | SULFATE | - | - | - | - | [1] 97 97 💬
|
| 1989 | SULFUR HEXAFLUORIDE | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [3] 96 96, 97, 215 💬
|
| 1990 | Sulphsalazine, Pentasa, Asacol, Colazide, Depentum | - | - | - | - | [1] 97 97 💬
|
| 1991 | Sulphur hexafluoride | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [2] 96 96, 97 💬
|
| 1992 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | [1] 97 97 💬
|
| 1993 | Suspension de microbiote fécal | - | - | - | - | [1] 97 97 💬
|
| 1994 | Suspension of adipose derived autologous adult stem cells | - | - | - | - | [2] 96 96, 97 💬
|
| 1995 | Switch of anti TNF for ustekinumab for paradoxical psoriasis. | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1996 | Synergy-1 | - | - | - | - | [1] 97 97 💬
|
| 1997 | Synergy1 | - | - | - | - | [1] 97 97 💬
|
| 1998 | Sübetaholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 1999 | Süßholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 2000 | TA-650 | - | - | - | - | [4] 37 37, 56, 96, 97 💬
|
| 2001 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 2002 | Tacrolimus Lipid Suspension for enema | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 2003 | TAK-279 | - | - | - | - | [3] 37 37, 96, 97 💬
|
| 2004 | Tauroursoursodeoxycholic acid, brand name Tudcabil | - | - | - | - | [1] 97 97 💬
|
| 2005 | TD-1473 | - | - | - | - | [2] 96 96, 97 💬
|
| 2006 | TD-1473 Dose A | - | - | - | - | [1] 97 97 💬
|
| 2007 | TD-1473 Dose B | - | - | - | - | [1] 97 97 💬
|
| 2008 | TD-1473 Dose C | - | - | - | - | [1] 97 97 💬
|
| 2009 | TD-3504 | - | - | - | - | [1] 97 97 💬
|
| 2010 | Telotristat | [1] Telotristat Telotristat | [1] Telotristat
Telotristat
💬
| [2] TPH1 TPH1, TPH2 💬
| [3] Folate biosynthesis Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬 | [1] 97 97 💬
|
| 2011 | Telotristat Etiprate | [2] Telotristat Telotristat, Telotristat ethyl | [3] Telotristat
Telotristat
,
Telotristat ethyl
,
Telotristat etiprate
💬
| [2] TPH1 TPH1, TPH2 💬
| [3] Folate biosynthesis Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬 | [1] 97 97 💬
|
| 2012 | Tempeh Isoflavone | [1] Isoflavone Isoflavone | - | - | - | [2] 96 96, 97 💬
|
| 2013 | Terbinafine | [1] Terbinafine Terbinafine | [2] Terbinafine hydrochloride
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | [3] 96 96, 97, 271 💬
|
| 2014 | Terbinafine Tablets | [1] Terbinafine Terbinafine | [2] Terbinafine hydrochloride
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | [2] 97 97, 271 💬
|
| 2015 | Tetomilast | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 💬
|
| 2016 | Tetracycline | [1] Tetracycline Tetracycline | [2] Tetracycline
Tetracycline
,
Tetracycline hydrochloride
💬
| - | - | [5] 13 13, 46, 53, 66, 97 💬
|
| 2017 | TEV-48574 | - | - | - | - | [2] 96 96, 97 💬
|
| 2018 | TEV-48574 Dose Regimen A | - | - | - | - | [2] 96 96, 97 💬
|
| 2019 | TEV-48574 Dose Regiment B | - | - | - | - | [2] 96 96, 97 💬
|
| 2020 | TEV-48574Product Code: TEV-48574Pharmaceutical Form: Solution for injectionINN or Proposed INN: TEV-48574Current Sponsor code: TEV-48574Other descriptive name: Fully human IgG1 monoclonal antibody specific for TL1AConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150- | - | - | - | - | [2] 96 96, 97 💬
|
| 2021 | Thalidomide | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 2 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
| 2022 | Thalidomide Pharmion | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 85 85, 96, 97 💬
|
| 2023 | The Colonic Transendoscopic enteral Tubing. | - | - | - | - | [1] 97 97 💬
|
| 2024 | Thiamin | - | - | - | - | [1] 97 97 💬
|
| 2025 | Thiopurine | - | - | - | - | [2] 96 96, 97 💬
|
| 2026 | Thiosix | - | - | - | - | [2] 96 96, 97 💬
|
| 2027 | Threonine | [1] Threonine Threonine | [1] Threonine
Threonine
💬
| - | - | [3] 86 86, 96, 97 💬
|
| 2028 | Thrombin | [1] Thrombin Thrombin | [1] Thrombin
Thrombin
💬
| - | - | [3] 86 86, 88, 97 💬
|
| 2029 | THRX-139060 | - | - | - | - | [2] 96 96, 97 💬
|
| 2030 | Tiamin DAK | - | - | - | - | [2] 93 93, 97 💬
|
| 2031 | Tiamin SAD | - | - | - | - | [2] 93 93, 97 💬
|
| 2032 | Tilpisertib | [1] Tilpisertib Tilpisertib | - | - | - | [1] 97 97 💬
|
| 2033 | Tilpisertib Fosmecarbil | [2] Tilpisertib Tilpisertib, Tilpisertib fosmecarbil | - | - | - | [1] 97 97 💬
|
| 2034 | Time and attention | - | - | - | - | [2] 96 96, 97 💬
|
| 2035 | Time and attention + active fructooligosaccharide supplementation | - | - | - | - | [2] 96 96, 97 💬
|
| 2036 | Tirzepatide | [1] Tirzepatide Tirzepatide | [1] Tirzepatide
Tirzepatide
💬
| [2] GIPR GIPR, GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [6] 67 67, 96, 97, 193, 233, 265 💬
|
| 2037 | TISSUCOL | - | - | - | - | [1] 97 97 💬
|
| 2038 | TISSUCOL DUO | - | - | - | - | [1] 97 97 💬
|
| 2039 | TISSUCOL DUO (5.0ML) FIBRIN TISSUE ADHESIVE | [1] Fibrin Fibrin | - | - | - | [1] 97 97 💬
|
| 2040 | TJ301 300mg | - | - | - | - | [1] 97 97 💬
|
| 2041 | TJ301 600mg | - | - | - | - | [1] 97 97 💬
|
| 2042 | TL-003 | - | - | - | - | [1] 97 97 💬
|
| 2043 | TLL018 | - | - | - | - | [1] 97 97 💬
|
| 2044 | TNF Inhibitor | - | - | - | - | [3] 46 46, 97, 107 💬
|
| 2045 | TNF inhibitors | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 2046 | TNF-a antagonists, non-TNFs, DMARD non-biologics | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 2047 | To be confirmed | - | - | - | - | [3] 46 46, 65, 97 💬
|
| 2048 | To be requested | - | - | - | - | [2] 96 96, 97 💬
|
| 2049 | TOFACINITIB | - | - | - | - | [1] 97 97 💬
|
| 2050 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 2051 | Tofacitinib 10 MG [Xeljanz] | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2052 | TOFACITINIB CITRATE | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 49, 97, 107, 271 💬
|
| 2053 | Tofacitinib citrate (clinical trial image) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 97 💬
|
| 2054 | Tofacitinib citrate (Phase III formulation) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 97 💬
|
| 2055 | Tofacitinib citrate (Proposed commercial formulation - debossed) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 97 💬
|
| 2056 | Tofacitinib citrate (Proposed commercial formulation – debossed) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 97 💬
|
| 2057 | Tofacitinib citrate (Proposed commercialFormulation - debossed) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2058 | Tofacitinib plus mesalamine | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2059 | Top down treatment if patient at high risk | - | - | - | - | [2] 96 96, 97 💬
|
| 2060 | TOP1288 | - | - | - | - | [1] 97 97 💬
|
| 2061 | TOP1288 Rectal solution | - | - | - | - | [1] 97 97 💬
|
| 2062 | TOPIRAMATE | [1] Topiramate Topiramate | [1] Topiramate
Topiramate
💬
| [37] CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [55] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Cadherin signaling, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, IgSF CAM signaling, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 6 6, 97, 140, 144, 156, 193 💬
|
| 2063 | TP05 | - | - | - | - | [1] 97 97 💬
|
| 2064 | TP05 Coating A | - | - | - | - | [1] 97 97 💬
|
| 2065 | TP05 Coating B | - | - | - | - | [1] 97 97 💬
|
| 2066 | TP05 Coating D | - | - | - | - | [1] 97 97 💬
|
| 2067 | TP05 Coating E | - | - | - | - | [1] 97 97 💬
|
| 2068 | TP05 Coating H | - | - | - | - | [1] 97 97 💬
|
| 2069 | TR004 (Treg immunotherapy) | - | - | - | - | [2] 96 96, 97 💬
|
| 2070 | Traditional treatments | - | - | - | - | [1] 97 97 💬
|
| 2071 | Tralokinumab | [1] Tralokinumab Tralokinumab | [1] Tralokinumab
Tralokinumab
💬
| [1] IL13 IL13 💬
| [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [2] 85 85, 97 💬
|
| 2072 | Treatment Algorithm A | - | - | - | - | [1] 97 97 💬
|
| 2073 | Treatment Algorithm B | - | - | - | - | [1] 97 97 💬
|
| 2074 | Treatment Algorithm C | - | - | - | - | [1] 97 97 💬
|
| 2075 | Treatment group: Rectal instillation of QHQYP | - | - | - | - | [1] 97 97 💬
|
| 2076 | Treatment vs control bread | - | - | - | - | [1] 97 97 💬
|
| 2077 | TREMFYA® | - | - | - | - | [2] 37 37, 97 💬
|
| 2078 | Trexan inj 25 mg/ml | - | - | - | - | [1] 97 97 💬
|
| 2079 | Trichuris suis eggs | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 2080 | Trichuris suis Ova | - | - | - | - | [4] 13 13, 46, 96, 97 💬
|
| 2081 | Trichuris suis ova (TSO) | - | - | - | - | [2] 96 96, 97 💬
|
| 2082 | Trilac | - | - | - | - | [2] 96 96, 97 💬
|
| 2083 | TSO | - | - | - | - | [3] 13 13, 46, 97 💬
|
| 2084 | Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [5] 46 46, 51, 96, 97, 271 💬
|
| 2085 | Tumor necrosis factor (TNF)-alpha inhibitors | - | - | - | - | [1] 97 97 💬
|
| 2086 | TYK2 Inhibitor | - | - | - | - | [1] 97 97 💬
|
| 2087 | UCB4940 | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 2088 | UCMSC group | - | - | - | - | [1] 97 97 💬
|
| 2089 | Umbilical cord blood mononuclear cells | - | - | - | - | [1] 97 97 💬
|
| 2090 | Umbilical cord mesenchymal stem cells | - | - | - | - | [5] 13 13, 46, 57, 97, 113 💬
|
| 2091 | Undetermined | - | - | - | - | [2] 96 96, 97 💬
|
| 2092 | Unknown | - | - | - | - | [3] 34 34, 67, 97 💬
|
| 2093 | Upadacitinib | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [12] 40 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
|
| 2094 | Upadacitinib (ABT-494) | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 53 53, 97 💬
|
| 2095 | Upadacitinib - Direct compression-yellow | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2096 | Upadacitinib - Wet Granulation-Yellow | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2097 | Upadacitinib -Direct compression-yellow | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2098 | Upadacitinib Extended Release Oral Tablet | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2099 | Upadacitinib Oral Product | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 💬
|
| 2100 | Updacitinib (ABT-494) | - | - | - | - | [1] 97 97 💬
|
| 2101 | UR-12746-S | - | - | - | - | [1] 97 97 💬
|
| 2102 | Urbason | - | - | - | - | [1] 97 97 💬
|
| 2103 | Ursodeoxycholic acid | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [10] 6 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
|
| 2104 | Ursodiol (ursodeoxycholic acid, UDCA) | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 97 97 💬
|
| 2105 | Ursofalk | - | - | - | - | [4] 93 93, 94, 96, 97 💬
|
| 2106 | US TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] Epinephrine
Epinephrine
,
Epinephrine hydrochloride
,
Bupivacaine hydrochloride
,
Epinephrine bitartrate
,
Bupivacaine
💬
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 2107 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
| 2108 | Ustekinumab (UST) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2109 | Ustekinumab - Standard Dosage | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2110 | Ustekinumab 130 mg IV | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2111 | Ustekinumab 90 mg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 50, 56, 93, 96, 97 💬
|
| 2112 | Ustekinumab 90 mg SC q12w | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2113 | Ustekinumab 90 mg SC q8w | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2114 | Ustekinumab Dose Based on BSA and Body Weight | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 97 97 💬
|
| 2115 | Ustekinumab IV | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 49 49, 97 💬
|
| 2116 | Ustekinumab IV Infusion | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2117 | Ustekinumab SC | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 49 49, 97 💬
|
| 2118 | Ustekinumab SC Injection | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 2119 | Usual current care | - | - | - | - | [2] 96 96, 97 💬
|
| 2120 | UTTR1147A | - | - | - | - | [2] 96 96, 97 💬
|
| 2121 | UTTR1147A, IL22-Fc, IL-22Fc | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] Efmarodocokin alfa
Efmarodocokin alfa
💬
| [1] IL22 IL22 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 2122 | UTTR1147A/RO7021610 (Active) | - | - | - | - | [2] 96 96, 97 💬
|
| 2123 | V565 | - | - | - | - | [2] 96 96, 97 💬
|
| 2124 | Vaccination against cholera | - | - | - | - | [1] 97 97 💬
|
| 2125 | Vaccine | - | - | - | - | [2] 49 49, 97 💬
|
| 2126 | Vaccine anti-H1N1 | - | - | - | - | [1] 97 97 💬
|
| 2127 | Vaccine Vivotif + Vaccine Dukoral | - | - | - | - | [1] 97 97 💬
|
| 2128 | Vaccine Vivotif + Vaccine Dukoral + oats | - | - | - | - | [1] 97 97 💬
|
| 2129 | Valganciclovir | [1] Valganciclovir Valganciclovir | [2] Valganciclovir
Valganciclovir
,
Valganciclovir hydrochloride
💬
| - | - | [6] 28 28, 60, 85, 97, 299, 331 💬
|
| 2130 | Vaminolac | - | - | - | - | [1] 97 97 💬
|
| 2131 | Vaminolac, komb. | - | - | - | - | [1] 97 97 💬
|
| 2132 | Vamorolone | [1] Vamorolone Vamorolone | [1] Vamorolone
Vamorolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 97 97, 113 💬
|
| 2133 | Vamorolone 4% suspension for oral dosing | [1] Vamorolone Vamorolone | [1] Vamorolone
Vamorolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 2134 | VANCOMICINA CLORIDRATO | - | - | - | - | [2] 94 94, 97 💬
|
| 2135 | Vancomycin | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [9] 6 6, 13, 46, 70, 94, 96, 97, 296, 299 💬
|
| 2136 | Vancomycin (blinded) | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [2] 94 94, 97 💬
|
| 2137 | Vancomycin (open-label extension) | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [2] 94 94, 97 💬
|
| 2138 | Vancomycin (POC) | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 2139 | Vancomycin /Amphotericin B (Fungizone®) /Gentamicine 80 mg | [2] Amphotericin B Amphotericin B, Vancomycin | [3] Amphotericin B
Amphotericin B
,
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [2] 96 96, 97 💬
|
| 2140 | Vancomycin Oral Capsule | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 2141 | Vancomycin Pre-Treat | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 2142 | Vancomycin Pre-Treatment | [1] Vancomycin Vancomycin | [2] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | [1] 97 97 💬
|
| 2143 | Vancomycin, mupirocin ointment | [2] Mupirocin Mupirocin, Vancomycin | [4] Vancomycin
Vancomycin
,
Vancomycin hydrochloride
,
Mupirocin
,
Mupirocin calcium
💬
| - | - | [1] 97 97 💬
|
| 2144 | Vatelizumab | [1] Vatelizumab Vatelizumab | - | - | - | [2] 13 13, 97 💬
|
| 2145 | VB-201 | [1] VB-201 VB-201 | - | - | - | [1] 97 97 💬
|
| 2146 | VB-201 160mg | [1] VB-201 VB-201 | - | - | - | [1] 97 97 💬
|
| 2147 | VE202 | - | - | - | - | [1] 97 97 💬
|
| 2148 | VEDOLIZUMAB | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 💬
|
| 2149 | Vedolizumab 108 mg SC | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 💬
|
| 2150 | Vedolizumab 300 mg | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 💬
|
| 2151 | Vedolizumab 300 mg IV | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 💬
|
| 2152 | Vedolizumab Injection | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 💬
|
| 2153 | Vedolizumab intravenous injection | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 2154 | Vedolizumab IV | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 💬
|
| 2155 | Vedolizumab SC | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 2156 | Vedolizumab subcutaneous injection | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 2157 | Vedolizumab, Entyvio | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 2158 | Vedolizumab, Ustekinumab, or Tofacitinib | [3] Tofacitinib Tofacitinib, Ustekinumab, Vedolizumab | [4] Vedolizumab
Vedolizumab
,
Ustekinumab
,
Tofacitinib citrate
,
Tofacitinib
💬
| [9] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, JAK1, JAK2, JAK3, TYK2 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬 | [1] 97 97 💬
|
| 2159 | VEDULIZUMAB | - | - | - | - | [1] 97 97 💬
|
| 2160 | Vegan drink | - | - | - | - | [1] 97 97 💬
|
| 2161 | Vegetarian meat alternative | - | - | - | - | [1] 97 97 💬
|
| 2162 | Vegetarian yogurt | - | - | - | - | [1] 97 97 💬
|
| 2163 | Velsipity | - | - | - | - | [1] 97 97 💬
|
| 2164 | Venlafaxine | [1] Venlafaxine Venlafaxine | [3] Venlafaxine hydrochloride
Venlafaxine hydrochloride
,
Venlafaxine
,
Venlafaxine besylate monohydrate
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 6 6, 13, 46, 97 💬
|
| 2165 | Venofer | - | - | - | - | [1] 97 97 💬
|
| 2166 | Venofer solution for injection, 100 mg iron | - | - | - | - | [1] 97 97 💬
|
| 2167 | Venofer solution for injection, 20 mg iron/ml | - | - | - | - | [1] 97 97 💬
|
| 2168 | Venofer solution for injection, 20 mg/ml iron | - | - | - | - | [1] 97 97 💬
|
| 2169 | Venous blood samples, anal swab samples, vaginal swab samples, high resolution anoscopy (HRA), anal biopsy samples | - | - | - | - | [2] 96 96, 97 💬
|
| 2170 | Vidofludimus | [1] Vidofludimus Vidofludimus | [2] Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [5] 13 13, 46, 94, 96, 97 💬
|
| 2171 | VIDOFLUDIMUS CALCIUM | [2] Calcium Calcium, Vidofludimus | [2] Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [4] 13 13, 94, 96, 97 💬
|
| 2172 | Vidofludimus calcium dihydrate | [2] Calcium Calcium, Vidofludimus | [2] Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 97 97 💬
|
| 2173 | Vigantol Oel | - | - | - | - | [3] 13 13, 96, 97 💬
|
| 2174 | Vigantol Oel TM | - | - | - | - | [2] 96 96, 97 💬
|
| 2175 | Visilizumab | [1] Visilizumab Visilizumab | [1] Visilizumab
Visilizumab
💬
| [3] CD3D CD3D, CD3E, CD3G 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 💬
|
| 2176 | Visilizumab (HuM291 | [1] Visilizumab Visilizumab | [1] Visilizumab
Visilizumab
💬
| [3] CD3D CD3D, CD3E, CD3G 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 97 97 💬
|
| 2177 | Visilizumab (Nuvion) | [1] Visilizumab Visilizumab | [1] Visilizumab
Visilizumab
💬
| [3] CD3D CD3D, CD3E, CD3G 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 97 97 💬
|
| 2178 | Visilizumab (Nuvion® | [1] Visilizumab Visilizumab | [1] Visilizumab
Visilizumab
💬
| [3] CD3D CD3D, CD3E, CD3G 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 97 97 💬
|
| 2179 | Vit-45 | - | - | - | - | [1] 97 97 💬
|
| 2180 | Vitamin A | [1] Vitamin A Vitamin A | [2] Vitamin A oil
Vitamin A oil
,
Vitamin A
💬
| [2] RARA RARA, RARB 💬
| [8] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [4] 13 13, 53, 90, 97 💬
|
| 2181 | Vitamin B2 | [1] Riboflavin Riboflavin | [1] Riboflavin
Riboflavin
💬
| - | - | [1] 97 97 💬
|
| 2182 | Vitamin B5 Tablets | - | - | - | - | [1] 97 97 💬
|
| 2183 | Vitamin B6 Tablets | - | - | - | - | [1] 97 97 💬
|
| 2184 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [26] 3 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
|
| 2185 | Vitamin D (Cholecalciferol ) | [2] Cholecalciferol Cholecalciferol, Vitamin D | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 2186 | Vitamin D drops | [1] Vitamin D Vitamin D | - | - | - | [2] 96 96, 97 💬
|
| 2187 | Vitamin D enriched milk | [1] Vitamin D Vitamin D | - | - | - | [1] 97 97 💬
|
| 2188 | Vitamin D-3 | [1] Vitamin D Vitamin D | - | - | - | [1] 97 97 💬
|
| 2189 | Vitamin D3 | - | - | - | - | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
|
| 2190 | Vitamin D3 (Cholecalciferol) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 96 96, 97 💬
|
| 2191 | Vitamin E | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [12] 2 2, 6, 13, 19, 20, 46, 90, 96, 97, 206, 299, 317 💬
|
| 2192 | Vitamin E 800IU | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [2] 96 96, 97 💬
|
| 2193 | Vitamin K 10 mg | - | - | - | - | [2] 96 96, 97 💬
|
| 2194 | Vixarelimab | [1] Vixarelimab Vixarelimab | [1] Vixarelimab
Vixarelimab
💬
| [1] OSMR OSMR 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, PI3K-Akt signaling pathway 💬 | [3] 51 51, 85, 97 💬
|
| 2195 | Vonoprazan | [1] Vonoprazan Vonoprazan | [1] Vonoprazan
Vonoprazan
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [3] 63 63, 97, 98 💬
|
| 2196 | Vorinostat | [1] Vorinostat Vorinostat | [1] Vorinostat
Vorinostat
💬
| [11] HDAC1 HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬
| [20] ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | [5] 65 65, 75, 96, 97, 156 💬
|
| 2197 | VSL#3 | - | - | - | - | [4] 96 96, 97, 107, 291 💬
|
| 2198 | VSL#3 (Original De Simone formulation) | - | - | - | - | [2] 96 96, 97 💬
|
| 2199 | VSL#3® | - | - | - | - | [2] 96 96, 97 💬
|
| 2200 | VTX002 | - | - | - | - | [1] 97 97 💬
|
| 2201 | VTX002 is not biologic | - | - | - | - | [1] 97 97 💬
|
| 2202 | VTX002Pharmaceutical Form: Film-coated tablet | - | - | - | - | [1] 97 97 💬
|
| 2203 | Warfarin | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [15] 6 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
|
| 2204 | Warfarin 10 mg | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [2] 96 96, 97 💬
|
| 2205 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 2206 | Water immersion | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 97 97 💬
|
| 2207 | Wharton Jelly Mesenchymal stem cells | - | - | - | - | [1] 97 97 💬
|
| 2208 | Wheat | [1] Wheat Wheat | [1] Wheat
Wheat
💬
| - | - | [5] 6 6, 53, 97, 98, 266 💬
|
| 2209 | Whey | [1] Whey Whey | - | - | - | [4] 6 6, 46, 96, 97 💬
|
| 2210 | Whey Protein Milk-Derived Exosomes | [1] Whey Whey | - | - | - | [1] 97 97 💬
|
| 2211 | WHOLE WHEAT MUFFIN | [1] Wheat Wheat | [1] Wheat
Wheat
💬
| - | - | [1] 97 97 💬
|
| 2212 | XELJANZ | - | - | - | - | [4] 46 46, 97, 107, 271 💬
|
| 2213 | XELJANZ - | - | - | - | - | [1] 97 97 💬
|
| 2214 | XELJANZ 5 mg film-coated tablets | - | - | - | - | [2] 46 46, 97 💬
|
| 2215 | Xeljanz 5mg film-coated tablets | - | - | - | - | [1] 97 97 💬
|
| 2216 | XmAb942 | - | - | - | - | [1] 97 97 💬
|
| 2217 | Xylitol | [1] Xylitol Xylitol | [1] Xylitol
Xylitol
💬
| - | - | [3] 53 53, 97, 299 💬
|
| 2218 | Yeast | [1] Yeast Yeast | [1] Dried yeast
Dried yeast
💬
| - | - | [2] 97 97, 113 💬
|
| 2219 | Zasocitinib | [1] Zasocitinib Zasocitinib | [1] Zasocitinib
Zasocitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [2] 96 96, 97 💬
|
| 2220 | ZEPIOSA® (Ozanimod) | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 2221 | ZEPOSIA® (ozanimod) | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 2222 | ZEPOSIA® indicated for the treatment of: Relapsing forms of multiple sclerosis, and active ulcerative colitis in adults | - | - | - | - | [2] 13 13, 97 💬
|
| 2223 | Zessly | - | - | - | - | [2] 96 96, 97 💬
|
| 2224 | Zessly, Remsima, Remicade | - | - | - | - | [1] 97 97 💬
|
| 2225 | ZL-82 100mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2226 | ZL-82 12.5mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2227 | ZL-82 200mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2228 | ZL-82 25mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2229 | ZL-82 300mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2230 | ZL-82 450mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2231 | ZL-82 50mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2232 | ZL-82 600mg | - | - | - | - | [2] 46 46, 97 💬
|
| 2233 | Zoenasa-1:4 | - | - | - | - | [1] 97 97 💬
|
| 2234 | ZOL446 | - | - | - | - | [2] 97 97, 274 💬
|
| 2235 | Zoledronic acid | [1] Zoledronic acid Zoledronic acid | [5] Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [16] 5 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬
|
| 2236 | Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night | - | - | - | - | [1] 97 97 💬
|